Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
1
CURRICULUM VITAE
Biographical Data
Name: Dr. Elizabeth Ann Esterl, RN
________________________________________________________________________
Professional Objective
Transformation and Servant Nursing & Hospital Leadership, Research, and Education
_________________________________________________________________________
Education
2012-2015 Regis University
Denver, Colorado
Major- Doctor of Nursing Practice
Specialization- Advanced Leadership in Health Care
Graduation Honors: Graduate Honors
2000-2002 Regis University
Denver, Colorado
Major- Master of Science in Nursing
Specialization- Leadership in Healthcare Systems
Graduation Honors: Graduate Honors
1996-1997 Regis University
Denver, Colorado
Major- Bachelor of Science in Nursing
Graduation Honors: Summa Cum Laude
Elected to membership Sigma Theta Tau (1997) and
Alpha Sigma Nu (1997)
1981-1983 Arapahoe Community College
Littleton Colorado
Major – Associate of Arts Registered Nursing
1977-1981 Metropolitan State College
Denver, Colorado
Major - Liberal Arts
1975-1976 Dekalb Community College
Atlanta, Georgia
Certification
Certified Clinical Research Coordinator
Basic Life Support
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
2
Pediatric Advanced Life Support
PICC Line Insertion- expired
________________________________________________________________________
Membership
Sigma Theta Tau - Alpha Chapter at Large since 1997
Alpha Sigma Nu- since 1997
American Academy Allergy, Asthma, and Immunology
American Nurses Association
Colorado Nurses Association
Pediatric Nurses Association
Association of Clinical Research Professionals
Society of Clinical Research Administrators
________________________________________________________________________
Nursing License
State of Colorado Registered Nursing License - 76685
State of California Registered Nursing License- active
State of Oregon Registered Nursing License- active
State of Tennessee Registered Nursing License- expired
________________________________________________________________________
Professional Experience
2017-present Ignatian Faculty Scholars Program
Regis University
Denver, Colorado
Affiliated Faculty Scholar
2016-present Friendship Bridge Nursing Project- Vietnam.
Ho Chi Minh City, Vietnam
Visiting Professor- Nursing Research
2011-present National Jewish Health
Denver, Colorado
Senior Nursing Leadership
Pediatric Director- Inpatient, Outpatient, Triage, Offsite Clinics and Research
Projects
Principal Investigator- Clinical Research protocols
2003-present Regis University
Denver, Colorado
Clinical Faculty- Online and Traditional Classroom Undergraduate and
Graduate Nursing Program
2009-2014 University of Phoenix
Denver, Colorado
Clinical Faculty- Online Graduate Nursing Research Program
2011-2011 iC42 Laboratory
Aurora, Colorado
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
3
Business Manager, Clinical Research Operations Consultant
1997-2011 The Children’s Hospital
Denver, Colorado
Director - Clinical Trials Organization
1988-1997 National Jewish Medical and Research Center
Denver, Colorado
Program Coordinator - Immunology Infusion Room
Program Coordinator - Pediatric Clinical Trials Program
1988 University Hospital
Denver, Colorado
R.N. - Pediatric Medical Unit
Charge Nurse
1987 University of California Davis Medical Center
Sacramento, California
R.N. - Level II Nursery
1984-1987 The Children’s Hospital
Denver, Colorado
R.N. III - Pediatric Medical-Surgical Unit
Home Health
Level II Nursery
Charge Nurse
Graduate Nurse Preceptor
1983 LeBonheur Children’s Medical Center
Memphis, Tennessee
Pediatric Nurse Internship Program
_____________________________________________________________________________________
Research
Research National Jewish Medical and Research Center Denver, Colorado
1991
OPEN LABEL STUDY OF HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN IN
SEVERE CHILDHOOD ASTHMA. SANDOZ PHARMACEUTICALS.
1991
OPEN LABEL TRIAL OF HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN IN
SEVERE ADULT ATOPIC DERMATITIS. SANDOZ PHARMACEUTICALS.
1993
THE USE OF INTRAVENOUS IMMUNOGLOBULIN IN ADULTS AND PEDIATRIC
STEROID DEPENDENT ASTHMATICS. MILES INC.
1995
DOUBLE BLIND IVIG STUDY AND HYPOGAMMAGLOBULINEMIA PATIENTS.
CENTEON.
1995
DOUBLE BLIND, DOSE RANGING STUDY COMPARING PRODUCTS IN
TREATMENT OF ASTHMA IN CHILDREN. RHONE-POULEC RORER
PHARMACEUTICALS, INC.
1995
DOUBLE BLIND, RANDOMIZED, PARALLEL GROUP STUDY COMPARING
PRODUCT TO PLACEBO IN CHILDREN WITH CHRONIC ASTHMA. MERCK &
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
4
CO.
1995
PREDNISONE PRODUCT COMPARISON STUDY. DURA PHARMACEUTICALS.
1996
A PILOT STUDY ON THE MECHANISMS UNDERLYING STEROID REDUCTION IN
SEVERE ASTHMATICS TREATED WITH IVIG. BAYER PHARMACEUTICALS.
1996
A RANDOMIZED, DOUBLE BLIND, PARALLEL GROUP CLINICAL TRIAL
ASSESSING THE SAFETY AND EFFICACY OF ALBUTEROL POWDER VS.
AEROSOL VS. INHALER VS. PLACEBO IN CHILDREN. GLAXO WELLCOME INC.
1996
MULTICENTERED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO
EVALUATE THE SAFETY AND EFFICACY OF ANTI IGE RECOMBINANT
HUMANIZED MONOCLONAL ANTIBODY. GENENTECH.
1996
MULTICENTERED, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED,
PARALLEL GROUP STUDY OF THE SAFETY AND EFFICACY OF LOW DOSE
ALBUTEROL SOLUTION IN CHILDREN. DEY LABORATORIES.
1997
A COMPARISON STUDY OF BECLOMETHASONE DIPROPIONATE VS PLACEBO
IN PEDIATRIC PATIENTS WITH SYMPTOMATIC ASTHMA. 3M
PHARMACEUTICALS, INC.
Research Clinical trials Organization at The Children’s Hospital- Denver, Colorado
2008 A 12-MONTH OPEN-LABEL EXTENSION STUDY EVALUATING THE
SAFETY AND TOLERABILITY OF FLEXIBLE DOSES OF PREGABALIN IN
PEDIATRIC PATIENTS WITH PARTIAL ONSET SEIZURES PROTOCOL
NUMBER: A0081075
2008 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER STUDY TO
COMPARE THE EFFICACY AND SAFETY OF MICAFUNGIN VERSUS
AMPHOTERICIN B DEOXYCHOLATE FOR THE TREATMENT OF
NEONATAL CANDIDIASIS. PROTOCOL 04-0-199
2008 AN OPEN-LABEL SAFETY AND TOLERABILITY STUDY OF
IMMEDIATE-RELEASE AND EXTENDED-RELEASE OXYMORPHONE IN
OPIOID-TOLERANT PEDIATRIC SUBJECTS WITH CHRONIC PAIN -
STUDY EN3202-036
2008 AN OPEN-LABEL, ASCENDING, TWO-PART, SINGLE- AND MULTIPLE-
DOSE EVALUATION OF THE SAFETY, PHARMACOKINETICS, AND
EFFECTIVENESS OF OXYMORPHONE FOR ACUTE POSTOPERATIVE
PAIN IN PEDIATRIC SUBJECTS
2008 GENETIC EPIDEMIOLOGY OF LIFE-THREATENING INFLUENZA
INFECTION IN CHILDREN AND YOUNG ADULTS
2008 LONGITUDINAL STUDY OF MITOCHONDRIAL HEPATOPATHY
2008 PHARMACOGENOMICS IN PULMONARY ARTERIAL HYPERTENSION
2008 PHASE II/III DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED,
CLINICAL TRIAL TO DETERMINE THE SAFETY AND EFFICACY OF
INTRAVENOUS L-CITRULLINE VERSUS PLACEBO IN CHILDREN
UNDERGOING CARDIOPULMONARY BYPASS
2008 TRIAL OF BETA BLOCKER THERAPY (ATENOLOL) VS. ANGIOTENSIN II
RECEPTOR BLOCKER THERAPY (LOSARTAN) IN INDIVIDUALS WITH
MARFAN SYNDROME. PROTOCOL NO. AGO/2006/009
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
5
13-Jul-99 A PROSPECTIVE, LONGITUDINAL STUDY OF CHILDHOOD
PULMONARY HYPERTENSION
11-Feb-00 A DOUBLE-BLIND, PLACEBO-CONTROLLED, VIROLOGIC EFFICACY
TRIAL OF PLECONARIL (VP63843) IN THE TREATMENT OF NEONATES
WITH EV SEPSIS SYNDROME (PROTOCOL VERSION 5.0/REVISED DATE
04-07-2006)
25-Apr-00 COLCHICINE THERAPY IN CHILDHOOD CIRRHOSIS
01-May-00 MAGNESIUM AND METABOLIC BONE DISEASE IN CHRONIC LIVER
DISEASE
17-May-00 A MULTICENTER GROUP TO STUDY ACUTE LIVER FAILURE
17-Jul-03 STUDIES IN PEDIATRIC LIVER TRANSPLANTATION (SPLIT)
11-Sep-03 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND PLACEBO-
CONTROLLED STUDY TO TEST THE SAFETY AND EFFICACY OF
LIPITOR (ATORVASTATIN) IN REDUCING THE PROGRESSION OF
CAROTID IMT IN EARLY CHILDHOOD SLE. THE ATHEROSCLEROSIS
PREVENTION IN PEDIATRIC LUPUS ERYTHEMATOSUS (APPLE)STUDY.
17-Oct-03 A MULTI-CENTER STUDY OF THE SAFETY AND EFFICACY OF N-
ACETYLCYSTEINE IN THE TREATMENT OF ACUTE LIVER FAILURE
NOT CAUSED BY ACETAMINOPHEN IN PEDIATRIC PATIENTS
22-Oct-03 ASSESSMENT OF INTER-OBSERVER VARIABILITY IN THE
HISTOLOGICAL DIAGNOSIS OF INFANTILE CHOLESTASIS
09-Dec-03 A RETROSPECTIVE STUDY OF BILIARY ATRESIA PATIENTS UP TO 2
YEARS OF AGE
23-Apr-04 A MULTICENTER, LONG-TERM EXTENSION STUDY TO ASSESS
SAFETY OF ORAL SILDENAFIL IN THE TREATMENT OF SUBJECTS
WHO HAVE COMPLETED STUDY A1481131 - (PROTOCOL # A1481156-
1005)
11-May-04 BILIARY ATRESIA CLINICAL RESEARCH CONSORTIUM (BARC): A
PROSPECTIVE DATABASE OF INFANTS WITH CHOLESTASIS
30-Jun-04 PEGYLATED INTERFERON +/- RIBAVIRIN FOR CHILDREN WITH HCV
12-Aug-04 CHILDHOOD ABSENCE EPILEPSY RX, PK-PD-PHARMACOGENETICS
07-Dec-04 MANAGEMENT OF HIV-INFECTED PREGNANT WOMEN
20-Jul-05 A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL
OF CORTICOSTEROID THERAPY FOLLOWING PORTOENTEROSTOMY
IN INFANTS WITH BILIARY ATRESIA
16-Sep-05 FUNCTIONAL OUTCOMES IN PEDIATRIC LIVER TRANSPLANT
25-Oct-05 AN OPEN-LABEL, LONG-TERM, SAFETY, AND TOLERABILITY
EXTENSION STUDY USING THE PEDIATRIC FORMULATION OF
BOSENTAN IN THE TREATMENT OF CHILDREN WITH IDIOPATHIC OR
FAMILIAL PULMONARY ARTERIAL HYPERTENSION WHO
COMPLETED FUTURE 1: FUTURE 2 AC-052-367
07-Feb-06 A PHASE III, OPEN-LABEL, NON-RANDOMIZED, INTERNATIONAL,
MULTICENTER TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF
CARDIOLITE MYOCARDIAL PERFUSION IMAGING IN PEDIATRIC
SUBJECTS WITH KAWASAKI DISEASE
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
6
22-Feb-06 RETROSPECTIVE LUNG BIOPSY PATHOLOGY REVIEW WITH IMAGING
AND CLINICAL CORRELATION FOR CHILDREN AGES 2-18 WITH
DIFFUSE LUNG DISEASE
12-Apr-06 A 16-WEEK, INTERNATIONAL, MULTICENTER, DOUBLE-BLIND,
RANDOMIZED, PLACEBO-CONTROLLED COMPARISON OF THE
EFFICACY AND SAFETY OF ORAL UT-15C SUSTAINED RELEASE
TABLETS IN COMBINATION WITH AN ENDOTHELIN RECEPTOR
ANTAGONIST AND/OR A PHOSPHODIESTERASE-5 INHIBITOR IN
SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION PROTOCOL
NUMBER: TDE-PH-301
12-Apr-06 AN OPEN-LABEL EXTENSION TRIAL OF UT-15C SR IN SUBJECTS WITH
PULMONARY ARTERIAL HYPERTENSION PROTOCOL NUMBER: TDE-
PH-304
14-Jul-06 BILIARY ATRESIA STUDY IN INFANTS AND CHILDREN (BASIC) -
SPONSOR PROJECT NUMBER P005
18-Aug-06 TREATMENT OF CLOGGED TYMPANOSTOMY TUBES: AN OFF-LABEL
USE OF DORNASE ALFA (PULMOZYME) STUDY NUMBER Z3816S
15-Sep-06 A MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED
RANDOMIZED, EFFICACY AND SAFETY STUDY OF DENUFOSOL
TETRASODIUM (INS37217) INHALATION SOLUTION IN PATIENTS WITH
MILD CYSTIC FIBROSIS LUNG DISEASE.
12-Jan-07 A PHARMACOKINETIC/ PHARMACODYNAMIC AND SAFETY
EVALUATION OF OSELTAMIVIR (TAMIFLU) FOR THE TREATMENT OF
CHILDREN LESS THAN 24 MONTHS OF AGE WITH CONFIRMED
INFLUENZA INFECTION (CASG 114) DMID PROTOCOL NUMBER 06-
0059, ROCHE PROTOCOL NUMBER: WP-20749
14-Mar-07 INTERNATIONAL, RANDOMIZED, DOUBLE BLIND CLINICAL STUDY
EVALUATING THE EFFICACY AND SAFETY OF CLOPIDOGREL
0.2MG/KG ONCE DAILY VERSES PLACEBO IN NEONATES AND
INFANTS WITH CYANOTIC CONGENTIAL HEART DISEASE PALLIATED
WITH A SYSTEMIC-TO-PULMONARY ARTERY SHUNT (I.E. MODIFIED
BLALOCK TAUSSIG SHUNT) PROTOCOL NO. EFC5314
21-Mar-07 A PHASE 3, OPEN-LABEL, RANDOMIZED, PARALLEL-GROUP, MULTI-
CENTER STUDY TO EVALUATE THE SAFETY AND IMMUNOGENICITY
OF NOVARTIS MENINGOCOCCAL ACWY CONJUGATE VACCINE WHEN
ADMINISTERED WITH ROUTINE INFANT VACCINATIONS TO
HEALTHY INFANTS PROTOCOL V59P14, INFANTS - US
06-Apr-07 A MULTI-CENTER, DOUBLE BLIND STUDY TO EVALUATE THE
SAFETY, EFFICACY AND PHARMACOKINETICS OF THE HUMAN ANTI-
TNF MONOCLONAL ANTIBODY ADALIMUMAB IN PEDIATRIC
SUBJECTS WITH MODERATE TO SEVERE CROHN'S DISEASE
17-May-07 A MULTICENTER, PROSPECTIVE, LONG-TERM, OBSERVATIONAL
REGISTRY OF PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL
DISEASE
19-Sep-07 A LONG-TERM SAFETY STUDY OF A COMBINATION PRODUCT
CONTAINING SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM
FOR THE TREATMENT OF MIGRAINE IN ADOLESCENTS
29-Sep-07 LONGITUDINAL STUDY OF GENETIC CAUSES OF INTRAHEPATIC
CHOLESTASIS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
7
05-Oct-07 A PHASE 1, OPEN-LABEL STUDY OF THE SAFETY AND
PHARMACOKINETICS OF REPEATED-DOSE MICAFUNGIN AS
ANTIFUNGAL PROPHYLAXIS IN CHILDREN AND ADOLESCENTS
UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
08-Nov-07 STUDIES OF PRIMARY SCLEROSING CHOLANGITIS (STOPSC)
14-Dec-07 A PHASE III, RANDOMIZED, PLACEBO-CONTROLLED, BLINDED
INVESTIGATION OF SIX WEEKS VS. SIX MONTHS OF ORAL
VALGANCICLOVIR THERAPY IN INFANTS WITH SYMPTOMATIC
CONGENITAL CYTOMEGALOVIRUS INFECTION (CASG 112)
02-Jan-08 PILOT STUDY TO DEFINE NUTRITIONAL INTERRELATIONSHIPS OF
CO-ENZYME Q10, RIBOFLAVIN AND MAGNESIUM IN THE
EVALUATION AND TREATMENT OF CHILDHOOD MIGRAINE
HEADACHES.
21-Mar-08 A PHASE 3, INTERNATIONAL, MULTI-CENTER, RANDOMIZED,
DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP
EFFICACY AND SAFETY STUDY OF DENUFOSOL TETRASODIUM
INHALATION SOLUTION IN PATIENTS WITH CYSTIC FIBROSIS LUNG
DISEASE AND FEV1 GREATER THAT 75% PREDICTED A PHASE 3,
INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND,
PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY
STUDY OF DENUFOSOL TETRASODIUM INHALATION SOLUTION IN
PATIENTS WITH CYSTIC FIBROSIS LUNG DISEASE AND FEV1
GREATER THAN 75% PREDICTED
25-Mar-08 A MULTICENTER INTERNATIONAL STUDY OF THE LONG-TERM
SAFETY OF INFLIXIMAB (REMICADE) IN ULCERATIVE COLITIS -
PROTOCOL C0168T62
27-Mar-08 DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY
STUDY OF CLOBAZAM (0.25, 0.5 AND 1.0 MG/KG/DAY) IN PATIENTS
WITH LENNOX-GASTAUT SYNDROME PROTOCOL NUMBER: OV-1012
WIRB #: 20071216
28-Mar-08 A PHASE 2, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP,
MULTICENTER TRIAL TO EVALUTE THE SAFETY AND EFFICACY OF
INFLIXIMAB (REMICADE) IN PEDIATRIC SUBJECTS WITH
MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS -
PROTOCOL C0168T72
03-Apr-08 SAFETY AND EFFECTIVENESS OF OPEN-LABEL CLOBAZAM IN
SUBJECTS WITH LENNOX-GASTAUT SYNDROME. PROTOCOL OV-1004
24-Apr-08 SAFETY AND EFFICACY OF EXENATIDE AS MONOTHERAPY AND
ADJUNCTIVE THERAPY TO ORAL ANTIDIABETIC AGENTS IN
ADOLESCENTS WITH TYPE 2 DIABETES.
25-Apr-08 AN EFFICACY AND SAFETY STUDY OF RESLIZUMAB (CTX55700) IN
THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS IN SUBJECTS AGED
5 TO 18 YEARS
14-May-08 COLORADO CLINICAL TRANSLATIONAL SCIENCE INSTITUTE (CCTSI)
28-May-08 A PHASE 2B EFFICACY AND SAFETY STUDY OF PTC124 IN SUBJECTS
WITH NONSENSE-MUTATION- MEDIATED DUCHENNE AND BECKER
MUSCULAR DYSTROPHY
02-Jun-08 GORE HELEX™ SEPTAL OCCLUDER POST APPROVAL STUDY
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
8
18-Jun-08 A PLACEBO-CONTROLLED, ESCALATING DOSE, MULTIPLE DOSE
STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND
PHARMACOKINETICS OF PREGABALIN IN PEDIATRIC PATIENTS WITH
PARTIAL ONSET SEIZURES PROTOCOL NUMBER: A0081074
25-Jul-08 TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND
YOUTH (TODAY): GENETICS STUDY
25-Aug-08 HMP 4009: A MULTICENTER, INPATIENT, OPEN-LABEL, WITHIN
SUBJECT DOSE TITRATION STUDY TO CHARACTERIZE THE
PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND
EFFICACY OF HYDROMORPHONE HCL ORAL SOLUTION IN SUBJECTS
FROM 28 DAYS TO 16 YEARS OF AGE, INCLUSIVE, WHO REQUIRE
OPIOID ANALGESICS FOR POST-OPERATIVE PAIN
26-Aug-08 PEDIATRIC FUNGAL NETWORK DATABASE
26-Sep-08 AN OPEN-LABEL SAFETY AND EFFICACY STUDY OF RESLIZUMAB
(CTX55700) FOR THE TREATMENT OF PEDIATRIC SUBJECTS WITH
EOSINOPHILIC ESOPHAGITIS WHO COMPLETED STUDY RES-5-0002
(PROTOCOL RES-5-0004) WIRB #: 20080586
15-Oct-08 RSV AND PIV3 IMMUNOLOGY PILOT
21-Nov-08 ORAL VISCOUS BUDESONIDE SUSPENSION (MB-7) IN SUBJECTS WITH
EOSINOPHILIC ESOPHAGITIS: A RANDOMIZED, PLACEBO-
CONTROLLED, DOSE-RANGING STUDY IN CHILDREN AND
ADOLESCENTS WIRB #: 20081925
25-Nov-08 PHARMACOKINETICS AND SAFETY OF AMBRISENTAN IN CHILDREN
WITH PULMONARY ARTERIAL HYPERTENSION
03-Dec-08 PILOT STUDY FOR BIOMARKERS FOR SPINAL MUSCULAR ATROPHY
09-Mar-99 TELEPHONE SURVEY OF PARENTS CALLING AN AFTER-HOURS CALL
CENTER
14-Jul-99 SICKLE CELL DISEASE AND OBSTRUCTIVE SLEEP APNEA
23-Aug-99 FILGRASTIM-MOBILIZED PERIPHERAL BLOOD STEM CELLS FOR
PRIMARY ALLOGENEIC TRANSPLANTATION WITH UNRELATED
DONORS
11-Nov-99 THE LONG TERM SAFETY AND EFFICACY OF RISPERIDAL IN
CONDUCT DISORDER IN MILD MODERATE, AND BORDERLINE
MENTALLY RETARDED CHILDREN AGED 5-14 YEARS
11-Nov-99 A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-
CONTROLLED, PARALLEL STUDY OF THE SAFETY AND EFFICACY OF
BOTOX (BOTULINUM TOXIN TYPE A) PURIFIED NEUROTOXIN
COMPLEX FOR THE TREATMENT OF INCREASED MUSCLE TONE OF
THE LOWER LIMB RESULTING IN ABNORMAL GAIT ASSOCIATED
WITH PEDIATRIC CEREBRAL PALSY
15-Nov-99 EVALUATION OF ENROLLMENT INTO THE COLORADO CHILD
HEALTH PLAN
17-Nov-99 A MULTI-CENTER, OPEN LABEL STUDY OF THE EFFICACY AND
SAFETY OF EXISULIND AT THE HIGHEST TOLERATED DOSE IN
PEDIATRIC PATIENTS WITH INTACT COLONS AND A DIAGNOSIS OF
ADENOMATOUS POLYPOSIS COLI (APC)
17-Nov-99 A STUDY OF THE SAFETY, TOLERANCE AND EFFICACY OF
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
9
PALIVIZUMAB (MEDI-493, SYNAGIS) FOR PROPHYLAXIS OF
RESPIRATORY SYNCYTIAL VIRUS IN CHILDREN WITH CONGENITAL
HEART DISEASE
18-Nov-99 AN OPEN-LABEL, NON-COMPARATIVE STUDY OF FK463 FOR THE
TREATMENT OF INVASIVE ASPERGILLOSIS
18-Nov-99 ASSESSING THE SAFETY AND EFFICACY OF DIASTAT (DIAZEPAM
RECTAL GEL) FOR THE TREATMENT OF FEBRILE SEIZURES
22-Nov-99 SURVEY OF HOSPITAL POLICIES AND PROCEDURES FOR NEONATAL
HEPATITIS B VACCINE
22-Nov-99 CELL-MEDIATED IMMUNE FUNCTION IN HIV INFECTED PATIENTS
COMPARED WITH UNINFECTED CONTROLS
23-Nov-99 ADOLESCENT ATTITUDES ABOUT PREGNANCY
23-Nov-99 THE EFFECT OF RECOMBINANT HUMAN GROWTH HORMONE
TREATMENT ON THE GROWTH OF INFANTS AND TODDLERS WITH
TURNER SYNDROME
24-Nov-99 OPEN-LABEL, MULTICENTER TRIAL TO EVALUATE THE SAFETY AND
IMMUNOGENICITY OF A FIFTH CONSECUTIVE DOSE (BOOSTER) OF
CERTIVA IN HEALTHY CHILDREN
24-Nov-99 AN OPEN-LABEL, NON-COMPARATIVE STUDY OF FK463 FOR THE
TREATMENT OF CANDIDEMIA OR INVASIVE CANDIDIASIS
26-Nov-99 VALACYCLOVIR FOR THE TREATMENT OF HERPES ZOSTER IN
IMMUNOCOMPROMISED CHILDREN
26-Nov-99 VALIDATION OF AN INNOVATIVE CLOSED DRUG DELIVERY SYSTEM
IN CRITICALLY ILL NEONATES: EFFECT ON SEPSIS RATES AND DRUG
STABILITY
30-Nov-99 AN EVALUATION OF THE PERFORMANCE OF THE CARDIOSEAL
STARFLEX SEPTAL OCCLUSION SYSTEM IN PATIENTS WITH
SECUNDUM ATRIAL SEPTAL DEFECT (ASD)
30-Nov-99 MANAGING INFANT IRRITABILITY: A CLINICAL TRIAL
01-Dec-99 THE EFFECTIVENESS OF SCHOOL-BASED SUPPORT GROUPS FOR
ADOLESCENTS WITH AN ADDICTIVE PARENT
06-Dec-99 EFFECT OF INTENSIVE EPILEPSY TREATMENT ON HEALTH-RELATED
QUALITY OF LIFE IN CHILDREN WITH MEDICALLY UNCONTROLLED
EPILEPSY
07-Dec-99 DEVELOPMENT OF AN INTELLIGENT PHONCARDIOGRAPHIC
SCREENING DEVICE - USING ADVANCED SIGNAL PROCESSING &
NEURAL NETWORKS
08-Dec-99 A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MONOTHERAPY
STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO DOSES OF
TOPIRAMATE IN THE TREATMENT OF NEWLY DIAGNOSED OR
RECURRENT EPILEPSY
10-Dec-99 LATE STEROID RESCUE STUDY (LASRS) VERSION IV: THE EFFICACY
OF CORTICOSTEROIDS AS RESCUE THERAPY FOR THE LATE PHASE
OF ACUTE RESPIRATORY DISTRESS SYNDROME
10-Dec-99 PROSPECTIVE MULTIDISCIPLINARY ASSESSMENT OF NUTRITION
AND HEALTH-RELATED QUALITY OF LIFE CHANGES IN CHILDREN
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
10
WITH REFRACTORY EPILEPSY TREATED WITH THE KETOGENIC DIET
20-Dec-99 AN OPEN, INTRAVENOUS STUDY TO EVALUATE THE PLASMA
CONCENTRATION PROFILES OF MK-0826 IN PATIENTS AGED 3
MONTHS THROUGH 17 YEARS
20-Dec-99 A MULTICENTER, PLACEBO-CONTROLLED, 8-MONTH STUDY OF THE
EFFECT OF TWICE DAILY CARVEDILOL IN CHILDREN WITH
CONGESTIVE HEART FAILURE DUE TO SYSTEMIC VENTRICULAR
SYSTOLIC DYSFUNCTION
20-Dec-99 EVALUTION OF PROJECT ENRICH'S HOME ACTIVITY AND PLAY
INTERVENTION
21-Dec-99 CARDIOSEAL SEPTAL OCCLUDER SYSTEM FOR PATIENTS WITH
VENTRICULAR SEPTAL DEFECT OR FENESTRATED FONTAN
PROCEDURE UNDER HUMANITARIAN DEVICE EXEMPTION
22-Dec-99 A MULTICENTER STUDY TO EVALUATE THE PHARMACOKINETICS,
DOSE-RESPONSE, EFFICACY, AND SAFETY OF BENAZEPRIL IN
PEDIATRIC SUBJECTS
27-Dec-99 COMMUNITY HEALTH NETWORK CHILDHOOD IMMUNIZATION
STUDY--POLIOVIRUS ANTIBODY SEROSURVEILLANCE
27-Dec-99 THE EFFECTS OF SECRETIN ON SYMPTOMS OF AUTISM
27-Dec-99 NUC30926, AN EXTENDED STRATIFIED FOLLOW-ON STUDY IN
PEDIATRIC SUBJECTS WITH CHRONIC HEPATITIS B WHO HAVE
COMPLETED PREVIOUS LAMIVUDINE STUDIES
29-Dec-99 AN INTERNATIONAL, MULTICENTER, UNCONTROLLED, OPEN
EVALUATION OF CHRONIC UT-15 PLUS CONVENTIONAL THERAPY IN
PATIENTS WITH PULMONARY HYPERTENSION: A CONTINUATION
STUDY
29-Dec-99 EFFECT OF TOPIRAMATE ON SPIKE WAVE ACTIVITY ON THE EEG IN
PATIENTS WITH PRIMARY GENERALIZED EPILIPSY
30-Dec-99 COMPUTER AND LABORATORY MODELING OF THE HEART WITH
CLINICAL VALIDATION
04-Jan-00 METABOLIC AND IMMUNOGENETIC EVALUATION OF RELATIVES OF
PATIENTS WITH TYPE I DIABETES EXPRESSING "BIOCHEMICAL"
ANTI-ISLET AUTOANTIBODIES
07-Jan-00 ACTG316-(VERSION 4) A PHASE III RANDOMIZED, BLINDED STUDY OF
NEVIRAPINE VS NEVIRAPINE PLACEBO FOR THE PREVENTION OF
MATERNAL-FETAL TRANSMISSION IN PREGNANT HIV-INFECTED
WOMEN WHO PRESENT DURING THE THIRD TRIMESTER OF
PREGANCY
10-Jan-00 GENOTYPE PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIES
10-Jan-00 VAGINAL DOUCHING IN ADOLESCENTS
10-Jan-00 TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS WITH
PAMIDRONATE IN CHILDREN AND ADOLESCENTS WITH SEVERE
ASTHMA
13-Jan-00 THE HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY
14-Jan-00 NITRIC OXIDE, NITRIC OXIDE METABOLITES, AND EXPRESSION OF
INDUCIBLE NITRIC OXIDE SYNTHASE IN THE AIRWAYS OF INFANTS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
11
AND CHILDREN WITH CYSTIC FIBROSIS
14-Jan-00 THE USE OF HOME OXYGEN IN THE OUTPATIENT MANAGEMENT OF
BRONCHIOLITIS COMPLICATED BY HYPOXIA
14-Jan-00 MOLECULAR EXPRESSION OF THE FRAGILE X GENE
14-Jan-00 A MULTICENTER, RANDOMIZED, SINGLE-BLIND,
PHARMACOKINETICS AND PHARMACODYNAMICS STUDY TO
EVALUATE SINGLE AND MULTIPLE DOSES OF OMEPRAZOLE IN A
PEDIATRIC POPULATION AGES 0 MONTHS-24 MONTHS, INCLUSIVE
14-Jan-00 DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL OF VITAMIN E AS
ADD-ON THERAPY FOR CHILDREN WITH EPILEPSY
17-Jan-00 OPEN-LABEL, NON-RANDOMIZED STUDY OF THE MIDDLE EAR FLUID
PENETRATION OF GATIFLOXACIN IN CHILDREN UNDERGOING
TYMPANOSTOMY TUBE PLACEMENT
17-Jan-00 A PHASE 111 PRETRANSPLANT B43-PAP IMMUNOTOXIN THERAPY IN
CHILDREN WITH POOR PROGNOSIS B-LINEAGE ACUTE
LYMPHOBLASTIC LEUKEMIA UNDERGOING BONE MARROW
TRANSPLANTATION
20-Jan-00 A MULTICENTER, LONGITUDINAL FOLLOW-UP OF PATIENTS WITH
CYSTIC FIBROSIS TO EVALUATE BREATHING FUNCTION, THE RATE
OF RESPIRATORY TRACT INFECTION AND THE SAFETY OF LONG-
TERM TREATMENT WITH PULMOZYME(PROTOCOL#Z0595N)
20-Jan-00 PULMONARY FUNCTION IN INFANTS WITH CYSTIC FIBROSIS
20-Jan-00 P1008 AN OBSERVATIONAL STUDY OF THE RATE OF OPPORTUNISTIC
INFECTIONS EVENTS IN HIV-INFECTED CHILDREN WHO HAVE
DEMONSTRATED IMMUNOLOGIC RECONSTITUTION AND WHO HAVE
DISCONTINUED OI PROPHYLAXIS
21-Jan-00 PORTABLE KERATOMETRY: EFFECT OF DIFFERENT LID SPECULA IN
PEDIATRIC PATIENTS UNDER GENERAL ANESTHESIA
21-Jan-00 PACTG 391- USE OF A LIVE-ATTENUATED VARICELLA-ZOSTER VIRUS
(VZV) VACCINE TO BOOST IMMUNITY TO VZV IN HIV-INFECTED
CHILDREN PREVIOUSLY INFECTED WITH VARICELLA (VERSION 3.0)
24-Jan-00 SERUM AMINO ACID CONCENTRATIONS AND NUTRITIONAL STATUS
IN CHILDREN WITH SICKLE CELL DISEASE
26-Jan-00 CHARACTERIZATION OF CHROMOSOME 8P23.1 BREAKPOINTS
26-Jan-00 MELATONIN AND SLEEP STUDIES WITH CHILDREN WITH
DEVELOPMENTAL DISABILITIES
27-Jan-00 PACTG 265 V 4.0 - PHASE I/II STUDY OF SAFETY AND
IMMUNOGENICITY OF LIVE-ATTENUATED VARICELLA VACCINE
(VARIVAX) IN HIV-INFECTED CHILDREN
03-Feb-00 MEASUREMENT OF METABOLIC SUBSTRATE TURNOVER RATES &
INTERCONVERSION RATES IN LOW BIRTH WEIGHT INFANTS
04-Feb-00 PEDIATRIC LATE OUTCOMES PROTOCOL (ACTG 219C)
07-Feb-00 CULTURE AND DEVELOPMENT IN CHILDREN AGES 0-3 IN ONE INDIAN
TRIBE
07-Feb-00 A DESCRIPTIVE STUDY ON THE USE OF A PEDIATRIC TREATMENT
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
12
ROOM
08-Feb-00 VAGUS NERVE STIMULATION PATIENT REGISTRY
09-Feb-00 MULTICENTER TRIAL OF SYNSORB PK IN E. COLI RELATED
HEMOLYTIC UREMIC SYNDROME
09-Feb-00 PHASE I/II STUDY OF RITONAVIR THERAPY IN HIV-I INFECTED
INFANTS AND CHILDREN ACTG-345 (VERSION 3.0)
10-Feb-00 EVALUATION OF COMPASSIONATE USE OF THE CARDIOSEAL DEVICE
SEPTAL OCCLUSION SYSTEM
10-Feb-00 RECOMBINANT 8 SYNDROME: EXTENDING LABORATORY RESEARCH
TO AN AT-RISK POPULATION
11-Feb-00 A DOUBLE-BLIND, PLACEBO-CONTROLLED, VIROLOGIC EFFICACY
TRIAL OF PLECONARIL (VP63843) IN THE TREATMENT OF INFANTS
WITH ENTEROVIRAL MENINGITIS (PROTOCOL VERSION 3.0/REVISED
DATE 5/15/00)
11-Feb-00 NASAL POTENTIAL DIFFERENCE MEASUREMENTS IN PATIENTS WITH
CYSTIC FIBROSIS AND NORMAL INDIVIDUALS
11-Feb-00 PERTUSSIS VACCINE EFFECTIVENESS STUDY
11-Feb-00 A RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF AN
INCREASE CALORIC DENSITY INFANT FORMULA AND ITS EFFECT ON
GROWTH AND NUTRITIONAL STATUS IN HIV-INFECTED INFANTS
(ACTG 247 VERSION 2.0)
11-Feb-00 TOBRAMYCIN IN YOUNG CYSTIC FIBROSIS PATIENTS
14-Feb-00 AN INQUIRY INTO THE UNDERSTANDING OF MATERNAL PKU IN
HYPERPHENYLALANEMIC WOMEN
18-Feb-00 DOES IV LOADING IMPROVE EFFICACY OF ORAL AZATHIOPRINE IN
TREATING CHILDREN WITH INFLAMMATORY BOWEL DISEASE
18-Feb-00 A STUDY TO INVESTIGATE USE OF NASAL NITIRIC OXIDE IN THE
TREATMENT OF PULMONARY HYPERTENSION IN PEDIATRIC
PATIENTS
23-Feb-00 AN OPEN-LABEL, MULTICENTER, NON-COMPARATIVE STUDY OF
GATIFLOXACIN IN THE TREATMENT OF RECURRENT OTITIS MEDIA
IN CHILDREN - PROTOCOL #AI420-076
23-Feb-00 INDENTIFICATION OF CHILDREN IN NEED OF REFERRAL FOR PART C
SERVICES
24-Feb-00 FAMILY-CENTERED CARE IN A NICU SETTING; FAMILY/PARENT
EXPECTATIONS AND PERCEPTIONS OF THEIR INFANT'S CARE IN AN
URBAN PEDIATRIC HOSPITAL
24-Feb-00 HUMAN PRIMARY VASCULAR SMOOTH MUSCLE CELL CULTURE
24-Feb-00 BLOOD DRAW FOR PRE-CLINICAL IMMUNOTHERAPY LABORATORY
INVESTIGATIONS
25-Feb-00 A CONTROLLED RANDOMIZED, PATIENT-MASKED PHASE II STUDY
TO EVALUATE THE SAFETY AND EFFICACY OF TOPICAL CIPRO DEX
(CIPROFLOXACIN 0.3%, DEXAMETHASONE 0.1%) SUSPENSION
COMPARED TO CILOXAN (CIPROFLOXACIN 0.3%) SOLUTION IN THE
TREATMENT OF ACUTE OTITIS MEDIA WITH TYMPANOSTOMY TUBES
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
13
(AOMT)
28-Feb-00 A SURVEY TO MEASURE ATTITUDES OF PATIENTS WITH CYSTIC
FIBROSIS REGARDING PERCUTANEOUS ENDOSCOPIC GASTROSTOMY
(PEG) TUBES
28-Feb-00 A STUDY TO ASSESS THE SAFETY, DOSE CONVERSION AND
TITRATION OF DURAGESIC (FENTANYL TRANSDERMAL SYSTEM) IN
PEDIATRIC SUBJECTS WITH CHRONIC PAIN REQUIRING OPIOID
THERAPY
29-Feb-00 A MULTICENTER, INTERNATIONAL, RANDOMIZED, PLACEBO-
CONTROLLED, DOUBLE-BLIND STUDY TO DETERMINE THE EFFECT
OF PULMOZYME ON PULMONARY FUNCTION OVER 96 WEEKS IN
SUBJECTS WITH CYSTIC FIBROSIS AGED 6-10 YEARS (PROTOCOL
Z0713G)
29-Feb-00 THE EFFECTS OF EXOGENOUS INSULIN ON PROTEIN METABOLISM IN
EXTREMELY LOW BIRTH WEIGHT INFANTS
02-Mar-00 CCC B947 - A GROUPWIDE PROTOCOL FOR COLLECTING AND
BANKING TUMOR SPECIMENS
02-Mar-00 THE COLORADO ADOLESCENT MATERNITY PROJECT- SISTERS
PROGRAM
06-Mar-00 DEVELOPMENTALLY-BASED MEDICATION INSTRUCTION
06-Mar-00 EFFECTS OF PUPILLARY DILATION AND CYCLOPLEGIA ON
INTRAOCULAR PRESSURE IN A PEDIATRIC POPULATION
08-Mar-00 THE EFFECTS OF HOME VISITS ON MEDICATION ADHERENCE IN
CHILDREN AND YOUTH WITH HIV.
08-Mar-00 EFFECT OF NICOTINE AND RELATED ALKALOIDS ON CELL CYCLE
(A.K.A. EFFECT OF NICOTINE AND ITS MAJOR METABOLITIES ON THE
LYMPHOCYTE CELL CYCLE)
09-Mar-00 THREE DIMENSIONAL ULTRASOUND METHODS FOR AORTIC
STENOSIS: IN VITRO AND PROSPECTIVE CLINICAL STUDY
13-Mar-00 COMPARISON OF TWO DIFFERENT TECHNIQUES OF SPUTUM
INDUCTION TO INVESTIGATE AIRWAY INFLAMMATION AND
INFECTION IN CYSTIC FIBROSIS
13-Mar-00 CCG 1952 RANDOMIZED COMPARISON OF ORAL MERCAPTOPURINE
VS ORAL THIOGUANINE & INTRATHECAL METHOTREXATE/
CYTARABINE/ HYDROCORTISONE FOR STANDARD RISK ACUTE
LYMPHOBLASTIC LEUKEMIA
14-Mar-00 NURSING ASSESSSMENT OF INFANT PAIN: MODEL AND TOOL
DEVELOPMENT
14-Mar-00 A MULTI-CENTER, OPEN-LABEL, LONG-TERM, FOLLOW-UP STUDY OF
THE SAFETY AND EFFICACY OF UCB L059 (250 MG AND 500 MG
TABLETS) IN CHILDREN WITH EPILEPSY
15-Mar-00 A PILOT STUDY TO DETERMINE THE EFFECTS OF TREADMILL
TRAINING ON INFANTS BORN PRETERM WITH GRADE III OR GRADE
IV INTRAVENTRICULAR HEMORRHAGE
15-Mar-00 THE EFFECTS OF THE PROBIOTIC AGENT LACTOBACILLUS CASEI GG
ON FAT ABSORPTION, BACTERIAL OVERGROWTH AND HEPATIC
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
14
FUNCTION OF CHILDREN WITH SHORT BOWEL SYNDROME
16-Mar-00 THE EFFECTS OF INHALED NITRIC OXIDE IN THE TREATMENT OF
ACUTE HYPOXEMIC RESPIRATORY FAILURE IN PEDIATRICS
16-Mar-00 CALCIUM AND ZINC HOMEOSTASIS IN CYSTIC FIBROSIS
20-Mar-00 INTER-NURSE RELIABILITY IN DETERMINING TRIAGE DISPOSITION
WHEN USING STANDARDIZED PEDIATRIC TELEPHONE TRIAGE
PROTOCOLS
20-Mar-00 PHASE I/II TRIAL OF RECOMBINANT INTERLEUKIN-2 IN
SYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED
CHILDREN (VERSION 2.0 ACTG 299)
20-Mar-00 CYTOMEGALOVIRUS QUANTITATION IN WHITE BLOOD CELLS
24-Mar-00 INVESTIGATION OF THE EFFECT OF IMPLEMENTIATION OF
COMPUTERIZED GROWTH CHARTS TO INCREASE COMPLIANCE OF
CHARTING GROWTH PARAMETERS
24-Mar-00 INFLUENCE OF ENDOTHELIAL DERIVED FACTORS ON SICKLE RED
BLOOD CELL ADHERENCE TO ENDOTHELIUM
27-Mar-00 RP59500V-324 OPEN LABEL, MULTICENTER, MULTIPLE DOSE, PHASE
III STUDY OF THE POPULATION PHARMACOKINETICS OF IV
SYNERCID (7.5 MG/KG Q 8H) IN 75 PEDIATRIC PATIENTS
27-Mar-00 REDUCING MEDICATION ERRORS THROUGH THE USE OF WIRELESS
NETWORKS AND HAND-HELD COMPUTERS
29-Mar-00 A PROSPECTIVE RANDOMIZED STUDY TO COMPARE CIPROFLOXACIN
WITH ESTABLISHED COMPARATIVE REGIMENS
03-Apr-00 IV IRON DEXTRAN INFUSION IN PEDIATRIC INFLAMMATORY BOWEL
DISEASE
04-Apr-00 IMMUNE BILE DUCT INJURY IN CD154 DEFICIENCY (XHIM)
04-Apr-00 USE OF CHEST RADIOGRAPHS FOR EVALUATION OF FIRST TIME
WHEEZING ILLNESSES
07-Apr-00 A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED,
MULTICENTER STUDY OF THE SAFETY AND ACTIVITY OF TENOVIL
(RHUIL-10) IN CLINICALLY STABLE CYSTIC FIBROSIS SUBJECTS;
PROTOCOL #SP9901
07-Apr-00 THE INCIDENCE OF OSTEOPOROSIS IN PEDIATRIC BONE MARROW
TRANSPLANT PATIENTS
13-Apr-00 RECOMBINANT HUMAN GROWTH HORMONE IN PEDIATRIC DIALYSIS
PATIENTS
14-Apr-00 ABT-378/R (ABT-378/RITONAVIR) EARLY ACCESS PROGRAM
14-Apr-00 PREVENTION OF CHRONIC ASTHMA IN YOUNG CHILDREN
18-Apr-00 MOLECULAR MECHANISMS IN ACANTHOSIS NIGRICANS
19-Apr-00 CCG-B971 MOLECULAR BIOLOGY OF PEDIATRIC BRAIN TUMORS
21-Apr-00 THE SAFETY, VIRAL KINETICS AND PHARMACOKINETICS OF
PEGASYS AFTER MULTIPLE DOSES IN YOUNG CHILDREN WITH
CHRONIC HEPATITIS C INFECTION
24-Apr-00 SPECIFIC CELL-MEDIATED IMMUNITY IN HIV-INFECTED CHILDREN
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
15
24-Apr-00 CHROMOSOME 22G DELETION TESTING: INVESTIGATION OF
CLINICAL PREDICTIVE FACTORS.
27-Apr-00 DIAGNOSTIC CRITERIA FOR URINARY TRACT INFECTIONS IN THOSE
CHILDREN REFERRED FOR URINARY TRACT IMAGING STUDIES
28-Apr-00 A 12 MONTH STUDY TO ASSESS THE SAFETY AND EFFICACY OF
MERIDIA (SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE) 10 AND
15 MG. IN OBESE ADOLESCENTS
01-May-00 PACTG 326: A PHASE I/II STUDY TO EVALUATE THE SAFETY AND
IMMUNOGENICITY OF ALVAC HIV VACCINES ALONE AND WITH
AIDSVAX B/B IN CHILDREN BORN TO HIV-INFECTED MOTHERS
(VERSION 4.0)
02-May-00 EVALUATION OF THE EFFICACY, SAFETY, TOLERANCE AND
PHARMACOKINETICS OF MEROPENEM FOR THE TREATMENT OF
ACUTE PULMONARY EXACERBATIONS IN PATIENTS WITH CYSTIC
FIBROSIS (#3591 US/0019).
03-May-00 MANOAMINE OXIDASE (MAO) IN ADOLESCENTS: RELATIONSHIP TO
ALCOHOL MISUSE AND TO BEHAVIORAL PREDICTORS OF RISK FOR
ALCOHOLISM
04-May-00 ROLE OF BACTERIAL SUPERANTIGENS IN KAWASAKI SYNDROME
04-May-00 AN OPEN-LABEL TRIAL EVALUATING THE SAFETY AND EFFICACY OF
NOLVADEX (TAMOXIFEN CITRATE) IN THE TREATMENT OF MCCUNE-
ALBRIGHT SYNDROME
08-May-00 C-AMP STIMULATED SWEAT RATE IN CYSTIC FIBROSIS
12-May-00 AUTOLOGOUS FRESH WHOLE BLOOD AND COAGULATION
FOLLOWING CARDIOPULMONARY BYPASS IN INFANTS
12-May-00 PROPHYLAXIS OF EARLY ADRENAL INSUFFICIENCY TO PREVENT
CHRONIC LUNG DISEASE
15-May-00 DIETARY SUPPLEMENTATION AND NUTRITIONAL STATUS IN
CHILDREN WITH SICKLE CELL DISEASE
19-May-00 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO
ASSESS THE SAFETY AND EFFICACY OF ANASTROZOLE (ZD1033,
ARMIDEX) VERSUS PLACEBO FOR THE TREATMENT OF
GYNECOMASTIA IN PUBERTAL BOYS
19-May-00 EFFECT OF INSULIN SENSITIVITY ON 24-H TOTAL AND DIETARY FAT
OXIDATION IN NON-OBESE SUBJECTS
22-May-00 A PILOT STUDY OF PERIPHERAL BLOOD STEM CELL
TRANSPLANTATION FOLLOWING PREPARATIVE THERAPY
CONSISTING OF CYCLOPHOSPHAMIDE, BCNU, AND ETOPOSIDE FOR
CHILDREN WITH RELASPED OR PRIMARILY REFRACTORY HODGKIN'S
AND NON-HODGKIN'S LYMPHOMA (A5962)
22-May-00 MEDICAL AND FINANCIAL OUTCOMES USING TELEMEDICINE FOR
DIAGNOSIS OF NEONATAL CONGENITAL HEART DISEASE
23-May-00 PROPHYLACTIC USE OF PRIMACOR IN PATIENTS AT HIGH RISK OF
DEVELOPING LOW CARDIAC OUTPUT SYNDROME FOLLOWING
CARDIAC SURGERY
30-May-00 FLUDARABINE AND LOW DOSE TOTAL BODY IRRADIATION
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
16
FOLLOWED BY UNRELATED CORD BLOOD TRANSPLANTATION FOR
PATIENTS WITH HIGH RISK MALIGNANCIES
30-May-00 AN OPEN LABEL RANDOMIZED TRIAL WITH TOBRAMYCIN SOLUTION
FOR INHALATION (TOBI) IN CYSTIC FIBROSIS PATIENTS WITH MILD
LUNG DISEASE
02-Jun-00 A DOSE-RESPONSE STUDY OF THE EFFICACY, SAFETY AND
PHARMACOKINETICS OF AMIODARONE AQUEOUS I.V. INJECTION IN
PEDIATRIC PATIENTS NEONATAL TO SIXTEEN YEARS OF AGE WITH
CLINICAL ARRHTHMIAS
05-Jun-00 PROGRAM EVALUATION FOR NEURO-ONCOLOGY TERMINAL CARE
PROTOCOL
06-Jun-00 TREATMENT OF CHILDREN WITH DOWN SYNDROME AND ACUTE
MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROME, OR
TRANSIENT MYELOPROLIFERATIVE DISORDER CCG-A2971
08-Jun-00 MONITORING THORACIC GAS VOLUME USING RESPIRATORY
INDUCTIVE PLETHYSMOGRAPHY
13-Jun-00 EVALUATION OF COMPASSIONATE USE (SINGLE PATIENT) OF THE
CARDIOSEAL DEVICE SEPTAL OCCLUSION SYSTEM (SHUYLER LEAN)
14-Jun-00 CCG 99702: TREATMENT OF HIGH RISK MEDULLOBLASTOMA AND
SUPRATENTORIAL PNETS WITH CONVENTIONAL RADIOTHERAPY
AND INTENSIVE CONSOLIDATION CHEMOTHERAPY WITH
PERIPHERAL BLOOD PROGENITOR CELL (PBSC) SUPPORT, A CCG
LIMITED INSTITUTION STUDY
15-Jun-00 IMPROVING PROTEIN BALANCE IN POSTOPERATIVE NEONATE USING
IV AMINO ACIDS
15-Jun-00 TREATMENT OF INSULIN RESISTANT ADOLESCENTS WITH
METFORMIN
19-Jun-00 A COMPARISON OF PREDNISONE AND DEFLAZACORT'S EFFECT ON
FUNCTIONAL SKILLS IN DUCHENNE MUSCULAR DYSTROPHY
19-Jun-00 DOES TWINNING INFLUENCE THE RELIABILITY OF THE THYROID
NBN SCREENING TEST
20-Jun-00 A NATURAL HISTORY STUDY OF NEONATES WITH ENTROVIRAL
SEPSIS SYNDROME
22-Jun-00 PEDIATRIC VEIN OCCLUSION
23-Jun-00 CONTINUED EVALUATION OF THE PERFORMANCE OF THE
CARDIOSEAL STARFLEX SEPTAL OCCLUSION SYSTEM IN PATIENT
WITH SECUNDUM ATRIAL SEPTAL DEFECT (ASD)
26-Jun-00 "SURFING THE WEB FOR GENETIC INFORMATION: PATIENT
UTILIZATION OF PERCEPTIONS OF AND RELIANCE ON THE WWW AS
AN INFORMATIONAL SOURCE IN THE GENERAL GENETICS SETTING
27-Jun-00 PACTG 402, VERSION 2.0: PHASE I/II OF SUBCUTANEOUS IL-2 WITH
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN HIV-INFECTED
CHILDREN WITH IMMUNOSUPRESSION
27-Jun-00 CCG-09714: A PHASE II STUDY OF ORAL TOPOTECAN IN CHILDREN
WITH RELAPSED ACUTE LEUKEMIA
28-Jun-00 A PHASE I-II LIMITED PILOT STUDY OF INTENSIVE CHEMOTHERAPY
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
17
WITH PERPHERAL BLOOD PROGENITOR CELL (PBSC) SUPPORT FOR
INFANTS WITH MALIGNANT BRAIN TUMORS
28-Jun-00 CLINICAL PERFORMANCE MEASURE FOR PEDIATRIC BRAIN INJURY
29-Jun-00 A PHASE II MUTICENTER STUDY OF GRANULOCYTE-COLONY
STIMULATING FACTOR (G-CSF)/DEXAMETHASONE MOBILIZED
GRANULOCYTE TRANSFUSIONS FOR TREATMENT OF SERIOUS
FUNGAL AND BACTERIAL INFECTIONS IN NEUTROPENIC PATIENTS
AFTER CHEMOTHERAPY OR HEMATOPOIETIC TRANSPLANTATION
29-Jun-00 PREDICTIVE FACTORS FOR CEREBRAL EDEMA COMPLICATING
DIABETIC KETOACIDOSIS IN CHILDREN
06-Jul-00 A PROSPECTIVE STUDY TO EVALUATE THE TESTING OF PLASMA
POOLS FROM VOLUNTARY BLOOD DONATIONS FOR THE PRESENCE
OF HIV-1 (HIV) RNA
06-Jul-00 A PROSPECTIVE STUDY TO EVALUATE THE TESTING OF PLASMA
POOLS FROM VOLUNTARY BLOOD DONATIONS FOR THE PRESENCE
OF HCV RNA
06-Jul-00 NM16189 A DOUBLE-BLIND, PLACEBO-CONTROLLED, 52-WEEK,
STUDY OF THE EFFICACY AND TOLERABILITY OF XENICAL
(ORLISTAT) IN THE WEIGHT MANAGEMENT OF OBESE PEDIATRIC
PATIENTS
10-Jul-00 PERPETRATORS OF ABUSIVE FRACTURES
11-Jul-00 COMPARISON OF FENTANYL AND REMIFENTANIL FOR TRACK
PEDIATRIC CARDIAC ANESTHESIA
11-Jul-00 COMPARISON OF FENTANYL AND REMIFENTANIL FOR FAST TRACK
PEDIATRIC CARDIAC ANESTHESIA
14-Jul-00 COMPARISON OF IV VS IM KETAMINE FOR SEDATION IN A PEDIATRIC
EMERGENCY DEPARTMENT
18-Jul-00 A PROSPECTIVE, OPEN-LABEL, NON-RANDOMIZED, NATURALISTIC,
LONG- TERM SAFETY SURVEILLANCE, OBSERVATIONAL STUDY OF
CIPROFLOXACIN (EITHER AS ORAL SUSPENSION, ORAL TABLETS, OR
SEQUENTIAL IV - ORAL THERAPY OR PURELY IV THERAPY) IN THE
TREATMENT OF PEDIATRIC PATIENTS WITH A VARIETY OF
INFECTIOUS DIAGNOSES
20-Jul-00 RISK FACTORS FOR RSV CR1 HOSPITALIZATION
26-Jul-00 CLOSURE OF ATRIAL SEPTAL DEFECTS WITH THE AMPLATZER
SEPTAL OCCLUDER (CONTINUED ACCESS)
27-Jul-00 ACTG 381(VERSION 3.0)-ESTABLISHMENT AND MAINTENANCE OF
LONG TERM UNDECTABLE PLASMA HIV-1 RNA: CORRELATION WITH
IMMUNOLOGIC RECONSTITUTION AND VIRAL DYNAMICS
31-Jul-00 ALTERNATE DAY STEROIDS VS FISH OILS VS PLACEBO IN CHILDREN
WITH IGA NEPHROPATHY
31-Jul-00 EVALUATION OF THE PHARMACOKINETICS AND TOLERANCE OF
ESCALATING DOSES OF ORAL PENTOXIFYLINE IN CHILDREN WITH
ACUTE KAWASAKI DISEASE (10080, 3/24/99)
31-Jul-00 POST MARKETING SURVEY
31-Jul-00 ACTG 366 - A PHASE I/II MASTER PROTOCOL OF NOVEL
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
18
ANTIRETROVIAL COMBINATION THERAPIES IN ANTIRETROVIRAL
EXPERIENCED CHILDREN WITH RAPIDLY PROGRESSING OR
ADVANCED HIV DISEASE(RAD) VERSION 1.0 RAD-1 A PHASE I/II
ANTIRETROVIRAL MANAGEMENT ALGORITHM FOR PEDIATRIC
SUBJECTS OF FOUR-DRUG COMBINATION THERAPIES BASED ON
PRIOR ANTIRETROVIRAL EXPERIENCE
31-Jul-00 VERSION 2.0 ACTG 367-MEDICAL CHART ABSTRACTION OF HIV-
INFECTED PREGNANT WOMEN AND THEIR INFANTS RECEIVING
CARE OR CONSULTATION AT STUDY SITES
02-Aug-00 A DOUBLE-BLIND, RANDOMIZED DOSE RESPONSE STUDY OF
LISINOPRIL IN CHILDREN WITH HYPERTENSION
02-Aug-00 A MULTICENTER, UNCONTROLLED, OPEN STUDY IN PATIENTS WITH
PULMONARY ARTERIAL HYPERTENSION, TRANSITIONING FROM
CHRONIC INTRAVENOUS FLOLAN THERAPY TO CHRONIC
SUBCUTANEOUS UNIPROST
03-Aug-00 COMPARISON OF THE SAFETY, TOLERABILITY, AND
IMMUNOGENICITY OF 3 CONSISTENCY LOTS OF FROZEN MEASLES,
MUMPS, RUBELLA AND VARICELLA (MMRV) IN HEALTHY CHILDREN
04-Aug-00 A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED SAFETY
AND EFFICACY TRIAL OF SUSPENSION FORMULATION OF
PLECONARIL IN THE TREATMENT OF VIRAL RESPIRATORY
INFECTION IN CHILDREN AGE 2 TO 12 YEARS
09-Aug-00 (CCG-B973) A GROUP WIDE PROTOCOL FOR COLLECTING AND/OR
BANKING NEUROBLASTOMA TUMOR SPECIMENS
10-Aug-00 IL-12 ABD IFN GAMMA PRODUCTION IN CHILDREN RECEIVING
PEGYLATED INTERFERON (PEG) THERAPY FOR CHRONIC HEPATITIS
15-Aug-00 VALIDATION OF CLINICAL DECISION RULES FOR OBTAINING KNEE
RADIOGRAPHS IN CHILDREN WITH ACUTE KNEE INJURIES
15-Aug-00 THE USE OF HUMAN WBC CONCENTRATED FROM RINSE-BACK OF
APHERESIS PRODUCTS OBTAINED FROM BELLE BONFILS BLOOD
CENTER
15-Aug-00 ENERGY EXPENDITURE IN NEONATES WITH HYPOXIC-ISCHEMIC
ENCEPHALOPATHY
16-Aug-00 PHASE 1/PHASE 2 TRIAL OF ANTIOXIDANT THERAPY IN BILIARY
ATRESIA
16-Aug-00 CCG 5941 A PILOT STUDY FOR THE TREATMENT OF NEWLY
DIAGNOSED DISSEMINATED ANAPLASTIC LARGE CELL KI-1 AND T-
LARGE CELL LYMPHOMA
18-Aug-00 ASSESSING BURN SURVIVOR'S SOCIAL EXPERIENCE AND IT'S IMPACT
ON BODY IMAGE SATISFACTION
18-Aug-00 TWO-WEEK RANDOMIZED CROSSOVER AND PHARMACODYNAMIC
MULTICENTER STUDY COMPARING CONVENTIONAL NEEDLE
INJECTION OF GH SUBCUTANEOUSLY VERSES SUBCUTANEOUS
INJECTION OF GH USING A NEEDLE-FREE INJECTOR
18-Aug-00 SIX MONTH PHARMACODYNAMIC MULTICENTER STUDY USING
SUBCUTANEOUS SAIZEN IN A NEEDLE-FREE JET INJECTOR FOR
CHILDREN WITH GROWTH HORMONE DEFICIENCY
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
19
18-Aug-00 SIX MONTH MULTICENTER STUDY USING SUBCUTANEOUS SAIZEN IN
A NEEDLE-FREE JET INJECTOR FOR CHILDREN REQUIRING LONG
TERM GROWTH HORMONE TREATMENT
24-Aug-00 ALLOGENIC BONE MARROW TRANSPLANTATION/PBSC
TRANSPLANTATION FOR REFRACTORY HEMATOLOGIC
MALIGNANCY OR HEMATOPOIETIC FAILURE
24-Aug-00 MEASUREMENT OF BONE MINERAL CONTENT USING DUAL X-RAY
ABSORPTIOMETRY (DEXA) IN INFANTS AND CHILDREN WITH
UNEXPLAINED FRACTURES
25-Aug-00 COMPARISON OF BODY COMPOSITION ASSESSMENT BY SKINFOLD
AND DEXA IN PATIENTS WITH ANOREXIA NERVOSA
28-Aug-00 MOLECULAR ANALYSIS OF SARCOMA
29-Aug-00 PROTOCOL TO EVALUATE USE OF INTRAVENOUS FLUIDS AND
ELECTROLYTE LEVELS AFTER CRANIOTOMY FOR BRAIN TUMORS
29-Aug-00 THE FORGOTTEN BOOSTER-AGE CHILD: PARENTAL ATTITUDES,
KNOWLEDGE, AND REPORTED BEHAVIORS ABOUT CHILD
PASSENGER SAFETY PRACTICES
30-Aug-00 THE EFFECTIVENESS OF THE FULLER INFANT ASSESSMENT TOOL
FOR TEACHING NOVICE NURSES TO ASSESS AND MANAGE INFANT
PAIN: A PILOT STUDY
30-Aug-00 FUNCTIONAL PROTEOMICS OF HUMAN EXOCYTIC ORGANELLES
30-Aug-00 NEEDS ASSESSMENT SURVEY IN BIOETHICS AT TCH
01-Sep-00 JUNGLEMOBILE: A MOBILE INJURY PREVENTION PROJECT FOR
CHILDREN
06-Sep-00 PACTG 1010-EFFECT OF ANTIRETROVIRAL THERAPY ON BODY
COMPOSITION IN HIV-INFECTED CHILDREN (VERSION 1)
12-Sep-00 PHENOTYPE AND ETIOLOGY OF PALLISTER-HALL SYNDROME
12-Sep-00 THE EFFECT OF FLUTICASONE PROPRIONATE ON GROWTH AND
ADRENAL FUNCTION
22-Sep-00 PREDICTORS OF RESPONSE TO RECALL FOR IMMUNIZATION WITH A
NEW VACCINE
29-Sep-00 POST REDUCTION MANAGEMENT OF INTUSSUSCEPTION: HOW LONG
TO OBSERVE FOR RECURRENCE?
02-Oct-00 COLORADO SHILD WELFARE CHILDREN EXPERIENCING PARENTAL
INCARCERATION: CHARACTERISTICS, NEED & HEALTH CARE
UTILIZATION
11-Oct-00 STUDY OF THE SAFETY AND EFFECTIVENESS OF THE MENTOR
SALINE-FILLED TESTICULAR PROSTHESIS AND ADJUNCT STUDY
PROTOCOL FOR THE MENTOR SALINE-FILLED TESTICULAR
PROSTHESIS
11-Oct-00 ADJUNCT STUDY PROTOCOL FOR THE MENTOR SALINE-FILLED
TESTICULAR PROSTHESIS
11-Oct-00 A COMPARATIVE STUDY OF NEWLY HIRED GRADUATE NURSES'
APPLICATION OF EVIDENCE-BASED PRACTICE: A PILOT STUDY
12-Oct-00 GAIT DISTURBANCE IN CHILDREN WITH OTITIS MEDIA
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
20
16-Oct-00 CCG-09705: A PHASE II STUDY OF NAVELBINE (VINORELBINE) IN
CHILDREN WITH RECURRENT OR REFRACTORY MALIGNANCIES
16-Oct-00 EVALUATION OF HEMOPHILIC CHILDREN WITH DUAL X-RAY
ABSORPTOMETRY (DEXA)
17-Oct-00 CCG-P9673 A PHASE II STUDY OF COMPOUND 506U78 IN PATIENTS
WITH REFRACTORY T-CELL MALIGNANCIES - A POG/CCG
INTERGROUP STUDY
20-Oct-00 CCG-0962 PHASE II STUDY OF DOCETAXEL (TAXOTERE) (NSC #628503)
IN CHILDREN WITH RECURRENT SOLID TUMORS
20-Oct-00 CCG-B972: IMMUNE STATUS AND ACTIVATION IN CHILDREN
PATICIPATING IN CCG-2961 (PREVIOUSLY 96-597C)
25-Oct-00 A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO
ASSESS THE EFFECTS OF RO 47-0203 (BOSENTAN) ON EXERCISE
CAPACITY IN PATIENTS WITH PULMONARY ARTERIAL
HYPERTENSION; PROTOCOL NUMBER AC-052-352
25-Oct-00 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP,
PLACEBO-CONTROLLED, 12-WEEK STUDY OF FLUTICASONE
PROPIONATE 44 MCG BID AND 88 MCG BID DELIVERED VIA CFC MDI
AND A VALVED HOLDING CHAMBER WITH FACEMASK IN SUBJECTS
WITH ASTHMA AGE 24 MONTHS TO 47 MONTHS.
25-Oct-00 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP,
PLACEBO-CONTROLLED, 12-WEEK STUDY OF FLUTICASONE
PROPIONATE 44 MCG BID AND 88 MCG BID DELIVERED VIA CFC MDI
AND A VALVED HOLDING CHAMBER WITH FACEMASK IN SUBJECTS
WITH ASTHMA AGE 6 MONTHS TO 23 MONTHS
25-Oct-00 TRANSCUTANEOUS CARBOXY HEMOGLOBIN (COHB) MONITORING
FOR ASSESSMENT OF ENVIRONMENTAL CARBON MONOXIDE
EXPOSURE IN CHILDREN HAVING SURGERY
27-Oct-00 CCG-4941: NATIONAL WILM'S TUMOR STUDY-5: THERAPEUTIC TRIAL
AND BIOLOGY STUDY
27-Oct-00 SPIRITUALITY IN YOUNG ADULT BURN SURVIVORS
27-Oct-00 A SAFETY AND EFFICACY STUDY OF TWO DOSAGE-LEVELS OF
PULMICORT RESPULES (BUDESONIDE INHALATION SUSPENSION, 0.5
OR 1.0 MG/DAY) VERSUS PLACEBO IN INFANTS BETWEEN THE AGES
OF SIX AND TWELVE MONTHS WITH MILD TO MODERATE ASTHMA
(STUDY NUMBER SD-004-0732)
30-Oct-00 A PROSPECTIVE, RANDOMIZED TRIAL OF SANDOSTATIN
(OCTREOTIDE ACETATE) FOR THE TREATMENT OF PEDIATRIC
HYPOTHALAMIC OBESITY
02-Nov-00 FIRST TIME AFEBRILE PEDIATRIC SEIZURES: USEFULNESS OF
EMERGENT HEAD CT IN EVALUATION AND MANAGEMENT
02-Nov-00 PEDIATRIC RAPID SEQUENCE INTUBATION
09-Nov-00 FIBRINOLYSIS AND POLYCYSTIC OVARY SYNDROME
10-Nov-00 TARGETED SURVEILLANCE OF STREPTOCOCCUS PNEUMONIAE;
PROTOCOL 1351-SKB-00ED
10-Nov-00 COMPARISON OF THE EFFICACY AND SAFETY OF SEDATION DRUGS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
21
USED IN A PEDIATRIC EMERGENCY DEPARTMENT
14-Nov-00 GUIDED BREATHING AND IMAGERY: A PREFERENCE STUDY IN
CHILDREN
20-Nov-00 USE OF AN IMMUNIZATION REGISTRY TO RECALL CHILDREN WITH
ASTHMA FOR INFLUENZA VACCINATION
20-Nov-00 CCG-B942: DETECTION OF MINIMAL RESIDUE DISEASE IN CHILDREN
RECEIVING THERAPY FOR AML OR MDS (PREVIOUSLY 96-597B)
20-Nov-00 EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINE IN
CHILDREN
27-Nov-00 CCG-P9462: RANDOMIZED TREATMENT OF REFRACTORY
NEUROBLASTOMA WITH TOPOTECAN REGIMENS, FOLLOWING
DEFEROXAMINE (POG ONLY) IN AN INVESTIGATIONAL WINDOW, A
POG/CCG PHASE II INTERGROUP STUDY
27-Nov-00 AN EXPLORATORY STUDY OF A WORK ENVIRONMENT MODEL
WITHIN AN ACUTE CARE SETTING
27-Nov-00 EVALUATION OF LEVELS OF CANCER PROCOAGULANT IN PEDIATRIC
PATIENTS WITH SARCOMAS AND CNS TUMORS AT DIAGNOSIS,
REMISSION, AND RELAPSE
30-Nov-00 SAFETY AND PHARMACOKINETIC STUDY OF ZONISAMIDE
(ZONEGRAN) ADMINISTERED TO CHILDREN WITH EPILEPSY
30-Nov-00 OPEN LABEL, EXTENDED TREATMENT SAFETY STUDY OF
ZONISAMIDE (ZONEGRAN) ADMINISTERED TO CHILDREN WITH
EPILEPSY; PROTOCOL NUMBER AN46046-226
01-Dec-00 CARDIAC DIASTOLIC FUNCTION: A NEW MEASUREMENT TECHNIQUE
04-Dec-00 CCG-4942: NATIONAL WILM'S TUMOR STUDY-5: RELAPSED
PROTOCOL
11-Dec-00 OUTCOMES SURVEY OF SYNAGIS PROPHYLAXIS
13-Dec-00 A MULTI-CENTER, OPEN-LABEL, SINGLE-DOSE STUDY TO EVALUATE
THE PLASMA CONCENTRATION-TIME PROFILE AND TOLERABILITY
OF A SINGLE 3.5 MG INTRAVENOUS DOSE OF MONTELUKAST
(SINGULAIR) IN CHILDREN AGED 2 TO 14 YEARS WITH ASTHMA;
PROTOCOL NO: 215-02
18-Dec-00 CCG-4941L NATIONAL WILMS TUMOR LATE EFFECTS STUDY
18-Dec-00 A SAFETY, TOLERABILITY AND EFFICACY STUDY OF
LEVALBUTEROL AND RACEMIC ALBUTEROL IN PEDIATRIC SUBJECTS
BIRTH TO 48 MONTHS OLD WITH REACTIVE AIRWAY DISEASE IN AN
ACUTE SETTING; PROTOCOL NUMBER 051-033
21-Dec-00 IMMUNOLOGIC RECONSTITUTION FOLLOWING HIGH DOSE
CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL BLOOD
PROGENITOR CELL TRANSPLANTATION (#98-383)
26-Dec-00 A PROTOCOL TO COLLECT AND EVALUATE TISSUE SAMPLES IN
SUBJECTS WITH CYSTIC FIBROSIS, CARRIERS OF CYSTIC FIRBROSIS,
AND HEALTHY NON-CARRIERS OF CYSTIC FIBROSIS
27-Dec-00 USE OF VIDEO TECHNOLOGY TO BRING THE PATIENT TO THE
TEACHING CONFERENCE
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
22
28-Dec-00 T20-301/NV16504 VERSION C: A PHASE III OPEN-LABEL, RANDOMIZED
ACTIVE-CONTROLLED STUDY ASSESSING THE EFFICACY AND
SAFETY OF T-20/RO 29-9800 (HIV-1 FUSION INHIBITOR) IN
COMBINATION WITH AN OPTIMIZED BACKGROUND REGIMEN,
VERSUS OPTIMIZED BACKGROUND REGIMEN ALONE, IN PATIENTS
WITH PRIOR EXPERIENCE AND/OR PRIOR DOCUMENTED RESISTANCE
TO EACH OF THE THREE APPROVED CLASSES OF ANTIRETROVIRALS
(NUCLEOSIDE REVERSE TRANSCRIPTASE, NON-NUCLEOSIDE
REVERSE TRANSCRIPTASE AND PROTEASE INHIBITORS)
05-Jan-01 VALIDATION OF SPUTUM INDUCTION AS AN OUTCOME MEASURE
FOR LOWER AIRWAY SAMPLING IN PATIENTS WITH CYSTIC FIBROSIS
(CF)
05-Jan-01 REGULATION OF HUMAN ALVEOLAR MACROPHAGE CHEMOKINE
PRODUCTION
05-Jan-01 RELATIONSHIP BETWEEN MOLECULAR STATUS AND COGNITIVE
ABILITY IN FEMALES WITH FRAGILE X
05-Jan-01 PROSPECTIVE ASSESSMENT AFTER PEDIATRIC CARDIAC ABLATION
09-Jan-01 A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, ACTIVELY
CONTROLLED, PARALLEL GROUP STUDY ON THE EFFICACY AND
SAFETY OF LIQUID IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
CE1160 10%, COMPARED TO IMMUNE GLOBULIN INTRAVENOUS
(HUMAN) GAMIMUNE N, 10% IN SUBJECTS WITH IMMUNE
THROMBOCYTOPENIC PURPURA (ITP) AMENDED AUGUST 16, 2000
09-Jan-01 MOVING TOWARD EVIDENCE-BASED DEVELOPMENTAL
POSITIONING
09-Jan-01 AN OPEN-LABEL SAFETY, EFFICACY AND TOLERABILITY STUDY OF
CARBATROL IN CHILDREN WITH EPILEPSY; PROTOCOL NUMBER
101.404
10-Jan-01 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
MULTICENTER, MULTIPLE DOSE, SEQUENTIAL DOSE ESCALATION
STUDY TO EVALUATE THE SAFETY, TOLERABILITY,
PHARMACOKINETICS, AND PHARMACODYNAMICS OF NBI-6024 IN
ADULT AND ADOLESCENT PATIENTS WITH INSULIN-DEPENDENT
TYPE-1 DIABETES MELLITUS. AMENDMENT 1 VERSION DATE: NOV.
27,2000. FINAL VERSION DATE: SEPT. 21, 2000
11-Jan-01 THE BURDEN OF ILLNESS OF RESPIRATORY SYNCYTIAL VIRUS (RVS):
A STUDY OF CHILD AND FAMILY DISTRESS AND ADJUSTMENT
DURING HOSPITALIZATION AND RECOVERY
12-Jan-01 CCG-AE23 EPIDEMIOLOGY OF DOWN SYNDROME-LEUKEMIA AND
DOWN SYNDROME
17-Jan-01 RESEARCH PROTOCOL C0015-40: A PHASE 2, RANDOMIZED, DOUBLE-
MASKED, PLACEBO-CONTROLLED, MULTI-CENTER STUDY OF
INTRANASALLY ADMINISTRATED RFI-641 FOR SECONDARY
PREVENTION AND THERAPEUTIC TREATMENT OF RESPIRATORY
SYNCYTIAL VIRUS INFECTION (RSV) IN ADULTS IN HOUSEHOLDS
19-Jan-01 AN OPEN-LABEL, NON-COMPARATIVE PROTOCOL FOR THE
EMERGENCY USE OF VORICONAZOLE (UK 109,496) IN PATIENTS WITH
LIFE-THREATENING, INVASIVE MYCOSES WHO ARE FAILING ON
CURRENTLY AVAILABLE ANITFUNGAL AGENTS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
23
22-Jan-01 AN OBSERVATIONAL STUDY OF THE EPIDEMILOGY AND NATURAL
HISTORY OF ASTHMA: OUTCOMES AND TREATMENT REGIMENS
(Q2196N)
24-Jan-01 ROLE OF RIGHT AND LEFT VENTRICULAR ANNULAR MOTION IN
RIGHT VENTRICULAR FUNCTION
25-Jan-01 ACUTE LIVER FAILURE STUDY
26-Jan-01 INFLAMMATORY AND VASOACTIVE MEDIATORS IN SEVERE RSV
DISEASE
29-Jan-01 PILOT STUDY OF MYCOPHENOLATE MOFETIL (MMF) IN CHILDREN
WITH STEROID-DEPENDENT NEPHROTIC SYNDROME (SDNS) A STUDY
BY THE SOUTHWEST PEDIATRIC NEPHROLOGY STUDY GROUP
(SPNSG)
01-Feb-01 THE USE OF DUAL ENERGY ABSORPTIOMETRY TO DETERMINE BONE
MINERAL DENSITY IN CHILDREN WITH SPINA BIFIDA
02-Feb-01 A PILOT STUDY OF FISH OIL (OMEGA-3-POLYUNSATURATED FATTY
ACIDS) FOR TREATMENT OF HYPERLIPIDEMIA IN CHILDREN WITH
CHRONIC GLOMERULAR DISEASE
05-Feb-01 INVESTIGATION OF GROWTH HORMONE DEFICIENCY IN PATIENT
WITH ORGANIC ACIDEMIA AND SHORT STATURE
07-Feb-01 2ND OSOM ULTRA STREP A TEST VS. BACK-UP CULTURE FOR THE
DIAGNOSIS OF STREPTOCOCCUS PYOGENES PHARYNGITIS
12-Feb-01 A PHASE I/II STUDY OF INTERFERON GAMMA-LB BY INHALATION
FOR THE TREATMENT OF PATIENTS WITH CYSTIC FIBROSIS
14-Feb-01 THREE MONTH DOUBLE MASKED, ACTIVE TREATMENT
CONTROLLED, MULTICENTER STUDY OF 2% DORZOLAMIDE T.I.D.
AND OF TIMOLOL MALEATE IN GEL-FORMING SOLUTION Q.D. IN
PEDIATRIC PATIENTS AGE <6 YEARS WITH ELEVATED INTRAOCULAR
PRESSURE OR GLAUCOMA, MERCK PROTOCOL 100-05
16-Feb-01 A 12 WEEK DOUBLE-BLIND RANDOMIZED TRIAL, WITH A 12 WEEK
OPEN-LABEL EXTENSION, TO INVESTIGATE THE EFFICACY AND
SAFETY OF MELOXICAM ORAL SUSPENSION ADMINISTRATION ONCE
DAILY AND NAPROXEN ORAL SUSPENSION ADMINISTERED TWICE
DAILY IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS;
PROTOCOL NUMBER: 107.235
16-Feb-01 SAFETY AND EFFICACY OF PENTAVALENT (G1, G2, G3, G4, P1)
HUMAN-BOVINE REASSORTANT ROTAVIRUS VACCINE IN HEALTHY
INFANTS (PROTOCOL 006-00)
23-Feb-01 AN OPEN, RANDOMIZED, MULTICENTER STUDY OF THE SAFETY,
TOLERABILITY, ND IMMUNOGENICITY OF FROZEN MMRV GIVEN
CONCOMITANTLY VERSUS NONCONCOMITANTLY WITH OTHER
PEDIATRIC VACCINES IN HEALTHY CHILDREN 12 TO 15 MONTHS OF
AGE PROTOCOL 013-02
14-Mar-01 PACTG P1024 EVALUATION OF THE IMMUNOGENICITY OF
PNEUMOCOCCAL CONJUGATE VACCINE AND ROUTINE PEDIATRIC
IMMUNIZATIONS IN HIV-INFECTED CHILDREN TREATED WITH
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
14-Mar-01 VENOUS ACCESS IN PEDIATRIC POST-RUPTURED APPENDECTOMY
PATIENTS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
24
14-Mar-01 CHARACTERISTICS AND ROLE FUNCTIONS OF ADVANCED PRACTICE
NURSES
14-Mar-01 VALPROIC ACID RELATED PROTEIN C DEFICIENCY
15-Mar-01 AN EXPLORATION OF PARENTS' PATTERNS OF STRESS AND ANXIETY
WITH THEIR PREOPERATIVE CHILDREN
16-Mar-01 LINEZOLID IV/PO VS VANCOMYCIN IV FOR THE TREATMENT OF
RESISTANT GRAM-POSITIVE BACTERIAL INFECTIONS IN CHILDREN;
PROTOCOL NUMBER M/1260/0082
19-Mar-01 MULTICENTER PIVOTAL STUDY OF THE HELEX SEPTAL OCCLUDER
19-Mar-01 TISSUE PLASMINOGEN ACTIVATOR (TPA) DOSE-FINDING IN
CHILDREN WITH VENOUS THROMBOSIS
20-Mar-01 CLINICAL VERIFICATION OF A MODIFIED DIRECTIGEN RSV KIT
28-Mar-01 A DESCRIPTIVE STUDY OF SPIRITUALITY AMONG PARENTS AND
GUARDIANS OF CHILDREN WITH BRAIN TUMORS, HEAD INJURIES
AND SPINAL CORD INJURIES, THEIR NURSES AND CHAPLAINS
29-Mar-01 AIRWAY EPITHELIAL CELL GENOMICS AND PSEUDOMONAS
AERUGINOSA INFECTION IN CYSTIC FIBROSIS PATIENTS
29-Mar-01 MODIFIERS OF EARLY PANCREATIC INJURY IN CYSTIC FIBROSIS
29-Mar-01 COMPARISON OF FASCIA ILIACA COMPARTMENT NERVE BLOCK TO
TRADITIONAL ANALGESICS FOR FEMUR FRACTURES IN A PEDIATRIC
EMERGENCY DEPARTMENT
30-Mar-01 EPIDEMIOLOGY, OUTCOMES, AND REASONS FOR LATE
PRESENTATION IN CHILDREN DIAGNOSED WITH KAWASKI'S DISEASE
02-Apr-01 PHARMACOKINETICS AND TOLERABILITY OF TRACLEER
(BOSENTAN) IN PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL
HYPERTENSION: SINGLE AND MULTIPLE ORAL DOSES; PROTOCOL
NUMBER AC-052-356.
02-Apr-01 A MULTICENTER, DOUBLE BLIND, RANDOMIZED TRIAL OF STEROID
WITHDRAWAL IN SIMULECT, SIROLIMUS, AND CYCLOSPORINE OR
TACROLIMUS TREATED PRIMARY TRANSPLANT RECIPIENTS,
CONDUCTED BY THE NORTH AMERICAN PEDIATRIC RENAL
TRANSPLANT COOPERATIVE STUDY (NAPRTCS)
04-Apr-01 A RANDOMIZED, INVESTIGATOR BLIND, MULTICENTER STUDY TO
ASSESS THE EFFICACY OF ORAL AUGMENTIN ES TWICE DAILY FOR
10 DAYS VERSUS ORAL ZITHROMAX ONCE DAILY FOR 5 DAYS IN THE
TREATMENT OF ACUTE OTITIS MEDIA IN INFANTS AND CHILDREN
(PROTOCOL BRL-25000/611)
16-Apr-01 AN INTERNET FOCUSED DISCUSSION SURVEY ON THE USE OF
AUDITORY SCANNING AS AN ACCESS METHOD FOR AUGMENTATIVE
AND ALTERNATIVE COMMUNICATION SYSTEMS
17-Apr-01 DEVELOPMENT OF OPTICAL METHODS TO MEASURE BLOOD
COAGULATION TIMES
19-Apr-01 SAFETY AND TOLERABILITY OF OXYBUTYNIN CHLORIDE (DITROPAN
XL EXTENDED RELEASE TABLETS, DITROPAN TABLETS OR
DITROPAN SYRUP) IN THE TREATMENT OF DETRUSOR
HYPERREFLEXIA DUE TO NEUROGENIC CONDITIONS IN CHILDREN
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
25
AGED 6 TO 15 YEARS (INCLUDING AMENDMENT 1)
19-Apr-01 LIMB PAIN ASSOCIATED WITH AN UNDIAGNOSED
HEMOGLOBINOPATHY
23-Apr-01 SAFETY AND EFFICACY OF HMR4396 FOR THE MANAGEMENT OF
ANEMIA IN PEDIATRIC SUBJECTS WITH CHRONIC RENAL FAILURE
(PREDIALYSIS, HEMODIALYSIS, PERITONEAL DIALYSIS); PROTOCOL
NUMBER HMR4396A/3003
25-Apr-01 OPEN LABEL USE OF HUMAN IMMUNE GLOBULIN
02-May-01 A PHASE 1B/2A ASCENDING DOSE COHORT STUDY TO ASSESS THE
SAFETY, TOLERABILITY, AND EFFECTS OF FIVE DOSE LEVELS OF
INS37217 AND PLACEBO FOLLOWED BY FIVE DAYS TWICE DAILY
TREATMENT WITH MAXIMUM TOLERATED DOSE ADMINISTERED BY
INHALATION VIA THE PARI LC STAR NEBULIZER IN ADULT AND
PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS
02-May-01 CORRELATION OF OUTCOME MEASURES FOR POST-THROMBOTIC
SYNDROME IN CHILDREN WITH VENOUS THROMBOSIS
09-May-01 IMMUNOLOGIC ASPECTS OF THE PATHOGENESIS OF CHRONIC
SINUSITIS IN CHILDREN
09-May-01 MECHANISMS OF STEROID RESISTANT ASTHMA
09-May-01 RESPIRATORY SYNCITIAL VIRUS INFECTION: INCIDENCE IN YOUNG
INFANTS
13-May-01 LONG TERM FOLLOW-UP PROTOCOL TO ASSESS PEDIATRIC
SUBJECTS AFTER COMPLETING 24 WEEKS OF FOLLOW-UP IN SPRI
CLINICAL TRIAL FOR CHRONIC HEPATITIS C
14-May-01 LINEZOLID INJECTION: SINGLE DOSE PHARMACOKINETIC
ASSESSMENT IN PEDIATRIC PATIENTS FOLLOWING AN
INTRAVENOUS INFUSION; PROTOCOL NUMBER 766-INF-0026-111.
15-May-01 DEVELOPMENT OF A HOSPITAL BASED HOME PROGRAM FOR THE
USE OF INHALED NITRIC OXIDE IN THE CHRONIC MANAGEMENT OF
SEVERE CARDIOPULMONARY DISEASES
15-May-01 CHROMOGENIC IX ASSAY
24-May-01 ATTITUDES TOWARDS SMOKING AND SMOKING CESSATION IN
ADOLESCENT PATIENTS WITH DIABETES AND WITHOUT DIABETES
01-Jun-01 HANDWASHING BEHAVIOR IN PRESCHOOL CHILDREN:
OBSERVATIONS AND IMPLICATIONS IN ACCIDENTAL VS. ABUSIVE
SCALD INJURY
07-Jun-01 DOSE-FINDING FOR LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN
CHILDREN WITH THROMBOSIS
08-Jun-01 DOSE-RANGING TRIAL UTILIZING A RECOMBINANT UROKINASE
(ABT-120) IN THE TREATMENT OF OCCLUDED CENTRAL VENOUS
CATHETERS PRIMARILY IN ONCOLOGY SUBJECTS, PROTOCOL
NUMBER: M99-116
13-Jun-01 A RANDOMIZED, PLACEBO-CONTROLLED, TRIAL TO ASSESS SAFETY,
TOLERABILITY, AND IMMUNOGENICITY OF INFLUENZA VIRUS
VACCINE, TRIVALENT, TYPES A & B, LIVE COLD-ADAPTED (FLUMIST)
AND MEASLES, MUMPS, RUBELLA, (MMRII) AND VARICELLA (VARIX
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
26
AX) VACCINES ADMINISTERED CONCURRENTLY TO HEALTHY
CHILDREN
15-Jun-01 SUPPORTIVE CARE NETWORK AT THE CHILDREN'S HOSPITAL
18-Jun-01 A MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND
PHARMACOKINETICS OF BREVIBLOC (ESMOLOL HYDROCHLORIDE)
FOR THE TREATMENT OF HYPERTENSION IN INFANTS AND
CHILDREN AFTER SURGICAL REPAIR OF COARCTATION OF THE
AORTA; PROTOCOL NO.: 20,015-004
20-Jun-01 COMPARISON OF DISEASE SEVERITY AT TIME OF REFERRAL FOR
CHILDREN WITH OBESITY AND FAILURE TO THRIVE
20-Jun-01 THE USE OF THE MINIMED CONTINUOUS GLUCOSE MONITORING
SYSTEM IN THE MANAGEMENT OF GLYCOGEN STORAGE DISEASE,
TYPE IA
27-Jun-01 PACTG P1006 - THE EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL
THERAPY (HAART) ON THE RECOVERY OF IMMUNE FUNCTION IN HIV
- INFECTED CHILDREN.
28-Jun-01 RADIOGRAPHIC AND CLINICAL OUTCOME ASSESSMENT OF "SINGLE
CURVES" IN ADOLESCENT IDIOPATHIC SCOLIOSIS: A PILOT STUDY
PRELUDE TO A PROSPECTIVE INVESTIGATION.
29-Jun-01 P9962 A PHASE II STUDY OF INTRATHECAL TOPOTECAN IN PATIENTS
WITH REFRACTORY MENINGEAL MALIGNANCIES
05-Jul-01 BISPECTRAL INDEX MONITORING IN SEDATED PATIENTS IN THE
PEDIATRIC INTENSIVE CARE UNIT
05-Jul-01 HEMOPHILIA JOINT ATLAS
10-Jul-01 BRAIN TISSUE BANKING ACTIVITIES OF THE IMMUNOLOGY/NEURO-
ONCOLOGY RESEARCH LABORATORY
13-Jul-01 PERSISTENT TACHYPNEA OF INFANCY: A RETOSPECTIVE REVIEW
16-Jul-01 A STUDY OF SEQUENTIAL HIGH DOSE CYCLOPHOSPHAMIDE AND
HIGH DOSE CARBOPLATIN WITH PERIPHERAL STEM CELL RESCUE
23-Jul-01 EVALUATION OF PULMONARY FUNCTION TESTS FROM RAISED LUNG
VOLUMES AS OUTCOME MEASURES FOR CLINICAL TRIALS IN
INFANTS WITH CYSTIC FIBROSIS.
25-Jul-01 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY
AND EFFICACY STUDY OF SITAXSENTAN SODIUM TREATMENT IN
PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
25-Jul-01 AN EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND
PHARMACOKINETICS OF SITAXSENTAN SODIUM TREATMENT IN
PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
30-Jul-01 HHV-6 ASSOCIATED DISEASES OF THE CENTRAL NERVOUS SYSTEM
IN IMMUNOCOMPETENT AND IMMUNOCOMPROMISED CHILDREN
01-Aug-01 INVESTIGATION OF THE FINDING OF CORONARY ARTERY
PROMINENCE IN KAWASAKI DISEASE.
01-Aug-01 SUBTOTAL TONSILLAR ALBATION VS TRADITIONAL
TONSILLECTOMY FOR MANAGEMENT OF OBSTRUCTIVE TONSILLAR
HYPERTROPHY; PROTOCOL E1021
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
27
03-Aug-01 BISPECTRAL INDEX MONITORING DURING CONSCIOUS AND DEEP
SEDATION
06-Aug-01 GENETIC MODIFIERS IN CYSTIC FIBROSIS LUNG DISEASE
08-Aug-01 EFFECT OF CAFFEINE ON ENERGY EXPENDITURE IN PREMATURE
NEONATES
09-Aug-01 ANALYSIS OF PERPETRATORS' HISTORIES AND ADMISSIONS
CONCERNING INFLICTED TRAUMATIC BRAIN INJURY IN CHILDREN.
09-Aug-01 PEDIATRIC ELECTROCARDIOGRAM (EKG) INTERPRETATION
ACCURACY BY PEDIATRIC EMERGENCY MEDICINE (PEM)
PHYSICIANS.
14-Aug-01 A PROSPECTIVE MULTINATIONAL, MULTICENTER, CLINICAL TRIAL
OF THE SAFETY AND EFFICACY OF RECOMBINANT HUMAN ACID A-
GLUCOSIDASE (RHGAA) IN CROSS-REACTING IMMUNOLOGIC
MATERIAL-POSITIVE (CRIM(+)) PATIENTS WITH CLASSICAL
INFANTILE POMPE DISEASE
16-Aug-01 A 6-MONTH OPEN LABEL, MULTI-NATIONAL, EFFECTIVENESS, AND
SAFETY STUDY OF ELIDEL (PIMECROLIMUS) CREAM, 1% IN SUBJECTS
WITH ATOPIC DERMATITIS; PROTOCOL NUMBER: CASM981C2405
17-Sep-01 EPIDEMIOLOGICAL STUDY OF THE NATURAL HISTORY OF FABRY
DISEASE (AGAL 014-01)
12-Oct-01 INFLUENCE OF THE PROTONICS NEUROMUSCULAR SYSTEM ON
KINEMATICS AND EMG OF PATIENTS WITH PATELLOFEMORAL PAIN
SYNDROME
18-Oct-01 A MULTICENTER, RANDOMIZED STUDY TO DETERMINE THE
PHARMACOKINETICS AND PHARMACODYNAMICS OF FENOLDOPAM
MESYLATE IN PEDIATRIC SUBJECTS.
29-Oct-01 SURGICAL CORRECTION OF IDIOPATHIC SCOLIOSIS-ALGORITHM
STUDY
01-Nov-01 FAMILY AND YOUTH SERVICES STUDY
09-Nov-01 A TWELVE WEEK, MULTICENTER, DOUBLE-MASKED, PARALLEL
GROUP, PRIMARY THERAPY STUDY OF THE SAFETY AND EFFICACY
OF BETOPTIC S 0.25% COMPARED TO TIMOLOL GEL FORMING
SOLUTION 0.25% AND 0.57 % IN PEDIATRIC PATIENTS WITH
GLAUCOMA OR OCULAR HYPERTENSION.
16-Nov-01 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-
CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF
RECOMBINANT HUMAN A-GALACTOSIDASE A (R-HAGAL) ON
PROGRESSION OF RENAL DISEASE AND SIGNIFICANT CLINICAL
EVENTS IN PATIENTS WITH FABRY DISEASE
19-Nov-01 DEVELOPMENT OF A FINANCIALLY SELF-SUSTAINING CHILD SAFETY
SEAT DISTRIBUTION PROGRAM
19-Nov-01 THE DETERMINATION OF THE HEALING PROCESS OF ANAL/GENITAL
INJURIES IN CHILDREN AND ADOLESCENTS: A MULTI-CENTER
RETROSPECTIVE STUDY
20-Nov-01 USE OF THE EMOTIONAL REACTIONS CHECKLIST WITH
HOSPITALIZED CHILDREN AND ADOLESCENTS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
28
26-Nov-01 A PHENOMENOLOGICAL APPROACH TO INPATIENT EXPERIENCES OF
PEDIATRIC BURN AND TRAUMA PATIENTS IN A CRITICAL CARE UNIT
28-Nov-01 A SURVEY OF CHRONIC PAIN IN THE PEDIATRIC SPINAL CORD
INJURY POPULATION
30-Nov-01 AN OPEN, NON-RANDOMIZED, MULTICENTER STUDY IN CHILDREN
WITH VESICOURETERAL REFLUX GRADE II-IV RECEIVING
ENDOSCOPIC CORRECTION WITH DEFLUX.
30-Nov-01 PACTG P1015: INTENSIFICATION OF HIV-SPECIFIC CD4 AND CD8
ACTIVITY BY CYCLING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
(HAART) IN PEDIATRIC/ADOLESCENT PATIENTS WITH <50 HIV RNA
COPIES/ML
30-Nov-01 DURATION OF ANTIMICROBIAL TREATMENT EFFECT FOLLOWING
ADMINISTRATION OF TOBRAMYCIN FOR INHALATION (TOBI) IN
YOUNG CHILDREN WITH CYSTIC FIBROSIS
05-Dec-01 CLINICAL CORRELATIONS OF SIROLIMUS CONCENTRATIONS IN
BLOOD FROM LIVER AND KIDNEY TRANSPLANT PATIENTS
12-Dec-01 ADAPTATION OF THE PEDIATRIC TQPM INSTRUMENTS FOR
AMBULATORY SURGERY PATIENTS
13-Dec-01 CHILD PASSENGER SAFETY: ASSESSING KNOWLEDGE OF HEALTH
CARE PROVIDERS ON CURRENT RECOMMENDATIONS
20-Dec-01 CHART REVIEW OF PATIENTS WITH ABSENCE EPILEPSY
09-Jan-02 VERIFICATION OF A KIT (DIRECTIGEN LATERAL FLOW RSV TEST)
FOR RAPID LABORATORY DETECTION OF RESPIRATORY SYNCYTIAL
VIRUS INFECTIONS.
10-Jan-02 FABRY INTERNATIONAL RESEARCH EXCHANGE (F.I.R.E.) A REGISTRY
OF FABRY DISEASE: A MULTICENTER, LONGITUDINAL
OBSERVATIONAL STUDY
11-Jan-02 ESCHERICHIA COLI INFECTION STUDIES: VIRULENCE OF
EXTRAINTESTINAL STRAINS
12-Jan-02 EVALUATION OF OVARIAN STEROIDOGENESIS IN A PATIENT WITH
CONGENITAL LIPOID ADRENAL HYPERPLASIA
14-Jan-02 A COMPARISON OF NURSING PROFESSIONAL VALUES BETWEEN
STUDENTS AND STAFF.
18-Jan-02 AN INVESTIGATION OF CAMPS FOR BURN INJURED CHILDREN:
DEVELOPING A SOCIAL WORK MODEL OF PRACTICE AND
EVALUATION "THE BURN CAMP PROJECT"
18-Jan-02 OPEN-LABEL, LONG-TERM SAFETY STUDY OF ZONISAMIDE
(ZONEGRAN) ADMINISTERED TO CHILDREN WITH EPILEPSY
21-Jan-02 THE EFFECT OF DEHYDRATION ON THE QTC INTERVAL OF HEALTHY
CHILDREN
28-Jan-02 GENETIC DETERMINANTS OF CHRONIC RHINOSINUSITIS IN
CHILDREN
28-Jan-02 A RANDOMIZED PHASE 2 TRIAL OF GUIDED IMAGERY IN LYMPHOMA
AND LEUKEMIA BONE MARROW TRANSPLANT PATIENTS
31-Jan-02 CYSTOVENTRICULAR SHUNTING: A TREATMENT OPTION FOR
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
29
INTRACRANIAL ARACHNOID CYSTS.
31-Jan-02 COMPARISON AND PREDICTABILITY OF MIDDLE AND ANTERIOR
CEREBRAL ARTERY DOPPLER FLOW STUDIES IN ASPHYXIATED
NEAR-TERM INFANTS UNDERGOING BRAIN COOLING VERSUS
STANDARD TREATMENT
01-Feb-02 MULTICENTER INVESTIGATION OF INDUCTION OF STABLE MIXED
CHIMERSIM AFTER BONE MARROW TRANSPLANTATION FROM HLA-
IDENTICAL DONORS FOR SICKLE CELL DISEASE
07-Feb-02 COMPLICATIONS OF TITANIUM FLEXIBLE INTRAMEDULLARY NAILS
IN TREATING PEDIATRIC FEMUR FRACTURES: DIFFERENT
COMPLICATIONS FOR OLDER AND YOUNGER PATIENTS
12-Feb-02 BURN INJURIES ON PLAYGROUND EQUIPMENT
18-Feb-02 SPECTRUM OF TORSO INJURIES FROM RIDE-ON LAWNMOWERS:
REPORT OF A CASE AND A REVIEW OF THE NATIONAL PEDIATRIC
TRAUMA REGISTRY
18-Feb-02 DOUBLE TERMINATION OF THE ALIMENTARY TRACT IN A FEMALE:
CASE REPORT AND REVIEW OF THE LITERATURE
18-Feb-02 SPECTRUM OF ANORECTAL MALFORMATIONS IN PYGOPAGUS
CONJOINED TWINS
19-Feb-02 MEDICAL COSTS AND CHARACTERISTICS OF INPATIENTS WITH
ACCIDENTAL AND ABUSIVE HEAD TRAUMAS
21-Feb-02 A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND,
PLACEBO-CONTROLLED CLINICAL TRIAL TO DETERMINE THE
EFFICACY AND SAFETY OF ISEGANAN HCL ORAL SOLUTION IN
REDUCING THE INCIDENCE AND SEVERITY OF ORAL MUCOSITIS IN
PATIENTS RECEIVING STOMATOTOXIC CHEMOTHERAPY
21-Feb-02 CUTANEOUS AND OCULAR MANIFESTATIONS OF FAMILIAL
JUVENILE POLYPOSIS AND OTHER GASTROINTESTINAL TRACT
POLYPOSIS SYNDROMES
27-Feb-02 MINIMALLY INVASIVE OPEN APPENDECTOMY: AN EFFICACIOUS
ALTERNATIVE TO LAPAROSCOPY
27-Feb-02 MORBIDITY AFTER PERCUTANEOUS INSERTION OF CENTRAL LINES
IN CHILDREN
27-Feb-02 MINIMALLY INVASIVE TECHNIQUE FOR REMOVAL OF ESOPHAGEAL
COINS
12-Mar-02 A SAFETY TRIAL USING RECOMBINANT UROKINASE (ABT-120,
UROKINASE ALPHA) IN THE TREATMENT OF OCCLUDED CENTRAL
VENOUS CATHETERS
12-Mar-02 PROMOTION OF SEAT BELT AND CHILD RESTRAINT DEVICE USE
AMONG SUV OCCUPANTS
12-Mar-02 LONG-TERM SURVIVAL FROM THORACIC SPINE OSTEOSARCOMA
AFTER INTRALESIONAL RESECTION AND MULTI-MODAL THERAPY IN
AN ELEVEN YEAR OLD FEMALE
12-Mar-02 SCREENING CRITERIA FOR THE RECOGNITION OF CHILD PHYSICAL
ABUSE
13-Mar-02 BRAIN COOLING FOR THE TREATMENT OF PERINATAL HYPOXIC-
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
30
ISCHEMIC ENCEPHALOPATHY
18-Mar-02 AN EVALUATION OF THE SAFETY AND EFFICACY OF THE SEPTAL
REPAIR DEVICE IN PATIENTS WITH SECUNDUM ARTIAL SEPTAL
DEFECT (ASD) - AMENDED TO INCLUDE SURGICAL COHORT
27-Mar-02 ADVL0022, A PHASE II STUDY OF GEMITABINE (NSC # 613327) IN
CHILDREN WITH RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA OR
ACUTE MYELOGENOUS LEUKEMIA
29-Mar-02 P9761 A PHASE II TRIAL OF IRINOTECAN IN CHILDREN WITH
REFRACTORY SOLID TUMORS: A COG STUDY
31-Mar-02 TRAUMATIC RENOVASCULAR INJURY IN CHILDREN
31-Mar-02 ASSESSMENT OF FACTORS THAT INFLUENCE CLOSURE OF
GASTROSTOMIES.
31-Mar-02 DETERMINATION OF THE EFFECTIVENESS OF TISSEEL (FIBRIN GLUE)
AT REDUCING POST-OPERATIVE CHEST TUBE DRAINAGE AFTER
INTERIOR SPINAL EXPOSURE.
31-Mar-02 MALIGNANT THYMOMA IN CHILDREN
03-Apr-02 FETAL ABDOMINAL WALL DEFECTS AND MODE OF DELIVERY: A
REVIEW OF THE POPULATION DELIVERED AT UNIVERSITY HOSPITAL
05-Apr-02 PHASE II MULTIPLE DOSE TREATMENT OF TYPE 1 DIABETES
MELLITUS WITH HOKT3GAMMA-1 (ALA-ALA)
05-Apr-02 USE OF AN OBSESSIVE-COMPULSIVE SYMPTOM SCREENING TOOL IN
A PSYCHIATRIC DEPARTMENT OF A CHILDREN'S HOSPITAL.
08-Apr-02 A PROFILE OF PEDIATRIC EMERGENCY DEPARTMENT RECIDIVISM
08-Apr-02 ACTG A5093, VERSION 1.0: AN OPEN-LABEL, NON-RANDOMIZED
STUDY OF PHARMACOKINETIC INTERACTIONS BETWEEN DEPO-
MEDROXYYPROGESTERONE ACETATE (DMPA, DEPO-PROVERA ) AND
SELECTED PROTEASE INHIBITOR (PI) AND NONNUCLEOSIDE
REVERSE TRANSCRIPTASE INHIBITOR (NNRTI) THERAPIES AMONG
HIV-INFECTED WOMEN
11-Apr-02 STUDY FIVE: THE SENSORY ASSESSMENT STUDY DEVELOPING A
TEACHER SCALE OF SENSORY FUNCTIONING
11-Apr-02 MEDICAL COSTS, LONGITUDINAL MEDICAL HISTORY AND
CHARACTERISTICS OF CHILDREN HOSPITALIZED FOR ACCIDENTAL
AND ABUSIVE HEAD TRAUMAS
11-Apr-02 CLINICAL EXPERIENCE WITH 3360 C - 3360 L IN THE DIETARY
MANAGEMENT OF AMINO ACID INBORN ERRORS OF METABOLISM
15-Apr-02 ANTIMICROBIAL UTILIZATION OF LEVOFLOXICIN IN A TERTIARY
CARE PEDIATRIC HOSPITAL
17-Apr-02 A TWELVE-WEEK, MULTICENTER, DOUBLE MASKED, PARALLEL
GROUP, PRIMARY THERAPY STUDY OF THE SAFETY AND EFFICACY
OF BETAXON 0.5% COMPARED TO AZOPT 1% IN PEDIATRIC PATIENTS
WITH GLAUCOMA OR OCULAR HYPERTENSION
26-Apr-02 REGISTRY OF CRANIOFACIAL TREATMENT OUTCOMES
26-Apr-02 P 9963 A PHASE II TRIAL OF REBECCAMYCIN ANALOGUE (NSC
#655649) IN CHILDREN WITH SOLID TUMORS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
31
03-May-02 A RANDOMIZED, DOUBLE-BLIND STUDY OF IBUPROFEN L-LYSINE
INTRAVENOUS SOLUTION IN PREMATURE INFANTS FOR THE EARLY
TREATMENT OF PDA
08-May-02 PILOTING AN ATTENDING NURSE CARING MODEL WITH CHILDREN
IN PAIN
13-May-02 HEALTH UPDATE PROJECT: FEASIBILITY STUDY FOR INTERSEXUAL
DISORDERS
16-May-02 PVR GENES IN CLEFT LIP WITH OR WITHOUT CLEFT PALATE
21-May-02 DISTINCTION OF DIFFERENT PARTS OF THE QUADRICEPS FEMORIS IN
MUSCLE FIRING
22-May-02 RESPIRATORY OUTCOMES FOR INFANTS WITH CONGENITAL
MYOTONIC DYSTROPHY
28-May-02 DATA ABSTRACTION FOR DOSE-FINDING FOR LOW MOLECULAR
WEIGHT HEPARIN (LMWH) IN CHILDREN WITH VENOUS THROMBOSIS
28-May-02 DATA ABSTRACTION FOR DOSE-FINDING FOR TISSUE PLASMINOGEN
ACTIVATOR (TPA) IN CHILDREN WITH VENOUS THROMBOSIS
31-May-02 IMPACT OF ADENOTONSILLECTOMY FOR SLEEP APNEA ON QUALITY
OF LIFE
31-May-02 PREVALENCE AND CHARACTERISTICS OF A TREMOR-ATAXIA
DISORDER ASSOCIATED WITH THE FRAGILE X PREMUTATION
03-Jun-02 RESPONSIVE VIRTUAL HUMAN TECHNOLOGY (RVHT)
05-Jun-02 IMPLICATIONS OF INFLUENZA IN CHILDREN WITH BACTERIAL
TRACHEITIS
05-Jun-02 THE CHAIRSIDE SEPARATOR SYSTEM (CSS) USER INTERFACE STUDY
10-Jun-02 THE PREVALENCE OF URINARY TRACT INFECTION IN FEBRILE
CHILDREN WITH GASTROENTERITIS.
10-Jun-02 INSTRUMENTATION FOR FUSION OF IDIOPATHIC SCOLIOSIS: LENKE 1
CURVE PATTERNS ONLY
19-Jun-02 A PHASE III, DOUBLE-BLIND, RANDOMIZED, COMPARATIVE,
MULTICENTER STUDY OF THE IMMUNOGENICITY AND SAFETY OF
THREE DOSES OF GLAXOSMITHKLINE BIOLOGICALS/ THIOMERSAL-
FREE HEPATITIS B VACCINE (10 MCG/0.5 ML) COMPARED TO THE US-
LICENSED GLAXOSMITHKLINE BIOLOGICALS' PRESERVATIVE-FREE
HEPATITIS B VACCINE (ENGERIX-B, 10 MCG/0.5 ML) WHEN
ADMINISTERED INTRAMUSCULARLY ON A 0, 1, 6-MONTH SCHEDULE
TO HEALTHY INFANTS IN THEIR FIRST TWO WEEKS OF LIFE
19-Jun-02 OP-1 IMPLANT
21-Jun-02 COLLECTING AND BANKING RESEARCH SPECIMENS FOR THE STUDY
OF ADULT MALIGNANCIES
24-Jun-02 A MULTICENTER, OPEN LABEL, NON-COMPARATIVE TRIAL OF THE
SAFETY AND EFFICACY OF FLOXIN OTIC SOLUTION IN THE
TREATMENT OF ACUTE OTITIS MEDIA DUE TO HIGHLY PENICILLIN-
RESISTANT STREPTOCOCCUS PNEUMONIAE IN CHILDREN WITH
TYMPANOSTOMY TUBES
24-Jun-02 DEPTH OF DISSECTION DURING TONSILLECTOMY AND THE
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
32
CORRELATION WITH POST-OPERATIVE BLEEDING AND PAIN
26-Jun-02 THE USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF
CHILDREN WITH CONGENITAL MUSCULAR TORTICOLLIS
01-Jul-02 SPLENIC FLEXURE VOLVULUS IN CHILDREN
01-Jul-02 CONGENITAL PARAESOPHAGEAL HERNIAS IN PEDIATRIC PATIENTS
01-Jul-02 RECURRENT PSEUDOTUMORS
01-Jul-02 NEURODEVELOPMENTAL ASSESSMENT OF EXTREMELY LOW BIRTH
WEIGHT (ELBW) INFANTS: SENSITIVITY AND SPECIFICITY OF THE
AGES AND STAGES QUESTIONNAIRES (ASQ)
03-Jul-02 PACTG P1028S VERSION 1.0: HEPATITIS C PREVALENCE IN
PERINATALLY-INFECTED HIV POSITIVE CHILDREN ENROLLED IN
PACTG 219C
03-Jul-02 SUCCESSFUL MANAGEMENT OF GIANT OMPHALOCELE IN A
PREMATURE LOW BIRTH WEIGHT NEONATE UTILIZING A BEDSIDE
CLAMPING TECHNIQUE
19-Jul-02 PERCUTANEOUS INTERNAL PULMONARY ARTERY BANDS IN
INFANTS WITH HYPOPLASTIC LEFT HEART SYNDROME (HLHS)
22-Jul-02 PROMOTING LANGUAGE DEVELOPMENT DURING WELL CHILD
VISITS
23-Jul-02 PARTICIPATION IN GENZYME CORP. FABRY REGISTRY
29-Jul-02 AN OPEN-LABEL STUDY OF LEVOFLAXIN TO EVALUATE
BACTERIOLOGIC OUTCOME IN THE TREATMENT OF CHILDREN WHO
ARE AT RISK FOR ACUTE OTITIS MEDIA THAT IS DIFFICULT TO
TREAT
01-Aug-02 MARCH OF DIMES (MOD) NEWBORN INTENSIVE CARE UNIT (NICU)
PILOT PROJECT
05-Aug-02 EFFICACY OF LEFT THORACOSCOPY AND BLUNT MEDIASTINAL
DISSECTION DURING NUSS PROCEDURE FOR PECTUS EXCAVATUM
06-Aug-02 PROSPECTIVE OBSERVATIONAL STUDY OF MYLOTARG
(GEMTUZUMAB OZOGAMICIN) IN USUAL CARE: PROTOCOL NO.
0903X-100847
09-Aug-02 DEVELOPMENT OF A HOSPITAL-BASED HOME PROGRAM FOR THE
USE OF INHALED NITRIC OXIDE IN THE CHRONIC MANAGEMENT OF
SEVERE CARDIOPULMONARY DISEASES
09-Aug-02 PROSPECTIVE STUDY OF DEXAMETHASONE IN NEONATAL LUPUS
CHB WITH AIM1, AIM2, AIM2A
13-Aug-02 DEVELOPMENT AND CLINICAL VALIDATION OF NEW MEASURES OF
DYNAMIC BALANCE BASED ON CENTER OF MASS (COM) AND
CENTER OF PRESSURE (COP) DETERMINATION.
16-Aug-02 WALKING PERFORMANCE FOLLOWING GAIT ANALYSIS: THE EFFECT
OF NONCOMPLIANCE WITH THERAPEUTIC RECOMMENDATION
16-Aug-02 A MULTICENTER, OPEN-LABEL, STEADY STATE STUDY TO
EVALUATE THE PHARMACOKINETICS OF BENAZEPRIL IN PEDIATRIC
SUBJECTS
16-Aug-02 DISTAL ESOPHAGEAL PERFORATION AFTER BLUNT TRAUMA IN
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
33
CHILDREN
16-Aug-02 A MULTICENTER, RATER-BLIND, RANDOMIZED, AGE-STRATIFIED,
PARALLEL-GROUP STUDY COMPARING TWO DOSES OF
OXCARBAZEPINE AS MONOTHERAPY IN PEDIATRIC PATIENTS WITH
INADEQUATELY-CONTROLLED PARTIAL SEIZURES
18-Aug-02 A MULTICENTER TRIAL OF TOPICAL AMINOGLYCOSIDES TO
ACTIVATE CYSTIC FIBROSIS GENES IN CYSTIC FIBROSIS PATIENTS
18-Aug-02 THE EVALUATION OF PLATELET CALMODULIN AS A MARKER IN
IDIOPATHIC SCOLIOSIS
21-Aug-02 CLINICAL PERFORMANCE MEASURE FOR PEDIATRIC BRAIN INJURY -
PHASE II
23-Aug-02 EFFICACY AND SAFETY OF LEFLUNOMIDE VERSOS METHOTREXATE
IN THE TREATMENT OF PEDIATRIC PATIENTS WITH JUVENILE
RHEUMATOID ARTHRITIS
28-Aug-02 ASSESSMENT OF CHILDREN WITH SLEEP DISORDERS REQUIRING
LABORATORY EVALUATION
28-Aug-02 EFFECT OF BILATERAL PULMONARY ARTERY BANDING JON
SURGICAL OUTCOME OF HEART TRANSPLANTATION FOR OLDER
INFANTS WITH HYPOPLASTIC LEFT HEART SYNDROME
30-Aug-02 A PHARMACOKINETICS-GUIDED PHASE II TRIAL OF THE
REBECCAMYCIN ANALOG NSC# 655649 IN PEDIATRIC PATIENTS WITH
RELAPSE/REFRACTORY NEUROBLASTOMA (T98-0041)
03-Sep-02 A PHASE I TRIAL COMPARING SAFETY, SERUM PHARMACOKINETICS
AND DELIVERY TIME OF A CONCENTRATED TOBRAMYCIN SOLUTION
FOR INHALATION (120 MG/ML) DELIVERED BY AN INVACARE
MOBILAIRE(TM) COMPRESSOR TO TOBI (60 MG/ML). DELIVERED BY A
DEVILBISS PULMOAIDE (TM) COMPRESSOR IN YOUNG (> 6 MONTHS
TO < 12 YEARS OLD) CYSTIC FIBROSIS (CF) PATIENTS
03-Sep-02 PROSPECTIVE EVALUATION OF THE SURGICAL TREATMENT OF
PEDIATRIC IDIOPATHIC SCOLIOSIS
05-Sep-02 AMPLATZER PFO OCCLUDER
05-Sep-02 CLINICAL EXPERIENCE IN THE TREATMENT OF OSTEOPOROSIS AT
THE CHILDREN'S HOSPITAL - A CHART REVIEW
09-Sep-02 INVESTIGATION OF THE EFFICACY AND SAFETY OF DROTRECOGIN
ALFA (ACTIVATED) IN PEDIATRIC SEVERE SEPSIS
09-Sep-02 TEMPORAL TRENDS IN SEVERE RESPIRATORY SYNCYTIAL VIRUS
DISEASE IN COLORADO
13-Sep-02 A RANDOMIZED (2:1), STRATIFIED, DOUBLE-BLIND, PARALLEL-
GROUP, PLACEBO-CONTROLLED, 12 -WEEK, MULTI-CENTER TRIAL OF
FLUTICASONE PROPIONATE HFA INHALATION AEROSOL 88 MCG BID
VERSUS PLACEBO HFA DELIVERED VIA AN MDI AND A VALVED
HOLDING CHAMBER WITH FACEMASK IN PEDIATRIC SUBJECTS 1 TO
4 YEARS OF AGE WITH ASTHMA; PROTOCOL NUMBER: FAS30030.
18-Sep-02 PARENTS PERSPECTIVE ON SURVIVORSHIP
18-Sep-02 AN OPEN-LABEL, SAFETY AND EFFICACY STUDY OF CEFDINIR ORAL
SUSPENSION, 25 MG/KG ONCE DAILY, IN PEDIATRIC SUBJECTS WITH
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
34
ACUTE OTITIS MEDIA
20-Sep-02 THE INFLUENCE OF ATTACHMENT RELATIONSHIPS ON COPING
PROCESSES AND SUBJECTIVE DISTRESS OF ADOLESCENTS TREATED
FOR CANCER
20-Sep-02 GEOGRAPHIC TRENDS IN PNEUMOCOCCAL HOSPITALIZATION IN
COLORADO
20-Sep-02 A PHASE I, OPEN-LABEL SAFETY AND TOLERABILITY STUDY OF
ORAL THERACLEC-TOTAL IN SUBJECTS WITH CYSTIC FIBROSIS
25-Sep-02 EPIDEMIOLOGY OF PEDIATRIC FEMORAL FRACTURES COMBINED
WITH ADDITIONAL INJURIES, INCIDENCE. MECHANISMS AND
SOCIODEMOGRAPHIC RISK FACTORS
04-Oct-02 NATURAL HISTORY OF CHRONIC RHINOSINUSITIS IN CHILDREN
04-Oct-02 RESEARCH SUBJECT ADVOCATE PROGRAM ASSESSMENT AND
PROGRESS
04-Oct-02 MUSCLE ACTIVITY AND MOVEMENT OF PEOPLE WITH PARKINSON'S
DISEASE AND DEEP BRAIN STIMULATORS DURING TREADMILL
WALKING WITH SUPPORT
08-Oct-02 TOXIC SHOCK SYNDROME AND RHINOSINUSITIS IN CHILDREN
14-Oct-02 TREATING MENORRHAGIA IN WOMEN WITH BLEEDING DISORDERS
14-Oct-02 PILOT DOSE FINDING AND EFFICACY STUDY OF ANGIOMAX
(BIVALIRUDIN) AS PRIMARY ANTICOAGULATION IN NEONATES
WITH THROMBOSIS
14-Oct-02 INFLUENZA VACCINATION IN PEDIATRIC RHEUMATOLOGY
PATIENTS
15-Oct-02 STUDY OF SAFETY AND EFFICACY OF ANTIHEMOPHILIC FACTOR /
VON WILLEBRAND FACTOR COMPLEX (HUMATE-P) USING
INDIVIDUALIZED DOSING IN PEDIATRIC AND ADULT SURGICAL
PATIENTS WITH VON WILLEBRAND'S DISEASE.
15-Oct-02 SPINAL MUSCULAR ATROPHY TYPE 1: A RETROSPECTIVE REVIEW OF
PULMONARY AND NUTRITIONAL INTERVENTIONS
21-Oct-02 NON-ALCOHOLIC STEATOHEPATITIS IN TYPE 2 DIABETIC CHILDREN
04-Nov-02 COMPLICATIONS OF SPINAL ANESTHESIA IN PATIENTS WITH HLHS
11-Nov-02 MEASURABLE CHANGES IN CHILDREN WITH MOVEMENT DELAY
FOLLOWING A PEDIATRIC TREATMENT TRAINING COURSE
11-Nov-02 ANALYSIS OF BREATH CONDENSATE IN CHILDREN WITH CYSTIC
FIBROSIS
12-Nov-02 A PILOT STUDY OF DIRECTED DONATION, BANKING AND INFUSION
OF UMBILICAL CORD BLOOD IN INFANTS AT HIGH RISK FOR
DEVELOPING TYPE 1 DIABETES MELLITUS
13-Nov-02 ASCT0031, A PHASE III TRIAL OF HYDROXYCHLOROQUINE +
STANDARD THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
26-Nov-02 ALLOGENEIC NONMYELOABLATIVE HEMATOPOIETIC STEM CELL
TRANSPLANT FOR PATIENTS WITH STI-571PH+ ACUTE LEUKEMIA - A
MULTI CENTER TRIAL (FHCRC 1581.00)
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
35
27-Nov-02 A PILOT STUDY TO DETERMINE THE INFLUENCE OF THE
APOLIPOPROTEIN E GENE ON OUTCOMES IN PEDIATRIC
NEUROTRAUMA
06-Dec-02 A PHASE II STUDY OF INTRAVENOUS DX-8951F (EXATECAN
MESYLATE) ADMINISTERED DAILY FOR FIVE DAYS EVERY THREE
WEEKS TO PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY
RHABDOMYOSARCOMA
11-Dec-02 DOES ONDANSETRON REDUCE THE INCIDENCE OF VOMITING WHEN
USED IN CONJUNCTION WITH KETAMINE DURING PROCEDURAL
SEDATION IN THE PEDIATRIC EMERGENCY DEPARTMENT
14-Dec-02 GUIDELINES FOR APPROPRIATE SEDATION AND ANALGESIA PRIOR
TO NEUROMUSCULAR BLOCKADE IN THE PEDIATRIC INTENSIVE
CARE UNIT
18-Dec-02 THE UTILITY OF THE LANSKY PLAY PERFORMANCE SCALE IN A
PEDIATRIC CHRONIC PAIN OUTPATIENT SETTING.
18-Dec-02 ISOLETTE AIR CONTROL VERSUS SKIN CONTROL FOR TEMPERATURE
REGULATION OF THE NEONATE
19-Dec-02 ATAZANIVIR (BMS-232632) FOR HIV INFECTED INDIVIDUALS: AN
EARLY ACCESS PROGRAM
22-Dec-02 POTENTIAL ASYTOLIC ORGAN DONORS IN A PEDIATRIC INTENSIVE
CARE UNIT
02-Jan-03 A MULTICENTER, LONG-TERM, ACTIVE-SURVEILLANCE STUDY OF
MUSCULOSKELETAL DISORDERS THAT OCCUR AFTER INITIATING A
COURSE OF LEVOFLOXACIN (RWJ-25213-097) OR NON-
FLUOROQUINOLONE THERAPY FOR ACUTE INFECTIOUS DISEASES IN
CHILDREN WHO WERE ENROLLED IN PHASE 3 CLINICAL TRIALS
INVOLVING LEVOFLOXACIN THERAPY PROTOCOL (LOFBO-LTSS-01
(PRI/LOF-INT-4); PHASE 4
07-Jan-03 ESTABLISHMENT AND EVALUATION OF A CASE MANAGEMENT
PROGRAM TO ASSIST CLIENTS IN OBTAINING A PCP OR HEALTH
INSURANCE
08-Jan-03 IMPLEMENTATION OF ONDANSETRON DOSING GUIDELINES IN
POSTOPERATIVE PEDIATRIC PATIENTS
08-Jan-03 PROSPECTIVE POSTUROGRAPHIC ANALYSIS OF ACL
RECONSTRUCTION IN ADOLESCENT PATIENTS
08-Jan-03 CASE REPORT OF USE OF CLONIDINE IN AN INFANT
09-Jan-03 EVALUATING THE APPROPRIATENESS OF ADMISSION TO A
PEDIATRIC EMERGENCY DEPARTMENT OBSERVATION UNIT.
10-Jan-03 A PILOT, MULTICENTER, OPEN LABEL, NON COMPARATIVE STUDY
OF THE SAFETY AND EFFICACY OF FLOXIN OTIC SOLUTION IN THE
TREATMENT OF OTITIS MEDIA TWICE DAILY FOR SEVEN DAYS IN
CHILDREN WITH TYPANOSTOMY TUBES
13-Jan-03 THE MEDICAL CAREER COLLABORATIVE (MC2) - A FORMULA THAT'S
WORKING: THE EFFECTIVENESS OF THE FIRST FOUR YEARS OF MC2
ON ITS PARTICIPANTS AS THEY PREPARE TO GRADUATE
13-Jan-03 EFFECTS OF GROWTH PLATE COMPONENTS ON OSTEOSARCOMA
CELLS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
36
16-Jan-03 CCG-E22 A CASE-CONTROL STUDY OF MALIGNANT GERM CELL
TUMORS IN CHILDREN
17-Jan-03 THERAPEUTIC DRUG MONITORING OF PROTEASE INHIBITORS IN
PREGNANT WOMEN
21-Jan-03 AN OPEN-LABEL, MULTICENTER, SINGLE DOSE STUDY TO EVALUATE
THE PHARMACOKINETICS OF GLIMEPIRIDE (AMARYL: IN PEDIATRIC
PATIENTS WITH TYPE 2 DIABETES MELLITUS
22-Jan-03 OPEN, RANDOMIZED, PHASE II, CLINICAL TRIAL TO COMPARE THE
IMMUNOGENICITY AND SAFETY OF A BOOSTER DOSE OF GSK
BIOLOGICALS' DTAP-IPV VACCINE (INFANRIX-IPV) CO-
ADMINISTERED WITH A BOOSTER DOSE OF MERCK AND COMPANY'S
M-M-RII, TO THAT OF SEPARATE INJECTIONS OF GSK BIOLOGICALS'
DTAP VACCINE (INFANRIX), AVENTIS PASTEUR'S IPV (IPOL) AND M-
M-RII ADMINISTERED AS BOOSTER DOSES TO HEALTHY CHILDREN 4
TO 6 YEARS OF AGE
22-Jan-03 THE EFFECTIVENESS AND TOLERABILITY OF ATYPICAL
ANTIPSYCHOTICS FOR CHILDREN AND ADOLESCENTS
23-Jan-03 ONSET OF HARLEQUIN SYNDROME AFTER NUSS BAR PLACEMENT
24-Jan-03 TRIALNET PREVENTION SCREENING AND STAGING
24-Jan-03 STUDY 08-103: A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED,
PLACEBO-CONTROLLED, 28-DAY STUDY OF INS37217 INHALATION
SOLUTION IN SUBJECTS WITH MILD TO MODERATE CYSTIC FIBROSIS
LUNG DISEASE
24-Jan-03 RETROSPECTIVE REVIEW OF PATIENT CHART AND X-RAYS TO
DETERMINE A SINGLE POSSIBLE PARAMETER OF LENGTH OF STAY,
I.E. DAY OF WEEK OF ADMISSION, IN SPINAL FUSION SURGERY FOR
SCOLIOSIS
24-Jan-03 RETROSPECTIVE REVIEW OF PATIENT CHART AND X-RAYS TO
DETERMINE INDICATIONS OR NEED FOR POST-OPERATIVE X-RAYS IN
SPINAL FUSION SURGERY FOR SCOLIOSIS
24-Jan-03 A MULTI-CENTER PILOT STUDY OF HIGH-DOSE
IMMUNOSUPPRESSIVE THERAPY USING CYCLOPHOSPHAMIDE AND
ANTI-THYMOCYTE GLOBULIN AND FOLLOWED BY AUTOLOGOUS OR
SYNGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
FOR PATIENTS WITH REFRACTORY SYSTEMIC LUPUS
ERYTHEMATOSUS (COMIRB 01-681/FHCRC1630.00)
27-Jan-03 RETROSPECTIVE ANALYSIS OF CHILDREN WITH TESTICULAR
CANCER TREATED AT A SINGLE INSTITUTION
30-Jan-03 A PHASE I/II TRIAL OF PEG12000 INTERFERON ALFA-2B (PEG-INTRON)
FOR PLEXIFORM NEUROFIBROMAS
05-Feb-03 DONATION AFTER CARDIAC DEATH (DCD): SURVEY OF THE
CHILDREN'S HOSPITAL PROFESSIONAL STAFF
20-Feb-03 THE POSITIVE PREDICTIVE VALUE OF RIB FRACTURES AS IN
INDICATOR OF NON-ACCIDENTAL TRAUMA
20-Feb-03 BLUNT DIAPHRAGMATIC RUPTURE IN CHILDREN
20-Feb-03 A RANDOMIZED, MULTICENTER, PARALLEL-GROUP, DOUBLE-BLIND,
VEHICLE-CONTROLLED STUDY TO COMPARE PIMECROLIMUS CREAM
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
37
1% AND VEHICLE IN PRURITUS IMPROVEMENT AND RELIEF DURING
THE FIRST 7 DAYS OF TREATMENT IN PATIENTS _>2 YEARS OLD
WITH MILD TO MODERATE ATOPIC DERMATITIS
26-Feb-03 PEDIATRIC INTENSIVE CARE UNIT SEDATION: SURVEY OF
FELLOWSHIP TRAINING PROGRAMS
26-Feb-03 METHODS AND COMPLICATIONS OF SPLIT-APPENDIX TECHNIQUES
FOR ANTEGRADE CONTINENCE ENEMA
27-Feb-03 STUDY OF LONG-TERM SURVIVORS OF CHILDHOOD CANCER:
DISTURBANCES OF THE DEVELOPING DENTITION AND ASSOCIATED
ORAL STRUCTURES.
27-Feb-03 ANESTHETIC MANAGEMENT OF CHILDREN WITH NAVAJO
NEUROHEPATOPATHY
03-Mar-03 REVIEW OF BOWEL VAGINOPLASTY FOR VAGINAL
RECONSTRUCTION
05-Mar-03 DOES A SIMULATED POSITIVE TEST DOSE DETECT THE
INTRAVASCULAR INJECTION OF BUPIVACAINE WITH EPINEPHRINE
DURING TOTAL INTRAVENOUS ANESTHESIA (TIVA) WITH PROPOFOL
AND REMIFENTANIL?
06-Mar-03 GAIT CLASSIFICATION IN CEREBRAL PALSY USING STATISTICAL
PATTERN RECOGNITION: RETROSPECTIVE MODEL DEVELOPMENT
FROM FEBRUARY 2003
14-Mar-03 A PHASE II STUDY OF INTRAVENOUS DX-8951F (EXATECAN
MESYLATE) ADMINISTERED DAILY FOR FIVE DAYS EVERY THREE
WEEKS TO PEDIATRIC AND YOUNG ADULT PATIENTS WITH EWING'S
SARCOMA (ES), PRIMITIVE NEUROECTOFERMAL TUMOR (PNET), OR
DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRT)
14-Mar-03 EATING DISORDERS AND READINESS FOR CHANGE
18-Mar-03 SATISFACTION WITH SICKLE CELL CARE
26-Mar-03 BLOOD BETA-HYDROXYBUTYRATE (BETA-HBA) LEVELS DURING
THE TREATMENT OF DIABETIC KETOACIDOSIS (DKA)
26-Mar-03 CHROMOSOMAL MARKERS AND THEIR GENOTYPE/PHENOTYPE
CORRELATION
28-Mar-03 PHASE II RANDOMIZED TRIAL OF IRINOTECAN AND CARBOPLATIN
VS. IRINOTECAN IN CHILDREN 1-21 YEARS OF AGES WITH
REFRACTORY SOLID TUMORS
29-Mar-03 DESCRIPTIVE STUDY OF FAMILIES IN THE SUPPORTIVE CARE
NETWORK
01-Apr-03 ASSESSMENT OF A TEEN SICKLE CELL DISEASE FOCUS GROUP
03-Apr-03 COMPASSION FATIGUE/VICARIOUS TRAUMA: A SURVEY OF
CHILDREN'S HOSPITAL SOCIAL WORKERS.
03-Apr-03 A GAP ANALYSIS AND EDUCATION INITIATIVE RELATED TO STAFF
AWARENESS OF COMIRB GUIDELINES
09-Apr-03 PROMOTION OF CHILD RESTRAINT DEVICE USE IN A LOCAL
HISPANIC POPULATION
10-Apr-03 IMPROVING PERFORMANCE OF CF CENTERS IN THE DETECTION AND
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
38
MANAGEMENT OF CYSTIC FIBROSIS-RELATED DIABETES MELLITUS
15-Apr-03 PROTOCOL FOR COLLECTING AND STORING CLINICAL
INFORMATION FOR THE STUDY OF PEDIATRIC CANCER PATIENTS
16-Apr-03 FLEXION TYPE SUPRACONDYLAR HUMERUS FRACTURES IN
CHILDREN
23-Apr-03 THE USE OF A COMPREHENSIVE TOOL TO COMPARE
PHARMACEUTICAL PRACTICES BETWEEN HOSPITALS
23-Apr-03 CHOREOATHETOSIS AFTER OPEN HEART SURGERY - AN IATROGENIC
EPIDEMIC?
23-Apr-03 A COMPARISON OF EXERCISE RESPONSES IN CHILDREN AT SEA
LEVEL AND ALTITUDE: A RETROSPECTIVE REVIEW
24-Apr-03 A MULTI-CENTER, IN-PATIENT, OPEN-LABEL, DOSE RANGING STUDY
TO CHARACTERIZE THE PHARMACOKINETICS AND SAFETY OF AN
ORAL LIQUID FORMULATION OF OXYCODONE IN PATIENTS FROM
BIRTH TO 4 YEARS OF AGE, WHO REQUIRE OPIOID ANALGESIA
30-Apr-03 PREVALENCE OF EATING DISORDER SYMPTOMS IN OVERWEIGHT
YOUTH
30-Apr-03 A MULTICENTER, OPEN-LABEL, MULTIPLE-DOSE STUDY OF THE
CONVERSION FROM IMMEDIATE RELEASE OXYCODONE (OXYIR) TO
CONTROLLED RELEASE OXYCODE (OXYCONTIN) TO EVALUATE
PHARMACOKINETICS AND TO CHARACTERIZE SAFETY AND
EFFICACY IN PEDIATRIC PATIENTS 6 TO 16 YEARS OF AGE
(PROTOCOL # OXP3004 TREATMENT AND EXTENSION PHASE)
30-Apr-03 A RETROSPECTIVE, CHART REVIEW, DETERMINING EFFICACY AND
ADVERSE EFFECTS OF PRIMSOL TRIMETHOPRIM SOLUTION FOR
PROPHYLAXIS OF THE UPPER URINARY TRACT IN PEDIATRIC
PATIENTS WITH VESICOURETERAL REFLUX
02-May-03 MULTICENTER, DOUBLE BLIND, RANDOMIZED, DOSE RANGING
STUDY, IN PEDIATRIC PATIENTS 5 TO <16 YEARS OF AGE RECEIVING
MORPHINE AS STANDARD SUPPLEMENTAL PAIN MEDICATION, TO
EVALUATE PHARMACOKINETICS, SAFETY AND EFFICACY OF OXY
PEDIATRIC LIQUID (1MG/ML) VERSUS PLACEBO IN THE TREATMENT
OF ACUTE MODERATE TO SEVERE PAIN.
03-May-03 PROTOCOL FOR COLLECTING AND STORING CLINICAL
INFORMATION FOR THE STUDY OF PEDIATRIC HEMATOPOIETIC
STEM CELL TRANSPLANT
08-May-03 STAFF PERCEPTIONS OF THE ROLE OF INFORMATION TECHNOLOGY
AS A RESULT OF THE HEALTH INSURANCE PORTABILITY AND
PRIVACY ACT
09-May-03 TREATMENT OF PREPUBERTAL LABIAL ADHESIONS WITH
BETAMETHASONE CREAM
09-May-03 CARDIOPULMONARY EXCERCISE TESTING (CPT)IN PEDIATRIC HEART
TRANSPLANT CANDIDATES
14-May-03 PROTOCOL FOR COLLECTING AND STORING CLINICAL
INFORMATION FOR THE STUDY OF PEDIATRIC NEUROONCOLOGY
16-May-03 A STRATIFIED, RANDOMIZED, DOUBLE-BIND, PLACEBO-
CONTROLLED, PARALLEL GROUP, 12-WEEK TRIAL EVALUATING THE
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
39
SAFETY AND EFFICACY OF THE FLUTICASONE
PROPIONATE/SALMETEROL DISKUS COMBINATION PRODUCT 100/50
MCG ONCE DAILY VERSUS FLUTICASONE PROPIONATE DISKUS
100MCG ONCE DAILY AND PLACEBO IN SYMPTOMATIC PEDIATRIC
SUBJECTS (4-11 YEARS) WITH ASTHMA
19-May-03 ARE ADOLESCENTS DIAGNOSED WITH ANOREXIA NERVOSA, BINGE-
EATING/PURGING TYPE MORE SIMILAR TO ADOLESCENTS
DIAGNOSED WITH ANOREXIA NERVOSA, RESTRICTING TYPE OR
BULIMIA NERVOSA IN TERMS OF CO-MORBID PSYCHIATRIC
SYMPTOMS?
22-May-03 ASSOCIATION OF CYTOCHROME P450 GENOTYPES AND TREATMENT
RESPONSE IN PEDIATRIC ACUTE LEUKEMIA
27-May-03 RETROSPECTIVE REVIEW OF PATIENTS CHARTS TO DETERMINE THE
EFFECTIVENESS OF THE HIGH RISK PATHWAY FOR PATIENTS WHO
UNDERWENT SPINE FUSION SURGERY FOR NEUROMUSCULAR
SCOLIOSIS
03-Jun-03 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-
CONTROLLED, PARALLEL-GROUP STUDY IN PEDIATRIC PATIENTS OF
THE SAFETY AND THE PHARMACOKINETIC PROFILE OF TWO
DIFFERENT INTRAVENOUS DOSES OF TMA-15
10-Jun-03 EVALUATION OF STATLOCK AS AN AID FOR SECURING INDWELLING
EPIDURAL CATHETERS
13-Jun-03 INFORMED CONSENT FOR GENETIC SCREENING
16-Jun-03 NON COMPLETED REFERRALS FROM SPECIAL CARE CLINIC: AN
ASSESSMENT OF FREQUENCY AND REASONS
16-Jun-03 PILOT STUDY OF OUTCOMES OF CHILDREN WITH KAISER
INSURANCE TRIAGED BY THE AFTER-HOURS CALL CENTER
16-Jun-03 POINT OF CARE INSTRUMENT FOR VIRAL RESPIRATORY DIAGNOSIS
17-Jun-03 SMITH-LEMLI-OPITZ (SLO) SYNDROME QUESTIONNAIRE
17-Jun-03 CAROTID ULTRASOUND TRAINING FOR CERTIFICATION
24-Jun-03 SURVEY OF MEDICAID PARTICIPATION AMONG PEDIATRICIANS AND
FAMILY PHYSICIANS IN COLORADO.
24-Jun-03 RETROSPECTIVE EVALUATION OF OUTCOMES OF
IMMUNOSUPPRESSIVE THERAPY FOR SEVERE APLASTIC ANEMIA IN
CHILDREN AT THE UCHSC DEPARTMENT OF PEDIATRICS/DIVISION
OF HEMATOLOGY, 1900-2002
27-Jun-03 A PHASE II, OPEN-LABEL STUDY OF CLOFAREX IN PEDIATRIC
PATIENTS WITH REFRACTORY OR RELAPSED ACUTE MYELOGENOUS
LEUKEMIA
01-Jul-03 CLINICAL EFFICACY AND SAFETY OF MESALAMINE SUPPOSITORIES
(CANASA SALOFALK) IN THE TREATMENT OF PEDIATRIC
ULCERATIVE PROCTITIS: A MULTI-CENTER, OPEN LABEL, PARALLEL
GROUP STUDY
03-Jul-03 CONTROLLED TRIAL OF INDUCTION THERAPY IN RENAL
TRANSPLANTATION / COOPERATIVE CLINICAL TRIALS IN PEDIATRIC
TRANSPLANTATION
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
40
03-Jul-03 PROCLEIX WEST NILE VIRUS ASSAY FOR SCREENING OF
VOLUNTARY DONATIONS OF WHOLE BLOOD OR SOURCE PLASMA
10-Jul-03 AN EVALUATION OF PROVIDER - PATIENT COMMUNICATION:
QUALITY ASSURANCE AND NEEDS ASSESSMENT
15-Jul-03 BREATHE BETTER ASTHMA SCREENING: DETECTION OF ASTHMA
SYMPTOMS IN AN UNDERSERVED POPULATION
18-Jul-03 AN OPEN-LABEL MULTICENTER, STUDY OF THE SAFETY AND
ANTIEMETIC EFFECT OF 0.15 MG/KG INTRAVENOUS ONDANSETRON
HYDROCHLORIDE ADMINISTERED FOR THREE DOSES TO PEDIATRIC
CANCER PATIENTS AGE 6 MONTHS TO 48 MONTHS WHO ARE
RECEIVING MODERATELY TO HIGHLY EMETOGENIC
CHEMOTHERAPY. S3A40320
18-Jul-03 A 7-DAY, OPEN-LABEL, MULTICENTER, PHARMACOKINETIC STUDY
(PART 1) FOLLOWED BY A 7-DAY, RANDOMIZED, MULTICENTER,
DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING,
PARALLEL GROUP STUDY (PART 2) OF IV SILDENAFIL IN THE
TREATMENT OF NEONATES WITH PERSISTENT PULMONARY
HYPERTENSION OF THE NEWBORN (PPHN) OR HYPOXIC
RESPIRATORY FAILURE AT RISK FOR PPHN
18-Jul-03 NURSES' PERCEPTIONS OF THE WORK ENVIRONMENT IN A
PEDIATRIC TERTIARY CARE SETTING
22-Jul-03 A COMPREHENSIVE ASSESSMENT OF PEDIATRIC AFTER-HOURS
TELEPHONE CARE: ONE YEAR'S EXPERIENCE
22-Jul-03 CORRECTION OF FACTITIOUS HYPERKALEMIA IN HEMOLYZED
SPECIMENS
01-Aug-03 THE IMPACT OF HOSPITALIZATION UPON SLEEP EFFICIENCY IN
CYSTIC FIBROSIS PATIENTS
05-Aug-03 A PHASE 1 SINGLE-DOSE, DOSE-ESCALATION TRIAL COMPARING
SAFETY, PHARMACOKINETICS, AND DELIVERY TIME OF
TOBRAMYCIN POWDER FOR INHALATION (TPI POWDER)
ADMINISTERED BY THE NEKTAR T-326 DRY POWDER INHALER
DEVICE (T-326 INHALER) TO TOBRAMYCIN SOLUTION FOR
INHALATION (TOBIr AT 300MG/5ML) ADMINISTERED BY A PARI LC
PLUS JET NEBULIZER/DEVILBISS PULMOAIDE COMPRESSOR IN
CYSTIC FIBROSIS (CF) PATIENTS
07-Aug-03 PROSPECTIVE EVALUATION OF DAILY LOW-DOSE WARFARIN
PROPHYLAXIS FOR CENTRAL VENOUS CATHETER-ASSOCIATED
THROMBOSIS IN CHILDREN WITH CANCER
12-Aug-03 HEALTH CARE SERVICES FOR CHILDREN PLACED IN FOSTER OR
KINSHIP CARE
12-Aug-03 A PILOT STUDY TO DETERMINE THE FREQUENCY AND SIGNIFICANCE
OF BCL-6 EXPRESSION AND MUTATION IN POST-TRANSPLANTATION
LYMPHOPROLIFERATIVE DISORDER IN CHILDREN
12-Aug-03 COMPARISON OF THE SAFETY AND EFFICACY OF DRUGS USED FOR
PEDIATRIC PROCEDURAL SEDATION AND ANALGESIA IN THE
EMERGENCY DEPARTMENT.
14-Aug-03 A COMPARISON OF ORAL PREDNISONE VERSUS ORAL
DEXAMETHASONE IN THE MANAGEMENT OF PEDIATRIC ASTHMA
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
41
EXACERBATIONS
14-Aug-03 KIMS-DATA ENTRY FOR ADULTS ON GROWTH HORMONE
19-Aug-03 NATIONAL AIRWAY CLEARANCE REGISTRY (NACR)
19-Aug-03 "STUDY OF MEDICATIONS FOR TREATMENT OF NEUROLOGICAL
SYMPTOMS ASSOCIATED WITH THE FRAGILE X PREMUTATION"
22-Aug-03 A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, DOSE
RANGING, PARALLEL GROUP STUDY OF ORAL SILDENAFIL IN THE
TREATMENT OF CHILDREN, AGED 1-16 YEARS, WITH PULMONARY
ARTERIAL HYPERTENSION (PROTOCOL A1481131 AND AMENDMENT
1-28, AUGUST 2003 AND AMENDMENT 2-17, DECEMBER 2003)
26-Aug-03 RETROSPECTIVE REVIEW OF CHILDREN WITH TRACHEOSTOMY
TREATED AT THE CHILDREN'S HOSPITAL
26-Aug-03 DETERMINATION OF NURSES' PERCEPTIONS OF THE NON-TASK
DEPENDENCIES OF PATIENTS, THEIR FAMILIES, AND THEIR
CAREGIVERS
29-Aug-03 PERCUTANEOUS PULMONARY ARTERY BANDING WITH THE
AMPLATZER FLOW RESTRICTOR DEVICE
29-Aug-03 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-
CONTROLLED, DOSE-RANGING, PARALLEL GROUP STUDY OF
INTRAVENOUS SILDENAFIL IN THE TREATMENT OF CHILDREN, AGED
0 TO 17 WITH PULMONARY HYPERTENSION AFTER CORRECTIVE
CARDIAC SURGERY
29-Aug-03 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL
EVALUATING THE SAFETY AND EFFICACY OF GLUCOVANCE VERSUS
METFORMIN AND GLYBURIDE MONOTHERAPIES IN PEDIATRIC
PATIENTS WITH TYPE 2 DIABETES MELLITUS (CV 138-059)
03-Sep-03 A PHASE IIA, SAFETY AND EFFICACY STUDY OF ORAL SPI-8811 IN
PATIENTS WITH CYSTIC FIBROSIS (CF)
03-Sep-03 EXPRESSION OF CYCLOXYGENASE AND LIPOXYGENASE ENZYMES
IN NASAL POLYP TISSUE FROM ASPIRIN-SENSITIVE AND ASPIRIN-
TOLERANT AND CYSTIC FIBROSIS PATIENTS
04-Sep-03 PARENTS' PERCEPTION OF DEAF AND HARD OF HEARING TODDLER
GROUP
04-Sep-03 CEREBRAL ISCHEMIA AND CEREBRAL EDEMA IN CHILDREN WITH
DIABETIC KETOACIDOSIS
09-Sep-03 PLATELET FUNCTION ANALYSIS POST TRANSFUSION IN CHILDREN
FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
11-Sep-03 COMPARISON OF ANTIBIOTIC USAGE BETWEEN HOSPITALS
19-Sep-03 AN OPEN-LABEL, RANDOMIZED, NON-INFERIORITY STUDY OF NOVEL
ERYTHROPOIESIS STIMULATING PROTEIN (NESP) AND
RECOMBINANT HUMAN ERYTHROPOIETIN (RHUEPO) FOR THE
TREATMENT OF ANEMIA IN PEDIATRIC SUBJECTS WITH CHRONIC
RENAL INSUFFICIENCY (CRI) OR END-STAGE RENAL DISEASE (ESRD)
RECEIVING DIALYSIS
25-Sep-03 A COMPARATIVE EVALUATION OF CLINICAL INTERPRETIVE
MODALITIES: TELEPHONIC VERSUS IN-PERSON
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
42
02-Oct-03 RETROSPECTIVE STUDY OF COMPUTERIZED TOMOGRAPHY-
GUIDED/CONFIRMED PEDIATRIC INTERVENTIONAL PAIN
PROCEDURES
02-Oct-03 MUCOPOLYSACCHARIDOSIS, TYPE I (MPS 1) DISEASE REGISTRY: A
MULTICENTER, LONGITUDINAL, OBSERVATIONAL STUDY
02-Oct-03 PILOT STUDY OF AN EVIDENCE SUPPORTED, FAMILY BASED WEIGHT
LOSS PROGRAM FOR CHILDREN AND ADOLESCENTS WITH TYPE 2
DIABETES
04-Oct-03 RELIABILITY OF VENTRICULAR SIZE IN ASSESSING CSF SHUNT
FAILURE
09-Oct-03 A PHASE II/III CLINICAL STUDY FOR THE DETERMINATION OF THE
EFFICACY AND SAFETY OF PROTEIN C CONCENTRATE IN SUBJECTS
WITH SEVERE CONGENITAL PROTEIN C DEFICIENCY
10-Oct-03 A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED
SAFETY AND EFFICACY STUDY OF SITAXSENTAN SODIUM
TREATMENT WITH AN OPEN-LABEL BOSENTAN ARM IN PATIENTS
WITH PULMONARY ARTERIAL HYPERTENSION
10-Oct-03 OCULAR INJURIES IN CHILDREN AFTER MAJOR TRAUMA
10-Oct-03 AACTG A5084, VERSION 1.0: EVALUATION OF METABOLIC
COMPLICATIONS ASSOCIATED WITH ANTIRETROVIRAL
MEDICATIONS IN HIV-1-INFECTED PREGNANT WOMEN
14-Oct-03 GENETIC MODIFIERS OF CF: SIBLING STUDY
14-Oct-03 EPIDEMIOLOGY AND NATURAL HISTORY OF CF
14-Oct-03 BEDSIDE STERILITY TESTING OF REPACKAGED FAT EMULSION AT 20
- 24 HOURS AFTER INFUSION INITIATION
14-Oct-03 A DOUBLE BLIND, RANDOMIZED, MULTICENTER STRATIFIED STUDY
TO ASSESS THE SAFETY OF AN INTRAVENOUS STAPHYLOCOCCUS
AUREUS IMMUNE GLOBULIN (HUMAN) {ALTASTAPH} IN LOW BIRTH
WEIGHT NEONATES
17-Oct-03 A PHASE I STUDY OF COMBINATION THERAPY WITH IMMUNOTOXINS
IMTOX 19 (IGG-HD370SMPTODGA) PLUS IMTOX 22 (IGG-RFB4-SMPT-
DGA) IN CHILDREN WITH REFRACTORY/RELAPSED CD10 (+), CD22 (+)
B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
21-Oct-03 EFFECTS OF MULTIPLE ANTI-SPASTICITY INJECTIONS ON GAIT IN
CEREBRAL PALSY
21-Oct-03 LATE PRESENTING SHUNT INFECTIONS
21-Oct-03 THREE-YEAR EXPERIENCE WITH INFLIXIMAB INFUSIONS IN
PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD).
21-Oct-03 BRAIN-COOLING FOR THE TREATMENT OF PERINATAL HYPOXIC-
ISCHEMIC ENCEPHALOPATHY - CONTINUED ACCESS PROTOCOL
23-Oct-03 CORTICOSTEROID TREATMENT IN DUCHENNE MUSCVULAR
DYSTROPHY: LONG-TERM EFFECTS IN DISEASE PROGRESS
23-Oct-03 PEDIATRIC ANESTHETIC IMPLICATIONS ASSOCIATED WITH
KAWASAKI DISEASE
23-Oct-03 EFFECTIVE CLINICAL PERFORMANCE MONITORING OF
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
43
BRONCHIOLITIS PATIENTS
24-Oct-03 EVALUATION OF INFANTILE ACID AND NON-ACID
GASTROESOPHAGEAL REFLUX UTILIZING COMBINED PH
MONITORING AND IMPEDANCE MEASUREMENT.
24-Oct-03 EVALUATION OF GASTROESOPHAGEAL REFLUX IN PEDIATRIC
PATIENTS WITH PULMONARY DISEASE UTILIZING IMPEDANCE
MONITORING
28-Oct-03 A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II
STUDY OF AEROSOLIZED TGAAVCF FOR THE TREATMENT OF CYSTIC
FIBROSIS
28-Oct-03 MICAFUNGIN PROTOCOL FG-463-21-08-"A MULTICENTER, DOUBLE-
BLIND, COMPARATIVE, RANDOMIZED,STUDY TO EVALUATE THE
EFFICACY AND SAFETY OF MICAFUNGIN (FK463) VERSUS
LIPOSOMAL AMPHOTERICIN B (AMBISOME) IN THE TREATMENT OF
INVASIVE CANDIDIASIS AND CANDIDEMIA"
28-Oct-03 GREATER TROCHANTERIC TRANSFER: BIOMECHANICAL ANALYSIS
AND RESULTS.
28-Oct-03 GONADOBLASTOMA AND TURNERS SYNDROME
28-Oct-03 TEEN AND YOUNG ADULT GROUP
30-Oct-03 LOCAL RESISTANCE PATTERNS IN PEDIATRIC URINARY TRACT
INFECTIONS - A RETROSPECTIVE REVIEW
30-Oct-03 OUTCOME OF HEART TRANSPLANTATION FOLLOWING FAILED
FONTAN OR CAVO-PULMONARY SHUNT PALLIATION
06-Nov-03 PROTOCOL CANCER RESEARCH NETWORK (CCRN)
06-Nov-03 PILOT STUDY OF SUB SARTORIAL SAPHENOUS NERVE BLOCK
06-Nov-03 RETROSPECTIVE CHART REVIEW OF: "INTRAVENOUS VALPROATE
(VPA) FOR ACUTE ADOLESCENT MIGRAINE"
06-Nov-03 PEDS-CORI PEDIATRIC ENDOSCOPIC DATABASE SYSTEM - CLINICAL
OUTCOMES RESEARCH INITIATIVE
10-Nov-03 OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF
SITAXSENTAN SODIUM TREATMENT WITH A BOSENTAN ARM IN
PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION.
10-Nov-03 A LONG-TERM OPEN-LABEL STUDY TO EVALUATE THE SAFETY OF
SITAXSENTAN SODIUM TREATMENT IN PATIENTS WITH PULMONARY
HYPERTENSION.
12-Nov-03 IMPACT OF SPECIAL PRIMARY CARE CLINIC ON TCH
14-Nov-03 A BLINDED, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED
TRIAL WITH AZTREONAM FOR INHALATION (AI) IN CYSTIC FIBROSIS
PATIENTS WITH LUNG DISEASE DUE TO P. AERUGINOSA INFECTION
(CP-AI-003)
24-Nov-03 ENDOTHELIAL FUNCTION IN PATIENTS WITH MARFAN SYNDROME: A
PILOT INVESTIGATION
25-Nov-03 USE OF BOTULINUM TOXIN INJUECTIONS TO DELAY ACHILLES
TENDON LENGTHENINGS, A RETROSPECTIVE REVIEW
03-Dec-03 A FOUR-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
44
CONTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY OF
VENTOLIN-F HFA MDI DELIVERED WITH A FACEMASK AND TWO
DIFFERENT HOLDING CHAMBERS IN SUBJECTS AGED 24 TO <48
MONTHS WITH ASTHMA SYMPTOMS (I.E., WHEEZE, COUGH,
DYSPNEA, OR CHEST TIGHTNESS) OR CONSISTENT WITH ASTHMA OR
OBSTRUCTIVE AIRWAY DISEASE OR BRONCHOSPASM.
09-Dec-03 A RANDOMIZED, 2-PERIOD, MULTICENTER, DOUBLE-BLIND,
PARALLEL-GROUP STUDY COMPARING THE EFFECTS OF 2 DOSES OF
MONTELUKAST GRANULES AND PLACEBO IN THE TREATMENT OF
RESPIRATORY SYMPTOMS ASSOCIATED WITH RESPIRATORY
SYNCTIAL VIRUS-INDUCED BRONCHIOLITIS IN CHILDREN AGED 3 TO
24 MONTHS( PROTOCOL/AMENDMENT 272-07)
09-Dec-03 FREQUENCY OF ASCA ANTIBODIES IN PEDIATRIC PATIENTS WITH
CYSTIC FIBROSIS
10-Dec-03 INFLUENZA VACCINE EFFECTIVENESS STUDY AMONG HEALTH CARE
WORKERS
12-Dec-03 STUDY OF THE SAFETY AND EFFECTIVENESS OF THE MENTOR SOFT-
SOLID TESTICULAR PROSTHESIS
17-Dec-03 PARTICIPATION BY CHILDREN IN LIFE SITUATIONS FOLLOWING
NEUROTRAUMA: A PRELIMINARY INVESTIGATION INTO THE
RELATIONSHIP BETWEEN FUNCTIONAL SKILL COMPETENCE AND
OCCUPATIONAL PERFORMANCE.
18-Dec-03 ACCEPTABILITY OF USING GENERAL ANESTHESIA FOR DRESSING
CHANGES IN EB PATIENTS
30-Dec-03 CEREBROSPINAL FLUID VANCOMYCIN CONCENTRATIONS
FOLLOWING INTRAVENOUS THERAPY IN CHILDREN
30-Dec-03 FORMOCRESOL VS. FERRIC SULFATE AS PULPOTOMY
MEDICAMENTS: A RETROSPECTIVE CHART REVIEW
07-Jan-04 TREATMENT OF ADOLESCENT HALLUX VALGUS WITH THE DOUBLE
FIRST METATARSAL OSTEOTOMY: THE DENVER EXPERIENCE
07-Jan-04 ALTE02C1 QUALITY OF LIFE IN CHILDREN WHO SURVIVED
NEUROBLASTOMA
16-Jan-04 ASSESSMENT AND MONITORING OF LIPID ABNORMALITIES IN HIV-
INFECTED INDIVIDUALS ON PROTEASE INHIBITORS
16-Jan-04 A RETROSPECTIVE REVIEW OF THE USE OF RISPERIDONE FOR THE
TREATMENT OF ANOREXIA NERVOSA
16-Jan-04 A PHASE I/II STUDY OF LOPINAVIR/RITONAVIR IN HIV-1 INFECTED
INFANTS < 6 MONTHS OF AGE (PACTG P1030)
20-Jan-04 RETROSPECTIVE STUDY OF NON-CT GUIDED PEDIATRIC
INTERVENTIONAL PAIN PROCEDURES
20-Jan-04 ORIENTATION OF THE LARYNX DURING USE OF THE COBRA
PERILARYNGEAL AIRWAY (PLA) AND LARYNGEAL MASK AIRWAY
(LMA) IN INFANTS AND CHILDREN
23-Jan-04 A RANDOMIZED, INVESTIGATOR-BLIND, MULTICENTER STUDY TO
ASSESS THE BACTERIOLOGICAL EFFICACY OF ORAL
AMOXICILLIN/CLAVULANATE (AUGMENTIN ES-600) 90/6.4MG/KG/D
TWICE DAILY FOR 10 DAYS VERSUS ORAL CEFDINIR (OMNICEF) 14
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
45
MG/KG/D TWICE DAILY FOR 10 DAYS IN THE TREATMENT OF ACUTE
OTITIS MEDIA IN INFANTS AND CHILDREN
27-Jan-04 AN EVALUATION OF THE DURATION OF PLATELET DYSFUNCTION
FOLLOWING NSAID USE
29-Jan-04 KIDSTREET PROGRAM EVALUATION
03-Feb-04 PROTOCOL FOR COLLECTING AND STORING CLINICAL
INFORMATION FOR THE STUDY OF THROMBOPHILIA
04-Feb-04 AN OUTBREAK OF ENTEROVIRUS-71 DISEASE IN COLORADO
06-Feb-04 PACTG P1045: PREVALENCE OF MORPHOLOGIC AND METABOLIC
ABNORMALITIES IN VERTICALLY HIV-INFECTED AND UNINFECTED
CHILDREN AND YOUTH
10-Feb-04 CAN EARLY HOSPITAL DISCHARGE, REGARDLESS OF ANC, BE
SAFELY EXECUTED IN NEUTROPENIC CHILDREN UNDERGOING
INDUCTION TREATMENTS FOR NEWLY DIAGNOSED ACUTE
LYMPHOBLASTIC LEUKEMIA (ALL)?
11-Feb-04 EFFECTS OF PALATAL FEEDING OBUTURATOR ON PATIENTS WITH
CLEFT LIP AND/OR PALATE
17-Feb-04 RESULTS AND COMPLICATIONS WITH SECOND LOOK SURGERY IN
THE TREATMENT OF PEDIATRIC EPENDYMOMAS
17-Feb-04 A DOUBLE-BLIND SAFETY AND EFFICACY STUDY OF SITAXSENTAN
SODIUM TREATMENT IN PATIENTS WITH PULMONARY ARTERIAL
HYPERTENSION WHO HAVE FAILED BOSENTAN THERAPY
17-Feb-04 IMPACT OF HLA MATCHING ON OUTCOME IN PEDIATRIC PATIENTS
UNDERGOING UNRELATED UMBILICAL CORD BLOOD
TRANSPLANTATION
19-Feb-04 THE ORAL HEALTH KNOWLEDGE, OPINIONS, AND PRACTICES OF
NON-ENGLISH SPEAKING HISPANIC PARENTS COMPARED TO
ENGLISH SPEAKING HISPANIC PARENTS.
25-Feb-04 VACCINE PREVENTABLE DISEASE IN THE USA
25-Feb-04 THE EFFECT OF INTRATHECAL BACLOFEN ON SCOLIOSIS
03-Mar-04 SUBMUSCULAR BRIDGE PLATING FOR PEDIATRIC FEMUR
FRACTURES.
03-Mar-04 PROPHYLACTIC ANTIBIOTICS AND CSF SHUNT INFECTION
08-Mar-04 THE USE OF BOTULINUM TOXIN A (BOTOX) IN TREATING THE
SUBSCAPULARIS MUSCLE IN CHILDREN WHO HAVE CONGENITAL
BRACHIAL PLEXUS LESIONS AND INTERNAL ROTATION
LIMITATIONS
09-Mar-04 EVALUATION OF EFFICACY OF CIDOFOVIR FOR TREATMENT OF
ADENOVIRAL INFECTIONS IN BONE MARROW TRANSPLANT
PATIENTS
09-Mar-04 CAREGIVER ASSESSMENT OF PUSHRIM-ACTIVATED, POWER-ASSIST
WHEELCHAIRS IN PEDIATRICS
09-Mar-04 PULMONARY VASCULAR REACTIVITY IN CHILDREN AND
ADOLESCENTS WITH BRONCHOPULMONARY DYSPLASIA
17-Mar-04 PACTG P1042S: COGNITIVE, BEHAVIORAL, AND PSYCHOSOCIAL
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
46
CORRELATES OF MEDICATION ADHERENCE IN CHILDREN AND
ADOLESCENTS WITH HIV-1 INFECTION
26-Mar-04 SAFETY AND EFFICACY OF THORACIC EPIDURALS IN PEDIATRIC
POPULATION
26-Mar-04 GROWTH AND METABOLIC CONSEQUENCES OF BLADDER
AUGMENTATION IN CHILDREN WITH MYELOMENINGOCELE AND
BLADDER EXSTROPHY
26-Mar-04 AN INTERNATIONAL, MULTICENTER, RANDOMIZED, OPEN-LABEL,
PARALLEL EFFICACY AND SAFETY TRIAL OF INTRAVENOUS
ZOLEDRONIC ACID COMPARED TO INTRAVENOUS PAMIDRONATE IN
CHILDREN WITH SEVERE OSTEOGENESIS IMPERFECTA
31-Mar-04 PATTERN RECOGNITION IN CHILDREN BY PEDIATRIC RESIDENTS
31-Mar-04 A PHASE 2, RANDOMIZED, DOUBLE BLIND, PARALLEL DOSE
RANGING STUDY OF ORAL THERACLECTM-TOTAL IN CYSTIC
FIBROSIS SUBJECTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
(TC-2A)
01-Apr-04 PARENTAL PERCEPTION OF ORAL REHABILITATION UTILIZING
GENERAL ANESTHESIA AT 2-3 WEEK POST-OPERATIVE
APPOINTMENT; RISK VERSUS BENEFIT, IS IT WORTH IT?
06-Apr-04 HIP SPICA CASTS AND SKIN FITNESS IN CHILDREN: GORE-TEX
VERSUS TRADITIONAL COTTON CAST LINERS.
06-Apr-04 TRENDS IN PEDIATRIC SKIER AND SNOWBOARDER INJURIES IN
COLORADO
06-Apr-04 CHILDHOOD DEATHS FROM NON-ACCIDENTAL TRAUMA
08-Apr-04 FAMILY SATISFACTION WITH CLINICAL SOCIAL WORK IN A
CHILDREN'S HOSPITAL
21-Apr-04 PSYCHIATRIC DAY TREATMENT FOR SCHOOL REFUSAL
27-Apr-04 TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH ANTIOXIDANT
SOLUTION: A PILOT STUDY
28-Apr-04 SENSITIVITY AND SPECIFICITY OF A NOVEL MYCOBACTERIUM
AVIUM SUBSPECIES PARATUBERCULOSIS PROBE IN PEDIATRIC
BOWEL DISEASES
28-Apr-04 FOLLOW-UP IMAGING OF CLOSED HEAD INJURY WITH
INTRACRANIAL BLEED – ARE REPEAT HEAD CT’S NECESSARY?
30-Apr-04 PRESSURE ANALYSIS IN PULMONARY HYPERTENSION
03-May-04 PHYSICIAN KNOWLEDGE OF EMTALA AT AN ACADEMIC TERTIARY
CARE PEDIATRIC HOSPITAL
05-May-04 MEASUREMENT OF CARDIAC OUTPUT IN CHILDREN UNDERGOING
CARDIAC SURGERY
05-May-04 SEROPREVALENCE AND INCIDENCE OF WEST NILE VIRUS
ANTIBODIES IN TRANSPLANT RECIPIENTS: CORRELATION WITH
CLINICAL OUTCOME AND NEUROLOGIC SEQUELAE
11-May-04 EFFECTIVENESS OF CARIOLOGY AND ART IN A RESIDENCY
PROGRAM
13-May-04 SURVEY FOR ASSESSING DENTAL CARE IN THE HOSPITAL SETTING
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
47
14-May-04 THE EFFECT OF EXERCISE ON THE DEVELOPMENT OF
HYPOGLYCEMIA IN CHILDREN WITH TYPE 1 DIABETES
14-May-04 SEVERE PEDIATRIC OPHTHALMIC TRAUMA SECONDARY TO GOLF-
RELATED INJURY
18-May-04 ASSESSMENT OF INDUCED SPUTUM AS A TOOL TO EVALUATE ANTI-
INFLAMMATORY AGENTS IN PATIENTS WITH CYSTIC FIBROSIS
18-May-04 A PROSPECTIVE STUDY TO EVALUATE AND DETERMINE THE
EFFICACY OF A BOWEL AND BLADDER TREATMENT PROGRAM FOR
PATIENTS WITH DYSFUNCTIONAL ELIMINATION SYNDROME
25-May-04 DNA EXTRACTION FOR COLORADO SUBJECTS WITH AUTISM
01-Jun-04 DIASTOLIC DYSFUNCTION IN MARFAN'S SYNDROME IN CHILDREN
AND YOUNG ADULTS
04-Jun-04 OUTCOME OF HEART TRANSPLANTATION FOR HYPOPLASTIC LEFT
HEART SYNDROME
04-Jun-04 SINGLE BREATH CARDIAC OUTPUT DETERMINATION DURING
EXERCISE IN INDIVIDUALS WITH AND WITHOUT HEART DISEASE
08-Jun-04 PILOT STUDY OF VEGF AND ENOS POLYMORPHISMS IN NEONATES
AT RISK FOR BRONCHOPULMONARY DYSPLASIA
24-Jun-04 TIME REDUCTION IN CLASSROOM ORIENTATION FOR NURSING
STAFF FOLLOWING THE IMPLEMENTATION OF A BLENDED
LEARNING FORMAT (INSTRUCTOR-LED AND ONLINE LEARNING
MODULES).
02-Jul-04 UNILATERAL ABSENT PULMONARY ARTERY: SURGICAL
RECONSTRUCTION AND LONG-TERM FOLLOW-UP
07-Jul-04 A PROSPECTIVE OBSERVATIONAL STUDY OF AIRWAY
MANAGEMENT BY PRE-HOSPITAL PROVIDERS WHO TRANSPORT
PATIENTS TO A DENVER METRO HOSPITAL
16-Jul-04 EXPLORING THE EXPERIENCES OF PEDIATRIC ONCOLOGY PATIENTS
IN THE YOUTH AND PETS SURVIVORS PROGRAM (YAPS)
21-Jul-04 EARLY EXPERIENCE WITH LAPAROSCOPIC PLYOROMYOTOMY IN A
TEACHING INSTITUTION
27-Jul-04 RETROSPECTIVE CHART REVIEW OF COMPLICATIONS OF INFLUENZA
IN THE PICU
28-Jul-04 TRANSITION FOR YOUTH WITH SPECIAL HEALTH CARE NEEDS FROM
PEDIATRIC TO ADULT ORIENTED CARE
03-Aug-04 PROTOCOL NUMBER: C200-002 A PLACEBO-CONTROLLED STUDY TO
EALUATE THE SAFETY AND PILOT EFFICACY OF ILOPROST
INHALATION SOLUTIONS AS ADD-ON THERAPY WITH BOSENTAN IN
SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION.
12-Aug-04 SINGLE DOSE ESCALATION STUDY TO EVALUATE SAFETY OF NASAL
ADMINISTRATION OF CFTR001 GENE TRANSFER VECTOR TO
SUBJECTS WITH CYSTIC FIBROSIS
16-Aug-04 A MULTICENTER, EPIDEMIOLOGICAL, OBSERVATIONAL SURVEY OF
THE MANAGEMENT OF ANEMIA IN CRITICALLY ILL PEDIATRIC
PATIENTS
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
48
16-Aug-04 MULTICENTER PROSPECTIVE ANALYSIS OF PEDIATRIC SEDATION
PRACTICE - THE PEDIATRIC SEDATION RESEARCH CONSORTIUM
17-Aug-04 PREMATURE LOSS OF THE PRIMARY MAXILLARY INCISORS: ITS
EFFECTS ON MAXILLARY INTER-CANINE ARCH WIDTH
18-Aug-04 ANALYSIS OF FACTOR VIII AND D-DIMER LEVELS WITH RESPECT TO
THROMBOTIC OUTCOMES IN CHILDREN (SUMMARY PER DOUG FORD
REQUEST)
25-Aug-04 A RANDOMIZED CONTROLLED TRIAL OF THE SHOTBLOCKER FOR
IMMUNIZATION INJECTION PAIN
25-Aug-04 LAPAROSCOPIC ASSISTED PERCUTANEOUS ENDOSCOPIC
GASTROSTOMY IN CHILDREN AND ADOLESCENTS
25-Aug-04 A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, MULTI-CENTER
STUDY OF ALBUTEROL SULFATE HFA INHALATION AEROSOL
DELIVERED CUMULATIVELY WITH A VALVED HOLDING CHAMBER
AND AN ATTACHED FACEMASK IN SUBJECTS BETWEEN BIRTH TO 23
MONTHS OF AGE WITH ACUTE WHEEZING DUE TO OBSTRUCTIVE
AIRWAYS DISEASE (SB030002)
26-Aug-04 PARENT AND FAMLIY CARE PROVIDER EXPERIENCES WITH
PASTORAL CARE SUPPORT IN THE CONTEXT OF SHAKEN BABY
SYNDROME
31-Aug-04 POSITIONING FOR THE NUSS PROCEDURE: AVOIDING BRACHIAL
PLEXUS INJURIES
31-Aug-04 VERIFICATION OF THE GENEXPERT FOR LABORATORY DETECTION
OF ENTEROVIRUS IN CLINICAL SPECIMENS
02-Sep-04 AEROBIC CAPACITY OF PHYSICIANS IN TRAINING PROGRAMS: THE
FIT-DOC STUDY
14-Sep-04 THE EFFECTIVENESS OF PSOAS LENGTHENING AND PROXIMAL
RECTUS FEMORIS RELEASES ON ANTERIOR PELVIC TILT AND HIP
EXTENSION
14-Sep-04 LAPAROSCOPIC GUIDANCE OR REVISION OF
VENTRICULOPERITONEAL SHUNTS
14-Sep-04 PRESERVATION OF AN ABERRANT LEFT HEPATIC ARTERY DURING
LAPAROSCOPIC NISSEN FUNDOPLICATION.
22-Sep-04 OUTCOMES OF SUBMUCOSAL RESECTION VS RADIO FREQUENCY
TISSUE ABLATION ON INFERIOR NASAL TURBINATES IN CHILDREN:
A CHART REVIEW
27-Sep-04 COLLABORATIVE IMPROVEMENT OF NUTRITIONAL MANAGEMENT
FOR CYSTIC FIBROSIS: THE MOUNTAIN WEST CYSTIC FIBROSIS
CONSORTIUM
28-Sep-04 COMPARISON OF OUTCOMES IN CHILDREN WITH CEREBRAL PALSY
WHEN THE RECOMMENDATIONS FROM GAIT ANALYSIS ARE
OBSERVED
28-Sep-04 THERAPEUTIC RECOMMENDATIONS FOR CHILDREN WITH CEREBRAL
PALSY: A COMPARISON BETWEEN RECOMMENDATIONS FOLLOWING
COMPREHENSIVE GAIT ANALYSIS AND RECOMMENDATIONS USING
CLINICAL DATA ONLY
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
49
28-Sep-04 PATHOLOGY AND IMAGING CORRELATION AND CLASSIFICATION
FOR PEDIATRIC INTERSTITIAL LUNG DISEASE (PILD)
28-Sep-04 PACTG P1057: A PHASE I/II RANDOMIZED TRIAL OF THE SAFETY AND
IMMUNOGENICITY OF COLD ADAPTED INFLUENZA VACCINE
(FLUMIST™)IN HIV-INFECTED CHILDREN AND ADOLESCENTS
04-Oct-04 SURGICAL MANAGEMENT OF THE DUPLICATED KIDNEY: A REVIEW
06-Oct-04 THE NEUROPSYCHOLOGICAL DIFFERENCES BETWEEN A CONTROL
GROUP OF PHYSICIANS AND PHYSICIANS REFERRED FOR
COMPETENCY EVALUATIONS.
08-Oct-04 A PHASE II, OPEN-LABEL STUDY OF CLOFARABINE IN PEDIATRIC
PATIENTS WITH REFRACTORY OR RELAPSED ACUTE
LYMPHOBLASTIC LEUKEMIA
08-Oct-04 TELEPHONE TRIAGE PARENTAL PRIOR INTENT STUDY
08-Oct-04 STEM CELL CORRELATION STUDY OF HEMATOLOGY ANALYZERS VS.
FLOW CYTOMETER: VALIDATION OF BECKMAN COULTER LH AND
MAXM HEMATOLOGY ANALYZERS TO COUNT HEMOPOIETIC
PROGENITOR CELL ( STEM CELLS ) WBCS
08-Oct-04 THE DETERMINATION OF ENCEPHALITIC EPIDEMIOLOGY WITHIN
THE HOSPITALIZED POPULATION OF COLORADO DURING THE YEARS
1993 TO 2002.
12-Oct-04 GAIT ANALYSIS ALTERS DECISION MAKING IN THERAPEUTIC
RECOMMENDATIONS FOR CHILDREN WITH CEREBRAL PALSY
12-Oct-04 INFLIXIMAB (REMICADE) FOR PATIENTS WITH ACUTE KAWASAKI
DISEASE WHO FAIL TO BECOME AFEBRILE AFTER INTRAVENOUS
GAMMA GLOBULIN THERAPY
12-Oct-04 PSYCHIATRIC DIAGNOSES IN PRESCHOOL CHILDREN WITH FETAL
ALCOHOL SPECTRUM DISORDERS
25-Oct-04 REPETITIVE BEHAVIORS AND SENSORY PROFILES IN CHILDREN
WITH AUTISM SPECTRUM DISORDERS AND DEVELOPMENTAL
DISABILITIES (CHART REVIEW)
25-Oct-04 AALL01B1 - MULTIPARAMETER FLOW CYTOMETRY FOR
ASSESSMENT OF EARLY MARROW RESPONSE IN PEDIATRIC ACUTE
LYMPHOBLASTIC LEUKEMIA (ALL): A COMPANION STUDY TO CCG
1991
29-Oct-04 A MULTICENTER PHASE I TRIAL OF 17-N-ALLYLAMINO-17-
DEMETHOXYGELDANAMYCIN (17-AAG, NSC#330507) IN PATIENTS
WITH RECURRENT/REFRACTORY PEDIATRIC SOLID TUMORS
(EWING'S SARCOMA, DESMOPLASTIC SMALL ROUND CELL TUMOR,
OSTEOSARCOMA, NEUROBLASTOMA, AND RHABDOMYOSARCOMA)
AND LEUKEMIA, NCI PROTOCOL NUMBER 6323
29-Oct-04 A PIVOTAL PHASE 3 STUDY OF MEDI-524 (NUMAX), AN ENHANCED
POTENCY HUMANIZED RESPIRATORY SYNCYTIAL VIRUS (RSV)
MONOCLONAL ANTIBODY, FOR THE PROPHYLAXIS OF SERIOUS RSV
DISEASE IN HIGH-RISK CHILDREN
04-Nov-04 ALTERNATIVE INTERMITTENT CHEMOPROPHYLAXIS FOR
PNEUMOCYSTIS CARINII IN PEDIATRIC LEUKEMIA AND LYMPHOMA
PATIENTS, THE CHILDRENS HOSPITAL EXPERIENCE
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
50
05-Nov-04 NATIONAL SURVEILLANCE FOR EMERGING ADENOVIRUS
INFECTIONS
12-Nov-04 A MULTICENTER, OPEN LABEL EXTENSION TO STUDY THE SAFETY
OF TWICE DAILY ORAL CARVEDILOL IN PEDIATRIC PATIENTS WITH
CHRONIC HEART FAILURE
16-Nov-04 ANTIMICROBIAL UTILIZATION IN THE NEONATAL INTENSIVE CARE
UNIT
16-Nov-04 CRITERIA FOR TRACHEAL EXTUBATION OF PEDIATRIC LIVER
TRANSPLANT PATIENTS IN THE OPERATING ROOM
16-Nov-04 A REVIEW OF PEDIATRIC PULMONARY HYPERTENSION PATIENTS
UNDERGOING GENERAL ANESTHESIA
16-Nov-04 PENTOBARBITAL VERSUS PROPOFOL FOR SEDATION OF PEDIATRIC
PATIENTS DURING RADIOLOGIC STUDIES
16-Nov-04 SEVOFLURANE AS THE SOLE ANESTHETIC FOR COMPUTED
TOMOGRAPHY (CT) IMAGING
16-Nov-04 A PHASE II, MULTI-CENTER, OPEN-LABEL, REPEAT-DOSE STUDY OF
FORODESINE HYDROCHLORIDE IN PATIENTS WITH ADVANCED T-
CELL LEUKEMIA WITH AN OPTION OF LONG-TERM FORODESINE
HYDROCHLORIDE USE
16-Nov-04 A 19-WEEK, RANDOMIZED, DOUBLE-BLIND, MULTICENTER,
PLACEBO-CONTROLLED SAFETY STUDY TO EVALUATE THE
COGNITIVE AND NEUROPSYCHOLOGICAL EFFECTS OF
LEVETIRACETAM 20-60 MG/KG/DAY, DIVIDED IN TWICE DAILY
DOSING, AS ADJUNCTIVE TREATMENT IN CHILDREN 4-16 YEARS OLD,
INCLUSIVE, WITH PARTIAL ONSET SEIZURES.
16-Nov-04 FAMILY INFANT RELATIONSHIP SUPPORT TRAINING (FIRST):
SUPPORTING INFANT-PARENT RELATIONSHIP DEVELOPMENT AFTER
DISCHARGE FROM THE NICU
01-Dec-04 REVIEW OF KIDNEY STONES AND TREATMENT EFFECTIVENESS IN A
PEDIATRIC POPULATION
03-Dec-04 LESSONS LEARNED IN ESTABLISHING A PEDIATRIC BOTOX CLINIC
FOR TREATMENT OF HEADACHES
06-Dec-04 CORRELATIONSHIP OF IL-13RA MRNA EXPRESSION WITH CLINICAL
PROGNOSTIC FACTORS IN EPENDYMOMA
06-Dec-04 EVALUATION FOR THE PRESENCE OF LYMPHOTROPIC
POLYOMAVIRUS, SIMIAN VIRUS 40, JC VIRUS AND BK VIRUS IN
LYMPHOBLASTS.
07-Dec-04 PERNIO IN PEDATRICS: A COLORADO EPIDEMIC?
07-Dec-04 FIVE-YEAR SAFETY SURVEILLANCE FOR "AN OPEN-LABEL TRIAL
EVALUATING THE SAFETY AND EFFICACY OF TAMOXIFEN CITRATE
(NOLVADEX) IN THE TREATMENT OF MCCUNE-ALBRIGHT
SYNDROME"
07-Dec-04 A MULTI-CENTER, OPEN-LABEL, LONG-TERM, FOLLOW-UP STUDY OF
THE SAFETY AND EFFICACY OF LEVETIRACETAM IN CHILDREN WITH
PARTIAL ONSET SEIZURES: N01148
09-Dec-04 THE ASSESSMENT OF PAIN SENSATION DURING LOCAL ANESTHESIA
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
51
DELIVERY USING THE VIBRAJECT DENTAL SYRINGE ATTACHMENT
VERSES A TRADITIONAL DENTAL INJECTION WHILE SHAKING THE
LIP AS A FORM OF STIMULATION.
10-Dec-04 NEUROHORMONAL REGULATION OF ENERGY BALANCE AMONG
PEDIATRIC BRAIN TUMOR SUBJECTS
10-Dec-04 DIRECTIGEN TM- EZ FLU A+B CLINICAL EVALUATION FOR
DETECTION OF INFLUENZA A AND B: DRY SWAB EVALUATION
(TRIAL NO.: 03C1-025-EZFLUD-CHD)
15-Dec-04 NURSES' PERCEPTIONS OF FEEDING INFANTS IN THE NICU AS
ILLUSTRATED BY THEIR STORIES
15-Dec-04 PACTG 394, A PHASE I STUDY OF THE SAFETY, TOLERANCE, AND
PHARMACOKINETICS OF TENOFOVIR DISOPROXIL FUMARATE (TDF)
AND THE COMBINATION OF TDF PLUS EMTRICITABINE IN HIV-1
INFECTED PREGNANT WOMEN AND THEIR INFANTS
20-Dec-04 THE EFFECT OF RECTUS FEMORIS TRANSFER LOCATION ON
CRITICAL KNEE JOINT KINEMATIC VALUES IN CHILDREN WITH
CEREBRAL PALSY.
21-Dec-04 DEVELOPMENT OF A PEDIATRIC FELLOWSHIP TRAINING PROGRAM
REPORT CARD
28-Dec-04 RETROSPECTIVE COMPARISON OF OUTCOMES IN ANTERIOR SPINE
FUSION TECHNIQUE: THORACOTOMY VS. THORASCOPY
30-Dec-04 PARENTAL SURVEY OF CHILD'S POST-SEDATION, 24-HOUR
RECOVERY
04-Jan-05 MARKETING FIELD EVALUATION OF NON-INVASIVE CRITSCAN
HEMATOCRIT MEASUREMENT TECHNOLOGY
07-Jan-05 RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-1 (RHIGF-1)
TREATMENT OF PREPUBERTAL CHILDREN WITH GROWTH FAILURE
ASSOCIATED WITH PRIMARY IGF-1 DEFICIENCY: A PHASE 3,
RANDOMIZED, OPEN-LABEL, OBSERVATION-CONTROLLED,
MULTICENTER, PARALLEL-DOSE COMPARISON TRIAL (MS301)
13-Jan-05 SEDATION ASSESSMENT PRACTICES AMONG EXPERIENCED CICU
NURSES
13-Jan-05 PARENT-CHILD CONFLICT, AUTONOMY AND DIABETES SELF-CARE,
ANCILLARY TO THE TODAY STUDY
14-Jan-05 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND TRIAL OF
SANDOSTATIN LAR DEPOT (40MG) VERSUS SALINE-CONTROL IN THE
TREATMENT OF PEDIATRIC HYPOTHALAMIC OBESITY
18-Jan-05 ACNS0122, A PHASE II STUDY TO ASSESS THE ABILITY OF
NEOADJUVANT CHEMOTHERAPY +/- SECOND LOOK SURGERY TO
ELIMINATE ALL MEASURABLE DISEASE PRIOR TO RADIOTHERAPY
FOR NGGCT
18-Jan-05 AALL01P2 INTENSIVE INDUCTION THERAPY FOR CHILDREN WITH
ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) WHO EXPERIENCE A
BONE MARROW RELAPSE
25-Jan-05 PILOT STUDY TO EVALUATE THE NAVIGATOR CONTINUOUS
GLUCOSE SENSOR IN THE MANAGEMENT OF TYPE 1 DIABETES IN
CHILDREN: A MULTICENTER TRIAL BEING CONDUCTED BY THE
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
52
DIABETES RESEARCH IN CHILDREN NETWORK
01-Feb-05 OBLIQUE PEDICLE SUBTRACTION OSTEOTOMY FOR THE TREATMENT
OF CONGENITAL KYPHOSCOLIOSIS
08-Feb-05 A 6-WEEK, INTERNATIONAL, MULTICENTER, RANDOMIZED, DOUBLE-
BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, PHASE IIIB
STUDY OF THE EFFICACY AND SAFETY OF QUETIAPINE FUMARATE
(SEROQUEL) IMMEDIATE-RELEASE TABLETS IN DAILY DOSES OF 400
MG AND 800 MG COMPARED WITH PLACEBO IN THE TREATMENT OF
ADOLESCENTS WITH SCHIZOPHRENIA
08-Feb-05 A 3-WEEK, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP,
PLACEBO-CONTROLLED, PHASE IIIB STUDY OF THE EFFICACY AND
SAFETY OF QUETIAPINE FUMARATE (SEROQUEL) IMMEDIATE-
RELEASE TABLETS IN DAILY DOSES OF 400 MG AND 600 MG
COMPARED WITH PLACEBO IN THE TREATMENT OF CHILDREN AND
ADOLESCENTS WITH BIPOLAR I MANIA
08-Feb-05 A 26-WEEK, INTERNATIONAL, MULTICENTER, OPEN-LABEL PHASE
IIIB STUDY OF THE SAFETY AND TOLERABILITY OF QUETIAPINE
FUMARATE (SEROQUEL) IMMEDIATE-RELEASE TABLETS IN DAILY
DOSES OF 400 MG TO 800 MG IN CHILDREN AND ADOLESCENTS WITH
BIPOLAR I DISORDER AND ADOLESCENTS WITH SCHIZOPHRENIA
11-Feb-05 CHART REVIEW DESCRIBING/REGARDING THE EFFECT OF
FENOLDOPAM ON MEAN ARTERIAL BLOOD PRESSURE AND URINE
OUTPUT IN PEDIATRIC CARDIAC INTENSIVE CARE PATIENTS
11-Feb-05 OPERATIVE COMPLICATIONS IN CHILDREN WITH KAWASAKI
SYNDROME
18-Feb-05 THROMBOTIC OUTCOMES AND UNDERLYING CONDITIONS IN
LEMIERRE SYNDROME (THROMBOSIS OF THE JUGULAR VEIN IN
ASSOCIATION WITH HEAD AND NECK INFECTION) IN CHILDREN: AN
ANALYSIS OF DATA COLLECTED ON COMIRB PROTOCOLS 02-255 AND
03-368
18-Feb-05 PEDIATRIC DENTAL RAMIFICATIONS OF KAWASAKI SYNDROME
18-Feb-05 EVALUATION OF THE EFFECTIVENESS OF NURSING INITIATIVES ON
PATIENT OUTCOMES: A RETROSPECTIVE STUDY
23-Feb-05 SENSORMEDICS VMAX ST: AGREEMENT WITH A BREATH-BY-
BREATH METABOLIC SYSTEM
23-Feb-05 SHORT TERM CONSEQUENCES OF AN EDUCATIONAL CONFERENCE
FOR THE MANAGEMENT OF PKU
25-Feb-05 YOUTH AND PET SURVIVORS PROGRAM: ASSESSING QUALITY OF
LIFE AMONG PEDIATRIC ONCOLOGY PATIENTS USING THE
PEDIATRIC ONCOLOGY QUALITY OF LIFE SCALE.
09-Mar-05 EVALUATION OF THE PROGRAM IN BIOETHICS AT THE CHILDREN'S
HOSPITAL (PB@TCH)
16-Mar-05 ECHOCARDIOGRAPHIC ASSESSMENT OF AORTIC DIMENSIONS IN
CHILDREN WITH ISOLATED BICUSPID AORTIC VALVE
16-Mar-05 THE ANALGESIC EFFICACY OF PREOPERATIVE HIGH DOSE (40
MG/KG) ORAL ACETAMINOPHEN DURING DENTAL PROCEDURES IN
CHILDREN
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
53
21-Mar-05 A 12-WEEK, MULTI-CENTER EVALUATION OF THE MEDTRONIC
MINIMED 407C INFUSION PUMP FOR DELIVERY OF INTRAVENOUS
REMODULIN IN PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL
HYPERTENSION
30-Mar-05 A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-
CONTROLLED, 28-DAY STUDY OF DENUFOSOL TETRASODIUM
(INS37217) INHALATION SOLUTION IN PATIENTS WITH CYSTIC
FIBROSIS LUNG DISEASE
30-Mar-05 ACNS0231, A PHASE III RANDOMIZED TRIAL FOR THE TREATMENT OF
PEDIATRIC HIGH GRADE GLIOMAS AT FIRST RECURRENCE WITH A
SINGLE HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL
TRANSPLANT VERSUS THREE COURSES OF INTERMEDIATE DOSE
CHEMOTHERAPY WITH PERIPHERAL BLOOD STEM CELL (PBSC)
01-Apr-05 PREVALENCE OF PORTOPULMONARY HYPERTENSION AND
HEPATOPULMONARY SYNDROME IN PEDIATRIC PATIENTS WITH
PORTAL HYPERTENSION
06-Apr-05 AAML00P2, A DOSE FINDING STUDY OF THE SAFETY OF
GEMTUZUMAB OZOGAMICIN COMBINED WITH CONVENTIONAL
CHEMOTHERAPY FOR PATIENTS WITH RELAPSED, REFRACTORY, OR
SECONDARY ACUTE MYELOID LEUKEMIA
06-Apr-05 RACIAL AND ETHNIC VARIATIONS IN LIFE COURSE DEVELOPMENT
OF ADOLESCENT MOTHERS OVER A 2-YEAR INTERVAL FOLLOWING
THE BIRTH OF THEIR FIRST CHILD
06-Apr-05 SATISFACTION WITH QUALITY OF LIFE IN ADOLESCENT CARDIAC
TRANSPLANT RECIPIENTS.
06-Apr-05 AN EXAMINATION OF PSYCHIATRIC TREATMENT'S INFLUENCE ON
THE HELP SEEKING ATTITUDES OF CHILDREN AND ADOLESCENTS
08-Apr-05 POST OPERATIVE COMPLICATIONS AND RISK FOR RE-TREATMENT
WITH PAN RETINAL LASER PHOTOCOAGULATION FOR RETINOPATHY
OF PREMATURITY
12-Apr-05 ADVL0421, A PHASE II STUDY OF OXALIPLATIN IN CHILDREN WITH
RECURRENT SOLID TUMORS
15-Apr-05 THE EFFECT OF RECTUS FEMORIS WITH AND WITHOUT
CONCOMITANT HAMSTRING LENGTHENING AT THE HIP AND PELVIS
IN CHILDREN WITH CEREBRAL PALSY
20-Apr-05 A PHASE 3, DOUBLE-BLIND, MULTICENTER, RANDOMIZED, PLACEBO-
CONTROLLED TRIAL WITH AZTREONAM LYSINATE FOR INHALATION
IN CYSTIC FIBROSIS PATIENTS WITH PULMONARY P. AERUGINOSA
REQUIRING FREQUENT ANTIBIOTICS (AIR CF2) PROTOCOL CP-AI-005.
20-Apr-05 RETROSPECTIVE CHART REVIEW OF TREATMENTS FOR PEDIATRIC
URETERAL REFLUX FROM 1990 TO PRESENT.
22-Apr-05 PATTERN OF AORTIC ROOT DILATION IN MARFAN SYNDROME
VERSUS BICUSPID AORTIC VALVE
22-Apr-05 LAPSE OF CARE AS A PREDICTOR FOR MORBIDITY IN ADULTS WITH
CONGENITAL HEART DISEASE
27-Apr-05 A GROUP INTERVENTION FOR EXECUTIVE FUNCTION PROBLEMS IN
ADOLESCENTS WITH TRAUMATIC BRAIN INJURY
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
54
28-Apr-05 A PILOT STUDY OF THE SAFETY OF ORAL HIGH FREQUENCY
OSCILLATION FOR AIRWAY SECRETION CLEARANCE IN CYSTIC
FIBROSIS.
04-May-05 PHASE I STUDY OF ERBITUX (CETUXIMAB) IN PEDIATRIC SUBJECTS
WITH REFRACTORY SOLID TUMORS: CHARACTERIZATION OF SERUM
PHARMACOKINETICS, SAFETY, AND EFFICACY FOLLOWING SINGLE
DOSES AND REPEATED DOSES ADMINISTRATION WHEN COMBINED
WITH IRINOTECA
05-May-05 EFFECT OF AGE AND SEDATIVE AGENT ON BISPECTRAL INDEX (BIS)
AND DEPTH OF SEDATION IN CHILDREN
05-May-05 FORMOCRESOL BLOOD LEVELS DURING AND AFTER PULPOTOMY IN
PRESCHOOL CHILDREN UNDERGOING COMPREHENSIVE ORAL
REHABILITATION UNDER GENERAL ANESTHESIA
13-May-05 RESULTS OF SPINE DEFORMITY CORRECTION IN PATIENTS WITH
MYELOMENINGOCELE
13-May-05 DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS FOR MIGRAINE
PROPHYLAXIS IN ADOLESCENTS: AN OPEN-LABEL, LONG-TERM
SAFETY STUDY. PROTOCOL #: M03-648 SPONSOR: ABBOTT
LABORATORIES
20-May-05 MULTINATIONAL, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY,
COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY
OF TELITHROMYCIN 25MG/KG GIVEN ONCE DAILY FOR 5 OR 10 DAYS
DEPENDING ON AGE AND PREVIOUS TREATMENT HISTORY VERSUS
CEFUROXIME AXETIL 15 MG/KG, GIVEN TWICE DAILY FOR 10 DAYS,
IN CHILDREN WITH ACUTE OTITIS MEDIA (HMR3647B/3001)
20-May-05 NEURODEVELOPMENTAL DISORDERS AND PSYCHOPHARMACOLOGY
IN PATIENTS WITH SEX CHROMSOME ANEUPLOIDY
25-May-05 PRACTICE PATTERNS AND MEDICAL MANAGEMENT OF CARCINOID
TUMORS WITH OR WITHOUT CARCINOID SYNDROME: A CHART
REVIEW OF 500 PATIENTS
27-May-05 IDURONATE-2-SULFATASE ENZYME REPLACEMENT THERAPY IN
MUCOPOLYSACCHARIDOSIS II (MPSII); TKT CLINICAL PROTOCOL NO.
TKT024EXT
31-May-05 AGCT01P1, PILOT STUDY OF CISPLATIN, ETOPOSIDE, BLEOMYCIN
AND ESCALATING DOSE CYCLOPHOSPHAMIDE THERAPY FOR
CHILDREN WITH HIGH-RISK MALIGNANT GERM CELL TUMORS
06-Jun-05 A MULTI-CENTER, OPEN-LABEL, ACTIVE-CONTROLLED, DOSE-
TITRATION STUDY EVALUATING THE SAFETY, EFFICACY AND
PHARMACOKINETICS OF OXYBUTYNIN TRANSDERMAL SYSTEMS IN
THE TREATMENT OF DETRUSOR OVERACTIVITY ASSOCIATED WITH
A NEUROLOGICAL CONDITION IN PEDIATRIC PATIENTS, FOLLOWED
BY A 12-WEEK OPEN-LABEL SAFETY EXTENSION STUDY
07-Jun-05 THE EFFECTS OF LIMITED ENGLISH PROFICIENCY ON PATIENT
SATISFACTION
13-Jun-05 ANALYSIS OF MRNA ALTERNATIVE SPLICE VARIANTS IN
CHILDHOOD LEUKEMIA: POTENTIAL FOR DIAGNOSTICS
13-Jun-05 UNDERSTANDING THE MOLECULAR BIOLOGY OF CONGENITAL NEVI
13-Jun-05 PERIPHERAL BLOOD MONONUCLEAR CELL GENE EXPRESSION IN
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
55
RESPONSE TO TREATMENT OF CYSTIC FIBROSIS
17-Jun-05 THREONINE AND LYSINE REQUIREMENTS FOR OPTIMAL PROTEIN
ANABOLISM IN NEONATES-A PILOT STUDY
17-Jun-05 A RETROSPECTIVE STUDY OF ORAL SEDATION REGIMENS USED IN
PEDIATRIC DENTISTRY
21-Jun-05 CLINICAL TRIAL OF THE GENEXPERT ENTEROVIRUS ASSAY FOR
DETECTION OF ENTEROVIRUS IN CEREBROSPINAL FLUID
28-Jun-05 PLATELET AGGREGATION INHIBITION IN CHILDREN ON
CLOPIDOGREL (PICOLO); DOSE-RANGING PHARMACODYNAMIC
ASSESSMENT OF PLATELET AGGREGATION INHIBITION WITH
CLOPIDOGREL IN CHILDREN OF BLALOCK-TAUSSIG SHUNT AGE
CATEGORIES (NEONATE AND INFANTS/TODDLERS) STUDY NO:
PDY4422-FINAL PROTOCOL VERSION DATE 16, DECEMBER 2002 AND
INCLUDING AMENDMENT 1 DATE 09 MAY 2003 AND AMENDMENT 2
DATED 02 APRIL 2004.
28-Jun-05 EVALUATION OF AN ACUITY SYSTEM AND NURSING WORKLOAD
19-Jul-05 A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 28-DAY
STUDY OF DENUFOSOL TETRASODIUM (INS37217) INHALATION
SOLUTION IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS LUNG
DISEASE
22-Jul-05 THE RELATIONSHIP OF ILIOTIBIAL BAND LENGTH AND GLUTEUS
MEDIUS STRENGTH IN SUBJECTS WITH PATELLOFEMORAL PAIN AND
TREATMENT IMPLICATIONS
26-Jul-05 A MULTI-CENTER PHASE IB STUDY OF OXALIPLATIN (NCS#266046) IN
COMBINATION WITH FLUOROURACIL AND LEUCOVORIN IN
PEDIATRIC PATIENTS WITH ADVANCED SOLID TUMORS
26-Jul-05 APHAKIC GLAUCOMA AND TREATMENT WITH ENDOLASER
CYCLOPHOTOCOAGULAION-THE CHILDREN'S HOSPITAL OF DENVER
EXPERIENCE
27-Jul-05 ASCENSION PIP
27-Jul-05 A CASE SERIES OF CHILDREN WITH COLPOCEPHALY AND ITS AFFECT
ON THE VISUAL SYSTEM.
02-Aug-05 POST-CONTRAST DELAYED MYOCARDIAL ENHANCEMENT
PATTERNS IN CONGENITAL HEART DISEASE
02-Aug-05 THE LUPUS ANTICOAGULANT AND THROMBOTIC OUTCOMES IN
CHILDREN: AN ANALYSIS OF DATA COLLECTED UNDER COMIRB
PROTOCOLS #02-255 AND #03-368
02-Aug-05 THE ASSOCIATION OF THROMBOPHILIC TRAITS WITH PERINATAL
THROMBOSIS: AN ANALYSIS OF DATA COLLECTED UNDER COMIRB
PROTOCOLS #02-255 AND #03-368.
05-Aug-05 ASSESSMENT OF AORTIC WALL COMPLIANCE IN PATIENTS WITH
BICUSPID AORTIC VALVE AND COARCTATION OF THE AORTA BY
TISSUE DOPPLER
05-Aug-05 A MULTICENTER, OPEN-LABEL, SINGLE-ARM, TWO-STEP STUDY TO
EVALUATE THE SAFETY AND SINGLE-DOSE PHARMACOKINETICS OF
FAMCICLOVIR AND MULTIPLE-DOSE SAFETY AFTER
ADMINISTRATION OF FAMCICLOVIR ORAL PEDIATRIC
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
56
FORMULATION TO CHILDREN 1 TO 18 YEARS OF AGE WITH HERPES
SIMPLEX INFECTION
05-Aug-05 A PHASE II STUDY OF CAMPATH-1H IN CHILDREN WITH ACUTE
LYMPHOBLASTIC LEUKEMIA IN SECOND OR REFRACTORY RELAPSE
05-Aug-05 NITRIC OXIDE METABOLISM IN STATIN-TREATED PEDIATRIC SLE
09-Aug-05 AN OPEN-LABEL MULTICENTER STUDY OF THE LONG-TERM SAFETY
OF DEPAKOTE SPRINKLE CAPSULES IN THE TREATMENT OF PARTIAL
SEIZURES IN CHILDREN. CLINICAL PROTOCOL M04-714 SPONSOR-
ABBOTT LABORATORIES
12-Aug-05 A PHASE III RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING HSPE7
AND PLACEBO IN THE TREATMENT OF CHILDREN AND YOUNG
ADULTS WITH RECURRENT RESPIRATORY PAPILLOMATOSIS
REQUIRING FREQUENT DEBULKING SURGERIES PROTOCOL NUMBER:
SGN-00101-0401
12-Aug-05 PULMONARY HYPERTENSION AND SICKLE CELL DISEASE
25-Aug-05 FEEDING PATTERS OF INFANTS AND TODDLERS WITH BRAIN
INJURIES DUE TO CHILD ABUSE
26-Aug-05 COARCTATION OF THE AORTA PRESENTING WITH SEVERE LEFT
VENTRICULAR DYSFUNCTION
26-Aug-05 THE RELATION BETWEEN CHILDHOOD WORKING MEMORY
PERFORMANCE AND PARENT REPORT OF EXECUTIVE FUNCTIONING
FOLLOWING TRAUMATIC AND ACQUIRED BRAIN INJURY.
30-Aug-05 FOLLOW-UP STUDY OF ADULT MALES WITH FRAGILE X SYNDROME:
QUALITY OF LIFE, SUPPORTS AND SERVICES
06-Sep-05 DIET RECORDS: ARE PICTURES REALLY WORTH A THOUSAND
WORDS?
07-Sep-05 REMICADE (INFLIXIMAB) INFUSIONS AND VITAL SIGN MONITORING
14-Sep-05 THE INCEDENCE OF PATIENTS WHO ARE GIVEN A PRESCRIPTION BUT
DISPENSED THE WRONG GLASSES
15-Sep-05 ESTABLISHING THE ETIOLOGY OF CHILDHOOD HEARING LOSS BY
ROUTINE CLINICAL, LABORATORY, AND IMAGING TECHNIQUES
16-Sep-05 A PHASE 3, OPEN-LABEL, FOLLOW-ON STUDY OF MULTIPLE COURSES
OF AZTREONAM LYSINATE FOR INHALATION (AI) IN CYSTIC
FIBROSIS PATIENTS (AIR-CF3)
28-Sep-05 SUBCUTANEOUS GLUCAGON AS A SIMPLE AND EFFICIENT MEANS OF
ASSESSING THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN
CHILDREN
29-Sep-05 OUTCOMES ASSOCIATED WITH OFF-LABEL USE OF RECOMBINANT
FACTOR VIIA IN CHILDREN.
30-Sep-05 CORRELATION BETWEEN DISTANCE WALKED IN SIX-MINUTES AND
MEASURES OF PULMONARY FUNCTION IN CYSTIC FIBROSIS
30-Sep-05 THE IMPACT OF MISSING INFORMATION AT PEDIATRIC EMERGENCY
AND OUTPATIENT CLINIC VISITS
30-Sep-05 TOTAL PARENTERAL NUTRITION PRIOR TO LIVER TRANSPLANT IN
INFANTS WITH BILIARY ATRESIA
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
57
10-Oct-05 A RETROSPECTIVE REVIEW OF THE USES FOR BOTULINUM TOXIN
TYPE A AND B IN A PEDIATRIC HOSPITAL
14-Oct-05 A STUDY TO EVALUATE THE SAFETY, TOLERABILITY,
PHARMACOKINETICS, AND IMMUNOGENICITY OF MEDI-524, A
HUMANIZED ENHANCED POTENCY MONOCLONAL ANTIBODY
AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV), IN CHILDREN
WITH HEMODYNAMICALLY SIGNIFICANT CONGENITAL HEART
DISEASE
20-Oct-05 EVALUATION OF PERCEPTIONS, KNOWLEDGE, AND AWARENESS OF
ITS EFFECTIVENESS HELD BY PEDIATRIC HEALTH CARE PROVIDERS
ON AAPD BEHAVIOR MANAGEMENT TECHNIQUES
21-Oct-05 USING MEDICAL CHART REVIEW TO VALIDATE AN ELECTRONIC
ANTIBIOTIC CLASSIFICATION SYSTEM
25-Oct-05 AN OPEN LABEL, MULTICENTER STUDY TO ASSESS THE
PHARMACOKINETICS, TOLERABILITY, AND SAFETY OF A PEDIATRIC
FORMULATION OF BOSENTAN IN CHILDREN WITH IDIOPATHIC OR
FAMILIAL PULMONARY ARTERIAL HYPERTENSION PROTOCOL:
FUTURE 1 AC-052-365
28-Oct-05 TOPMAT-PEP-3001: A RANDOMIZED, DOUBLE-BLIND,PLACEBO-
CONTROLLED,FIXED-DOSE RANGING STUDY TO ASSESS THE SAFETY,
TOLERABILITY, AND EFFICACY OF TOPIRAMATE ORAL LIQUID AND
SPRINKLE FORMULATIONS AS AN ADJUNCT TO CONCURRENT
ANTICONVULSANT THERAPY FOR INFANTS (1-24 MONTHS OF
AGE,INCLUSIVE) WITH REFRACTORY PARTIAL ONSET SEIZURES,
WITH OPEN-LABEL EXTENSION
04-Nov-05 A STUDY OF THE SAFETY AND PHARMACOKINETICS OF 552-02
FOLLOWING FOURTEEN DAYS OF DOSING BY INHALATION IN
PATIENTS WITH CYSTIC FIBROSIS
04-Nov-05 RETROSPECTIVE ANALYSIS OF VALVED HOMOGRAFT SHORT-TERM
PERFORMANCE: A COMPARISON OF SYNERGRAFT®
DECELLULARIZED GRAFTS TO NORMAL CRYO-PRESERVED
CRYOVALVE® GRAFTS
06-Nov-05 MEASURING NURSES' INDIVIDUAL PERCEPTION OF WORKLOAD
USING THE INDIVIDUAL WORKLOAD PERCEPTION SCALE (IWPS)
06-Nov-05 EFFECT OF SILDENAFIL THERAPY ON CHILDHOOD PULMONARY
ARTERIAL HYPERTENSION
10-Nov-05 PHARMACOGENOMICS OF PULMONARY ARTERIAL HYPERTENSION
10-Nov-05 PEDIATRIC HOSPITALIST CO-MANAGEMENT OF SPINE FUSION
SURGERIES: THE EXPERIENCE AT THE CHILDRENS' HOSPITAL
15-Nov-05 INCIDENCE OF COMMUNITY-ACQUIRED METHICILLIN-RESISTANT
STAPHYLOCCUS AUREUS HEAD AND NECK INFECTIONS IN A
PEDIATRIC POPULATION
21-Nov-05 STEREOTACTIC RADIOSURGERY AS A CURATIVE ADJUNCT IN
INCOMPLETELY RESECTED RECURRENT EPENDYMOMA
21-Nov-05 HUMAN METAPNEUMOVIRUS (HMPV) LOWER RESPIRATORY TRACT
INFECTION IN CHILDREN: CLINICAL VALIDATION OF AN HMPV PCR
AND DETERMINATION OF RISK FACTORS FOR SEVERE HMPV
INFECTION
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
58
01-Dec-05 KNOWLEDGE OF NOCSAE HELMET STANDARD AMONG HIGH
SCHOOL LACROSSE COACHES.
16-Dec-05 A PHASE I/II, MULTI-CENTER, OPEN-LABEL, REPEAT-DOSE STUDY OF
FORODESINE HYDROCHLORIDE INFUSION IN PATIENTS WITH B-CELL
ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN OPTION OF EXTENDED
USE OF FORODESINE HYDROCHLORIDE
30-Dec-05 ENVIRONMENTAL FACTORS AND BILIARY ATRESIA
05-Jan-06 ANESTHETIC CHALLENGES AND COMPLICATIONS ASSOCIATED WITH
RADIATION THERAPY AT AN OFFSITE HOSPITAL
06-Jan-06 MULTI-CENTER STUDY ON THE INCIDENCE OF INTRA-OPERATIVE
AWARENESS AND RECALL IN THE PEDIATRIC POPULATION
UNDERGOING GENERAL ANESTHESIA: CARE - CHILDHOOD
AWARENESS AND RECALL EVALUATION
13-Jan-06 INVASIVE PNEUMOCOCCAL INFECTION AND THE FREQUENCY OF
RENAL DYSFUNCTION, INCLUDING HEMOLYTIC UREMIC SYNDROME.
A 5 YEAR RETROSPECTIVE ANALYSIS.
25-Jan-06 INCIDENCE OF RECURRENT DECAY FOLLOWING DENTAL
REHABILITATION UNDER GENERAL ANESTHESIA, A CHART REVIEW
OF 100 CASES.
25-Jan-06 INCIDENCE OF NEW DECAY FOLLOWING DENTAL REHABILITATION
WITH CONSCIOUS SEDATION, A CHART REVIEW OF 50 CASES.
25-Jan-06 PARENTAL KNOWLEDGE AND EXPECTATIONS OF ORAL
REHYDRATION THEARAPY (ORT) IN CHILDREN WITH MILD TO
MODERATE DEHYDRATION
26-Jan-06 RESIDENCY TRAINING IN CHILD MALTREATMENT: A NATIONAL
STUDY OF RESIDENTS AND PROGRAM DIRECTORS
07-Feb-06 CORRELATION OF ABDOMINAL OXIMETER MONITORING WITH
GASTRIC TONOMETRY AS A MEASUREMENT OF SPLANCHNIC AND
RENAL PERFUSION IN INFANTS WITH CONGENITAL CYANOTIC
HEART DISEASE
07-Feb-06 PACTG P1059: PHASE I, OPEN-LABEL STUDY TO EVALUATE THE
SAFETY AND TOLERABILITY OF RECOMBINANT HIV-1 VACCINES IN
HIV-1 INFECTED YOUNG ADULTS WITH CONTROL OF HIV-1
REPLICATION AND ON STABLE HIGHLY ACTIVE ANTIRETROVIRAL
THERAPY (HAART)
12-Feb-06 THE EFFECTIVENESS OF STAFF NURSE INTERVIEW COMMITTEE ON
RETENTION/RECRUITMENT OF REGISTERED NURSES
14-Feb-06 LONG-TERM, OPEN-LABEL SAFETY STUDY OF ORAL ALMOTRIPTAN
MALATE 12.5 MG IN THE TREATMENT OF MIGRAINE IN
ADOLESCENTS (PROTOCOL CAPSS-368; PHASE IIIB)
22-Feb-06 A DOUBLE-BLIND, RANDOMIZED, VEHICLE-CONTROLLED TRIAL TO
DETERMINE THE EFFICACY AND SAFETY OF LOCOID LIPOCREAM
(HYDROCORTISONE BUTYRATE 0.1%) CREAM IN THE TREATMENT OF
MILD TO MODERATE ATOPIC DERMATITIS IN PEDIATRIC SUBJECTS,
PROTOCOL 04-110
24-Feb-06 OUTCOMES OF PROXIMAL FEMORAL RESECTION FOR HIP IN
CEREBRAL PALSY
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
59
15-Mar-06 EFFECT OF EDUCATION ON PARENTAL ATTITUDES AND
KNOWLEDGE REGARDING CT RADIATION.
22-Mar-06 A RETROSPECTIVE CHART REVIEW TO ASSESS THE SAFETY OF
OSELTAMIVIR (TAMIFLU) COMPARED TO ALTERNATE ANTIVIRAL
THERAPY (AMANTADINE OR RIMANTADINE) ADMINISTERED TO
CHILDREN LESS THAN 12 MONTHS OF AGE WITH DIAGNOSED OR
SUSPECTED INFLUENZA (CASG 113)
28-Mar-06 AN ONGOING EVALULATION OF THE SAFETY AND EFFICACY OF THE
CARDIOSEL SEPTAL OCCLUSION SYSTEM WITH QWIK LOAD IN
PATIENTS WITH VENTRICULAR SEPTAL DEFECT ("POST-MARKET VSD
FOLLOW-UP REGISTRY")
28-Mar-06 FAMIY PRESENCE DURING RESUSCITATIVE EFFORTS IN A PEDIATRIC
EMERGENCY DEPARTMENT
14-Apr-06 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III
STUDY OF THE PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITOR
TADALAFIL IN THE TREATMENT OF PATIENTS WITH PULMONARY
ARTERIAL HYPERTENSION (PROTOCOL LVGY)
14-Apr-06 A PROSPECTIVE STUDY OF SURGICAL PROCEDURES FOR THE
TREATMENT OF PERSISTENT NASOLACRIMAL DUCT OBSTRUCTION
IN CHILDREN LESS THAN FOUR YEARS OLD
19-Apr-06 MEDIASTINITIS IN CHILDREN AFTER HEART SURGERY
22-Apr-06 ANGIOGENESIS OF AORTOPULMONARY COLLATERAL VESSELS IN
SINGLE VENTRICLE PHYSIOLOGY
22-Apr-06 MOUNTAIN STATES GENETICS NETWORK REGIONAL
COLLABORATIVE CENTER SMALL GRANT PROGRAM NATURAL
HISTORY OF RECOMBINANT 8 SYNDROME
25-Apr-06 HEALTHY PEOPLE 2010 OBJECTIVES FOR A HEALTHY WORKFORCE:
AN EVALUATION OF EMPLOYEE WELLNESS PROGRAMS IN METRO
DENVER
26-Apr-06 A RANDOMIZED, ASSESSOR-BLIND, DOSE-RANGING, PHASE IIIB,
MULTICENTER TRIAL COMPARING THE INTUBATING CONDITIONS
AND TIME COURSE OF BLOCK OF THREE DIFFERENT INTUBATING
DOSES (0.45MG/KG, 0.6MG/KG, AND 1.0MG/KG) OF ZEMURON IN
PEDIATRIC AND ADOLESCENT SUBJECTS UNDER GENERAL
ANESTHESIA
26-Apr-06 VERIFICATION OF A MONOCLONAL ANTIBODY FOR RAPID
DETECTION OF HUMAN METAPNEUMOVIRUS (HMPV) BY DIRECT
IMMUNOFLUORESCENCE AND CULTURE
26-Apr-06 CURRENT TRENDS IN VENTRICULAR SEPTAL DEFECT MANAGEMENT.
28-Apr-06 PO2095 OPEN LABEL, LIMITED ACCESS PROTOCOL OF
POSACONAZOLE IN INVASIVE FUNGAL INFECTIONS
28-Apr-06 CLINICAL OUTCOMES OF PATIENTS IMPLANTED WITH A VAGUS
NERVE STIMULATOR (VNS) AT THE CHILDREN'S HOSPITAL, DENVER.
03-May-06 PNEUMOCOCCAL VACCINE AND HOSPITALIZATION RATES IN
COLORADO AND NATIONALLY
08-May-06 A DOUBLE-BLIND EXTENSION STUDY TO EVALUATE THE LONG-
TERM SAFETY AND EFFICACY OF THE PHOSPHODIESTERASE TYPE 5
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
60
(PDE5) INHIBITOR TADALAFIL IN THE TREATMENT OF PATIENTS
WITH PULMONARY ARTERIAL HYPERTENSION; PROTOCOL LVGX
12-May-06 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
PARALLEL-GROUP STUDY, CONDUCTED UNDER IN-HOUSE BLINDING
CONDITIONS, TO EXAMINE THE SAFETY, TOLERABILITY, AND
EFFICACY OF APREPITANT FOR THE PREVENTION OF
CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING ASSOCIATED
WITH EMETOGENIC CHEMOTHERAPY IN ADOLESCENT PATIENTS.
12-May-06 DESIRED COMPETENCIES OF FUTURE HEALTHCARE PROFESSIONALS:
PERSPECTIVES FROM ADMINISTRATORS, CLINICAL STAFF, PARENTS
AND PATIENTS.
07-Jun-06 C-05-36: SAFETY AND EFFICACY EVALUATION OF TOPICAL MOXIDEX
OTIC SOLUTION COMPARED TO MOXIFLOXACIN SOLUTION IN THE
TREATMENT OF ACUTE OTITIS MEDIA WITH OTORRHEA THROUGH
TYMPANOSTOMY TUBES (AOMT)
09-Jun-06 CORRELATION BETWEEN PHYSICAL EXAMINATION FINDINGS OF
SPASTICITY AND KINEMATIC DATA DURING GAIT LABORATORY
ANALYSIS IN CHILDREN WITH CEREBRAL PALSY
12-Jun-06 NURSES' PERCEPTIONS OF ORGANIZATIONAL RELOCATION
07-Jul-06 SAFETY AND EFFICACY OF INHALED ILOPROST IN PEDIATRIC
PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION PROTOCOL
NUMBER- C200-007
07-Jul-06 PEDIATRIC SPINAL CORD TUMORS AND FUNCTIONAL OUTCOMES
08-Aug-06 VOCAL CORD PARALYSIS AFTER PEDIATRIC CARDIAC SURGERY
22-Aug-06 A RANDOMIZED, SINGLE-BLIND, DOSE-RISING, PLACEBO-
CONTROLLED, CROSSOVER STUDY TO EVALUATE THE
PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY
OF EXENATIDE IN ADOLESCENT SUBJECTS WITH TYPE 2 DIABETES
MELLITUS
05-Sep-06 NURSE-PHYSICIAN RELATIONS
08-Sep-06 A FOUR WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III
TRIAL EVALUATING THE EFFICACY, SAFETY AND
PHARMACOKINETICS OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN
CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER, (MANIC
OR MIXED)
12-Sep-06 A PHASE II STUDY OF PENTOSTATIN FOR THE TREATMENT OF HIGH-
RISK OR REFRACTORY CHRONIC GVHD IN CHILDREN
20-Sep-06 SAFETY OF EMERGENCY DEPARTMENT PEDIATRIC PROCEDURAL
SEDATION AND ANALGESIA
27-Sep-06 26-WEEK OPEN-LABEL EXTENSION STUDY EVALUATING THE SAFETY
AND TOLERABILITY OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN
CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER (MANIC
OR MIXED)
03-Oct-06 BK: A VIRUS ON THE RISE?
10-Oct-06 CRYOVALVE SG HUMAN PULMONARY VALVE FOLLOW-UP STUDY
12-Oct-06 THE BONE MARROW TRANSPLANT REUNION PICNIC: A
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
61
CELEBRATION AND REJUVENATION
24-Oct-06 ASSESSMENT OF PAIN SENSATION DURING LOCAL ANESTHESIA
DELIVERY IN TRADITIONAL DENTAL INJECTIONS USING THE
VIBRAJECT DENTAL SYRINGE ATTACHMENT VERSUS LIP SHAKING
AS MEANS OF DISTRACTIVE STIMULATION.
28-Oct-06 BLADDER URINE CONCENTRATIONS OF TRANSFORMING GROWTH
FACTOR-B1 IN CHILDREN WITH UPPER URINARY TRACT
DILATATION.
28-Oct-06 A PROSPECTIVE, NON-INTERVENTIONAL STUDY TO EVALUATE THE
INCIDENCE OF HOSPITALIZATIONS AND MEDICALLY ATTENDED
LOWER RESPIRATORY TRACT INFECTION (MALRI) IN PREMATURE
INFANTS 32 TO 35 WEEKS GESTATIONAL AGE WHO ARE NOT
RECOMMENDED TO RECEIVE PROPHYLAXIS FOR RSV
03-Nov-06 A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-
CONTROLLED, PARALLEL-GROUP STUDY WITH THREE FIXED DOSES
OF ARIPIPRAZOLE IN THE TREATMENT OF CHILDREN AND
ADOLESCENTS WITH AUTISTIC DISORDER
03-Nov-06 NATIONAL US INPATIENT HEALTHCARE FACILITY METHICILLIN-
RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) SURVEY
10-Nov-06 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND EXPLORATORY
STUDY TO EVALUATE THE EFFICACY OF AN EXTENDED CYCLE
COMBINATION ORAL CONTRACEPTIVE, DP3-84/10, WHICH UTILIZES
ETHINYL ESTRADIOL DURING THE USUAL HORMONE-FREE
INTERVAL, COMPARED TO PLACEBO FOR THE TREATMENT OF
CYCLIC PELVIC PAIN IN ADOLESCENTS. PROTOCOL NUMBER: DR-
PSE-306
12-Nov-06 EVALUATION OF QUETIAPINE USE IN AN INPATIENT PEDIATRIC
POPULATION AT A TEACHING HOSPITAL.
15-Nov-06 EVALUATION OF A COMPUTER-BASED AND MOCK CODE
CURRICULUM TO TEACH PEDIATRIC PHARMACISTS RESUSCITATION
SKILLS.
17-Nov-06 DEPTH OF ANESTHESIA AND THE INCIDENCE OF EMERGENCE
AGITATION AND POST-OPERATIVE BEHAVIORAL CHANGES IN A
POPULATION OF PEDIATRIC DENTAL PATIENTS
01-Dec-06 A PHARMACOKINETIC STUDY OF UT-15C IN SUBJECTS WITH
PULMONARY ARTERIAL HYPERTENSION (PROTOCOL TDE-PH-306)
01-Dec-06 DIURNAL VARIATIONS IN SALIVARY STEROIDS OF BIPOLAR
ADOLESCENT PATIENTS RECEIVING PSYCHOEDUCATION
08-Dec-06 ORTHOPEDIC AND REHABILITATION MEDICINE ENCOUNTERS AFTER
GAIT ANALYSIS STUDIES FOR CHILDREN WITH CEREBRAL PALSY
12-Jan-07 A PHASE 3, RANDOMIZED, OBSERVER-BLIND, CONTROLLED, MULTI-
CENTER STUDY TO EVALUATE THE LOT TO LOT CONSISTENCY OF
NOVARTIS MENINGOCOCCAL ACWY CONJUGATE VACCINE WHEN
ONE DOSE IS ADMINISTERED TO HEALTHY ADOLESCENTS 11-18
YEARS OF AGE AND TO COMPARE THE SAFETY AND
IMMUNOGENICITY OF NOVARTIS MENINGOCOCCAL ACWY
CONJUGATE VACCINE WITH THAT OF LICENSED MENINGOCOCCAL
ACWY CONJUGATE VACCINE (MENACTRA) WHEN ONE DOSE IS
ADMINISTERED TO HEALTHY SUBJECTS 11-55 YEARS OF AGE
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
62
PROTOCOL V59P13
19-Jan-07 RISK OF ADVERSE EVENTS OR MENINGITIS IN FEBRILE INFANTS 28-60
DAYS OF LIFE WITH UTIS AND DERIVATION OF A CLINICAL DECISION
RULE TO IDENTIFY INFANTS 28-60 DAYS OF LIFE WITH UTIS AT VERY
LOW RISK OF BACTEREMIA, ADVERSE EVENTS OR MENINGITIS
25-Jan-07 EVALUATION OF A CLINICAL CARE GUIDELINE FOR THE PEDIATRIC
APPENDECTOMY PATIENT
06-Mar-07 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-
CENTER, CROSSOVER STUDY TO EVALUATE THE EFFECTIVENESS
AND SAFETY OF PANCRECARB MS-16 (PANCRELIPASE) IN REDUCING
STEATORRHEA IN CHILDREN AND ADULTS WITH CYSTIC FIBROSIS
06-Mar-07 MOTHERS AND TODDLERS
30-Mar-07 ARST0431 INTENSIVE MULTI-AGENT THERAPY, INCLUDING DOSE-
COMPRESSED CYCLES OF IFOSFAMIDE/ETOPOSIDE (IE) AND
VINCRISTINE/DOXORUBICIN/CYCLOPHOSPHAMIDE (VDC) FOR
PATIENTS WITH HIGH-RISK RHABDOMYOSARCOMA
06-Apr-07 ANAKINRA FOR SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
04-May-07 EFFECTS OF ETHANOL ON ESSENTIAL TREMOR PATIENTS WITH DEEP
BRAIN STIMULATORS
16-May-07 OUTCOMES OF REPARATIVE AND TRANSPLANT TREATMENT
STRATEGIES FOR CONGENITAL MITRAL STENOSIS WITH
ASSOCIATED MULTILEVEL LEFT HEART OBSTRUCTIONS
16-May-07 PEDIATRIC ANTI-REFLUX SURGERY AT US HOSPITALS (2000-2006)
30-May-07 PRACTICE PATTERNS IN THE EVALUATION OF FEBRILE INFANTS (30
TO 90 DAYS) WITH FEVER DURING WINTERTIME
05-Jul-07 OUTCOMES OF PEDIATRIC MITRAL VALVE REPAIR AND
REPLACEMENT
12-Jul-07 EPIDEMIOLOGIC MULTICENTER STUDY ON MECHANICAL
VENTILATION MANAGEMENT IN CHILDREN WITH ACUTE LUNG
INJURY
18-Jul-07 ASSESSMENT OF THE SINGLE DOSE PHARMACOKINETIC
CHARACTERISTICS OF ZANAFLEX CAPSULES (TIZANIDINE
HYDROCHLORIDE) AFTER A STANDARD MEAL IN CHILDREN WITH
CLINICAL EVIDENCE OF SPASTICITY (AT06-ZC-02)
31-Aug-07 SURGICAL REPAIR OF SUPRAVALVULAR AORTIC STENOSIS AND
OTHER CONGENITAL VASCULAR DEFECTS IN PATIENTS WITH
WILLIAMS SYNDROME
04-Oct-07 THE LOCATION AND DENSITY OF FUNGAL COLONIZATION OF
HEALTHCARE WORKERS AND THEIR PETS: A PRELIMINARY STUDY
10-Oct-07 SAPROPTERIN EXPANDED ACCESS PROGRAM - SEAP-001
22-Oct-07 LAPAROSCOPIC PLACEMENT OF DISTAL VENTRICULOPERITONEAL
SHUNTS
26-Oct-07 RELIABILITY OF THE OXYCON MOBILE GAS ANALYZER DURING A 5-
MINUTE WALK TEST
15-Nov-07 EFFECT OF SILDENAFIL THERAPY ON CHILDHOOD PULMONARY
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
63
HYPERTENSION
21-Nov-07 EVALUATION OF PROLONGED DEXMEDETOMIDINE (DEX, PRECEDEX
(R)) INFUSIONS IN CRITICALLY ILL INFANTS AND CHILDREN.
29-Nov-07 RETROSPECTIVE EVALUATION OF ERTAPENEM IN PEDIATRIC
PATIENTS WITH PERFORATED APPENDICITIS
30-Nov-07 A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
DOSE ESCALATING STUDY TO EVALUATE THE SAFETY,
TOLERABILITY, IMMUNOGENICITY, AND VIRAL SHEDDING OF MEDI-
534, A LIVE, ATTENUATED INTRANASAL VACCINE AGAINST
RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS
TYPE 3 (PIV3) IN HEALTHY CHILDREN 6 TO <24 MONTHS OF AGE
PROTOCOL NUMBER: MI-CP149
30-Nov-07 AN EXPANDED PHASE 1/2A RANDOMIZED, DOUBLE-BLIND, PLACEBO
CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY,
IMMUNOGENICITY, AND VIRAL SHEDDING OF MEDI-560, A LIVE,
ATTENUATED RECOMBINANT PARAINFLUENZA VIRUS TYPE 3 (PIV3)
VACCINE, ADMINISTERED INTRANASALLY TO HEALTHY INFANTS 1
TO <12 MONTHS OF AGE PROTOCOL NUMBER: MIC-CP150
02-Jan-08 BIOMARKERS OF LUNG INJURY AND REMODELING IN CHILDREN
WITH CYSTIC FIBROSIS
01-June-13 PEDIATRIC IMMUNEDEFICIENCY RESEARCH DATABASE
01 Jan 1
03-Mar-14 REDUCING VARIABILITY AMONG MULTIPLE OPERATORS USING A SINGLE
TECHNIQUE AND DEVICE FOR SKIN PRICK TESTING IN CHILDREN
04-Jan-15 EXERCISE DYSPNEA AND THE LARYNX STUDY
11-Nov-15 VALIDATION OF A RAPID MOLECULAR DIAGNOSTIC METHOD FOR MRSA/MSSA IN
PEDIATRIC ATOPIC DERMATITIS PATIENTS
12-Dec-15 ROLE OF Cyp11a1 IN NON-ALLERGIC CHILDREN
14-Dec-15 THE UTILITY OF FOOD-SPECIFIC IGE MEASURED WITH THE IMMULITE 2000 ASSAY
TO PREDICT SYMPTOMATIC FOOD ALLERGY (SIEMENS)
15-Dec-15 SENSITIVITY AND SPECIFICITY OF EXTRACTS MIXES VERSUS COMPONENTS
DURING IMMEDIATE HYPERSENSITIVITY SKIN TEST IN PEDIATRIC
19-Jan-16 INTEGRATED BIOINFORMATION AND SPECIMEN CENTER- GENERAL PROTOCOL
Publications and Abstracts
1995 Esterl B. Immunological Disorders. Medfacts. National Jewish.
1995 Esterl B. Immune Deficiencies. Medfacts. National Jewish.
1996 Gelfand EW, Esterl B, and Mazer B. Benefit of a 12% solution of IVIG
in the treatment of steroid-dependent asthma. In: Immunoglobulins:
Extending the Horizon. Kazatchkine MD and Louwagie A, eds. Parthenon
Publishing Group Ltd. (London, UK), pp.49-62, 1995.
1996 Gelfand EW, Landwehr LP, Esterl B, and Mazer B. Intravenous
Immunoglobulin: An alternative therapy in steroid-dependent
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
64
allergic diseases. Clin Exp Immunol, 10461-66, 1996.
1998 Landwehr LP, Jeppson JD, Katlan MG, Esterl B, McCormick D, Hamilos DL,
and Gelfand EW. Benefits of high dose intravenous immunoglobulin in patients
with severe steroid-dependent asthma. Chest 114:1349-1356, 1998
2001 Abzug, MA, Esterl B. Establishment of a Clinical Trials Office at a Children’s
Hospital. Pediatrics 2001.
2005 Kristine M. Bisgard, Philip Rhodes, Beverly L. Connelly, Daoling Bi, Christine
Hahn, Sarah Patrick, Mary P. Glodé, Kristen R. Ehresmann and the Pertussis
Investigation Team. Pertussis Vaccine Effectiveness Among Children 6 to 59
Months of Age in the United States, 1998–2001. Pediatrics 2005.
2005 Utterson, E. C., Shepherd, R. W., Sokol, R. J., Bucuvalas, J., Magee, J. C.,
McDiarmid, S. V., & Anand, R. (2005). Biliary atresia: clinical profiles, risk
factors, and outcomes of 755 patients listed for liver transplantation. The
Journal of pediatrics, 147(2), 180-185.
2006 Shneider, B. L., Brown, M. B., Haber, B., Whitington, P. F., Schwarz, K.,
Squires, R., ... & Sokol, R. J. (2006). A multicenter study of the outcome of
biliary atresia in the United States, 1997 to 2000. The Journal of pediatrics,
148(4), 467-474.
2007 DeRusso, P. A., Ye, W., Shepherd, R., Haber, B. A., Shneider, B. L.,
Whitington, P. F., ... & Sokol, R. J. (2007). Growth failure and outcomes in
infants with biliary atresia: a report from the Biliary Atresia Research
Consortium. Hepatology, 46(5), 1632-1638.
2011 Russo, P., Magee, J. C., Boitnott, J., Bove, K. E., Raghunathan, T., Finegold,
M., ... & Sokol, R. J. (2011). Design and validation of the biliary atresia research
consortium histologic assessment system for cholestasis in infancy. Clinical
Gastroenterology and Hepatology, 9(4), 357-362.
2015 Esterl, E. (2015). Reducing Variability Among Multiple Operators Using a
Single Technique and Device for Skin Prick Testing in Children. Regis
University Library.
2015 Mark J. Abzug, Marian G. Michaels, Ellen Wald, Richard F. Jacobs, José R.
Romero,…….. and Elizabeth Esterl (2015). A Randomized, Double-Blind,
Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With
Enterovirus Sepsis. Journal of the Pediatric Infectious Diseases Society,
Volume 5, Issue 1, 1 March 2016, Pages 53-
62, https://doi.org/10.1093/jpids/piv015
Invited Presentations and Participations
1990 Infusions Using IVIG. Film Sandoz Pharmaceuticals
1992 IVIG Infusions. Fitzsimmons Army Medical Center
Physician and Pharmacist Lecture
1994 Parvovirus and IVIG. Rose Medical Center Nursing Conference
1994 Rapid Infusions with Sandoglobulin Multi-Centered
Telecommunication Conference
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
65
1996 Rapid Infusions. Film Bayer Pharmaceuticals
1996 The Use of Intravenous Immunoglobulin: Practical Considerations in Disease
State Management. Philadelphia, Pennsylvania
1996 Rapid Infusions of IVIG. Intravenous Nurses Society.
Charlotte, North Carolina
1997 Children’s Miracle Network. Immunodeficiencies and IVIG.
Denver, Colorado.
1997 Rapid Infusion of IVIG. Local Chapter of Intravenous Nurses Society.
Denver, Colorado.
1998 IVIG and Asthma. Case Management Society Annual Meeting.
Reno, Nevada.
1998 Infusion of IVIG, How’s and Why’s. Olsten Health Care.
Englewood, Colorado.
1999 Infusion of IVIG. Intravenous Nurses Society. Charlotte, North Carolina
2001 National Institute of Health. Vaccination Protocols and Grants Review.
Arlington, Virginia.
2002 National Institute of Health. Vaccination Protocols and Grants Review.
Arlington, Virginia.
2014 35th
Annual Keystone Pulmonary and Allery Conference. Keystone, Colorado
2014 Life Scripts. Human Enterovirus 68 interview for internet publication.
2014 NPR. Human Enterovirus 68 interview for internet publication.
2014 ABC Nightline. Human Enterovirus 68 interview for televised viewers.
2015 36th
Annual Keystone Pulmonary and Allery Conference. Keystone, Colorado
2015 American Academy Allergy, Asthma and Immunology annual meeting. Skin
Prick Test research protocol. Houston, Texas.
2015 Channel 9 News- Ask an Expert.
2016 37th
Annual Keystone Pulmonary and Allery Conference. Keystone, Colorado
2016 Good Morning Vietnam- A global perspective of nursing education. Nursing
Grand Rounds. National Jewish Health. Denver, Colorado.
2016 Colorado FARE Walk Chair. Food Allergy, Education and Research. Denver,
Colorado
2017 Colorado FARE Community Engagement Leader. Colorado
2017 38th
Annual Keystone Pulmonary and Allery Conference. Keystone, Colorado
Dr. Elizabeth Ann Esterl, RN
October 10, 2017
66
2017 Colorado FARE Walk Team Leader, Board Member. Food Allergy, Education
and Research. Denver, Colorado